From c28cfa3a770c2daca7a70536e46582989264c7bd Mon Sep 17 00:00:00 2001 From: "Matthijs S. Berends" Date: Thu, 16 Mar 2023 08:55:37 +0100 Subject: [PATCH] fix documentation --- DESCRIPTION | 4 ++-- NEWS.md | 8 +++++++- R/aa_helper_functions.R | 7 ++++++- R/like.R | 4 ++-- R/sysdata.rda | Bin 81724 -> 81728 bytes R/zzz.R | 9 ++++----- data-raw/_pre_commit_hook.R | 1 + man/AMR.Rd | 2 +- man/eucast_rules.Rd | 2 +- man/like.Rd | 4 ++-- man/mdro.Rd | 2 +- 11 files changed, 27 insertions(+), 16 deletions(-) diff --git a/DESCRIPTION b/DESCRIPTION index 7a1b6ac8..16054385 100644 --- a/DESCRIPTION +++ b/DESCRIPTION @@ -1,6 +1,6 @@ Package: AMR -Version: 2.0.0.9002 -Date: 2023-03-14 +Version: 2.0.0.9003 +Date: 2023-03-16 Title: Antimicrobial Resistance Data Analysis Description: Functions to simplify and standardise antimicrobial resistance (AMR) data analysis and to work with microbial and antimicrobial properties by diff --git a/NEWS.md b/NEWS.md index 3e453a7d..ddd8ef7a 100755 --- a/NEWS.md +++ b/NEWS.md @@ -1,4 +1,10 @@ -# AMR 2.0.0.9002 +# AMR 2.0.0.9003 + +## Changed +* formatting fix for `sir_interpretation_history()` + + +# AMR 2.0.0 This is a new major release of the AMR package, with great new additions but also some breaking changes for current users. These are all listed below. diff --git a/R/aa_helper_functions.R b/R/aa_helper_functions.R index 65c0c6b8..7a973af8 100755 --- a/R/aa_helper_functions.R +++ b/R/aa_helper_functions.R @@ -670,10 +670,15 @@ create_eucast_ab_documentation <- function() { atcs <- ab_atc(ab, only_first = TRUE) # only keep ABx with an ATC code: ab <- ab[!is.na(atcs)] + atcs <- atcs[!is.na(atcs)] + + # sort all vectors on name: ab_names <- ab_name(ab, language = NULL, tolower = TRUE) ab <- ab[order(ab_names)] + atcs <- atcs[order(ab_names)] ab_names <- ab_names[order(ab_names)] - atc_txt <- paste0("[", atcs[!is.na(atcs)], "](", ab_url(ab), ")") + # create the text: + atc_txt <- paste0("[", atcs, "](", ab_url(ab), ")") out <- paste0(ab_names, " (`", ab, "`, ", atc_txt, ")", collapse = ", ") substr(out, 1, 1) <- toupper(substr(out, 1, 1)) out diff --git a/R/like.R b/R/like.R index 3af884ab..fed26c22 100755 --- a/R/like.R +++ b/R/like.R @@ -49,8 +49,8 @@ #' @seealso [grepl()] #' @examples -#' # data.table has a more limited version of %like%, so: -#' detach("package:data.table", unload = TRUE) +#' # data.table has a more limited version of %like%, so unload it: +#' try(detach("package:data.table", unload = TRUE), silent = TRUE) #' #' a <- "This is a test" #' b <- "TEST" diff --git a/R/sysdata.rda b/R/sysdata.rda index 3033c22831bf8e1d541283c25f533be360dd160e..113339654b863839b4cae5ccbabb51fe23b96ded 100755 GIT binary patch literal 81728 zcmV(nK=Qx+H+ooF0004LBHlIv03iV!0000G&sfangir7OT>vQ&2UJ%gRpOV=m zVLY=O$8P(6bs^RCy)47fwt4RM8P?8;^)PqdUeV7Xd8*&(C5Y&cAc)h!m|u~Vm_w_S z@@m14b;A{y>nAvM@;v=rdRWfen?tKpC)k@OIUeH`0u&&buH0AY`O}M2DOl8e7T}MS zWAAi4!uD$H?Bs35PqWNykdGK^8GN33X<@VY4*cA|`a2!u|C$5pR0+3ab{(uQF9<59 zyBKzD<%I!7jw@U0a;fQWe?^h_pA2Yu=||i3Yt%|8&HI`zQF8}Vq(t;dWFv=`sX)~F z{ToaXyxCM8gJ!%>E}j%A9|gpmooPa28eSDAHlXv*9aXnpz1ol6EEvF-;5GFh+i38# zWqc4}Ih?E>23FeCvo#hxs=XB6J}wo>4_(eZ76CobC-@LbsY)!;%wZ)9$FIR2kLq$y zM7PIxnW<84W?m{+R^if=vU=dwE`GTp=BO;Ak46kP#Kw9hZf?n--?n1f-9Pf<#h#p+ zfH?la-(jm>4*6Wx%U--()FI&l%a8eMQH`|m*f(rMke3-oCm9Xdfe`|`WzGNg%bwg% zi!-kb=HeCH3e!?ms~3j*ZI50k<0U zx+g^#?irJUzb6b-?UxKG%D#*%#i0{g-NML;7pfL{)SmI+m1i&9nI z2j_Ct^JY6I`yB>{kj^`j38*HTk?a>KJDT}UcHKBKG4vMVEHD_mGZT+mv#)VpI#G=Y zPd}Q`u2=eUC;~iwpk&D)(*O+SjeHLB6n_=qP(~rb=N4x^I?#s5&Gr1M6XBi^fkai0 z4dRj1U9%A6bb2@QPUqGBaw-?YBuEa9ikqZ<2xja^`aGq<_`!)>r1 zMu0i?_fUyS*ph7g?NITck^L4&9aeynY@Q+SE#z&IqPONDGZU&gQ-(q4uG^`(!m&{o~mE#bXI+RGXr|v1C^i)jaXUYN= z2=E%o7Is^$n@w-y+FxLi8SuzwI@EttCAe=62nbvjO9;^~^!hu@{pjjy4SNhnteVb| zU%$kVS`Az};l|ejR7gJeNa)*qXd1#~;Pt+qc(cCBLBLeF(ODI4c5dK_BzKTZD0t6+ z)s3-hg9)T%;@#|-A7un*6o?f_ ze+7vRz$^znod+dFP?*!Y=ldb=s+^PKwm%WMY>=?Tq#i>y2}qmYsTy>DcJonTdda62 zpVirG$TOt+F-~h~zW8Q1H@nCllmaYRsmDU{U?M#qsxtFpb4U|)A4a2g3T6;`JF2d| zV<|yh6yaNVN=kK;7p;r*lQ;J6jPjealHXqq1X=ds3dCfHl3yAJD|EVLkjE&`VvN|z zi*gBT?wt6dNljn)-wZF&Xmo41z!1$kUlH(1gOR$Xp#hklpp>{%uQo#$5-FPx$lbH! z;;@aIBbB&TV0S2FXXMjde<_{;WFMt{nSZ~UL?=j9e;?Hq@Jz^`y@T4>n@2bK@B$ru z2$0R(OKQ7mxeY;J`@Zkf?iqXW1Ka6iW`Rahea{eRIHfC;;OKaEq$2@?=+JtZc)p4Z zcp+!0Y4PGxp6zy@d-3EYXLM8~o+D*vY~0lwCckG&T|E)ndVG51$O$h7PEw*swqIG9 zwy6wMlZ(W2sv8V9;+8%@97#0j2LYDmu8u8uN%j*_Q;iSo&XH~03D03~3{vQS!la|k z1}ssz&+2%P5Nhr1oU>i#&eg2%8d%dh`{5z<<~n*v6ByDhP6ba9t|QR`X5$R8EB6?G z){TO;1x^JB_o_}O9TjV``YPuN3Wyp%=k-U9OM9}%+8*7&cY2&eEakNzOB`XAK>gI& zD`(yYxQG@Z-ySMEZLZ^=d%`(~z(E+&)ji+%(#C=M^6hzJA{Ck*ky+xfSCQ9=>$Cn$@ znIV5$1x#JKFbIw?vd_*0TWeLn?=}QKTT=B>VrwYv4WqH3T%qJe$X3K~Xh3e*6VB;? zVg=yr1;qATB@|d4>k=hm_9(D(SvN<*-A22a5MW2(n!U&s9Hmt2*~MV1_A_=(6x}74 z&@ULxRiIW*<{2UKYSd+Cyh#qj-0{EFd#KoxV+cj|Sj%oG)7_iZ6fF@TJzM+NEt*i{ z5tVm9msjdRx-gnD+O)~=bAUiewrCx&J`6}1`fGbtN+#xk!D5F-pNsPU60<8mxJM|e zEyNl!;0-}dcE^?$L)D{yqr%^(vw4MsJuC>vGEQo-TvKV>b z=P;R9!AJ&Z^LxX2IGFUBCSwObq4(wAO!px1zfNeXKIG^(neV2VOEZA>At7w@mXZ^R zB+7Qqw38rsTENO116a}c6(Qlhyx*cdu-JCs{L%BSQLc}Y@m1g(?0gZ(TC*AiTi?N1 z;t6i^>4cO^A4XaG0+u{;)@u$1{1XaCtl4?W&Gnt-Sh%?$E}!i~Xj&D|?tbLy0Ce z($)sjM6Na!=S{h^YpQGlsrn_vaBKVUPf&GCfJxG9fYbgQ1hS}kl0v`zE!1D6O`tCu z;#7TOj?YjMC5kW4q;}a z;ad7zVmA9*#>XV$O$-w14~ub=gJkbGD;+K)Uy;rI=i)Ez1j`9mO*v&lU&*gj9 z!xi#bas38wS^^-o5RYd`^B}?u!YE8?t9#L35?Z^&IzqeDe&`mr|wdfqG+6O9ga~T;%%HV zgh;3pskQA^1ATS4IeXyhRq*Ne=8o(my3wqgn*AnLg_R4M=it9vu z`*Y5lPafE0a{EzdJEiOZ)POBi-QX@h>$W2Ql?{>0oVzry^&d@ls(4rR@ntd_bK-X> zC~$%n9Wj@%gTO~6=a3Pa#iD(U-L;`lE_tI9ndXdFD{VttM%^|0deK>}OeNG<@s@%% zFZ}J<`zAS|{uIz|(`@lGeb}|gnD~+BmSr58=E(Li+weN+iM=Rg+9EL~i( zFm`lcvtnh(U?eV|S~8mTSs=t%SwJ*pj5lu5L_b2CYDhg9h5Yad&23N+pPRQ902zO( z?n^O+(UAU7@!wCSksqbcCi%U0H~>tyudm{A=RmN+M9Gk+DD5D5PI#rW>) zWHGhq`1J8i7sF?IuEuykzr&|yP6m(RsN2in9wG7E$}?XHDMBDEaJ5hbw;^_t{g)Vw zEp}b9xJ5-193C|Gtv|8mDgpS=+qbx`C>m|{OZ>do#Y)07)hJmS6z=zpGpfpRlBK;=Vef%Uy4Lz(oM4QObF_$1f>%)(pQWIsu)H{la$qP=3wAov8f7BQ` zF0bFZoe4~H$poS zO;Yz3B|IVco zqaEW}R|;GjnkjQ`FgIN6i9lmKFJ9qnA2pn>f928*?2<=HeS~eMvT5BSpJD;qv!V$l z^QD3#t=NNshZz^Vc=#LZpkP}&w0Em8MN?W*@ zO;v1|m811O^w^zs(1kPAd24n$y~s6KCNR!mkDdE<+v*5V2lj_ltx34V4>8NWCw$Kw zRlV#btD=}hrx4js?>!I!*@-EWLh3PVUlm+D>`ZfUc5Y_&yla!#rwXQ$XoK>q**9)j zc60+i;Z#8w1Af-K*2(*W2Hk_4^8apOl33Zag}UGBKOo5s&;{XdI+59-ar-F;fgh9& zy5$WwCaXcamN>lC?4g{$g-eW_BBW9s<+X!I7!=;km|7o%llYr%r8g2)lVi1)Sj|vG z%}bBOtf?T1Vr8<=wMeS>$w1gpMmx4Uz8qpY6*hS4p|q(wO>6UX2=!98pd%R%H9dVo zB%B!)F6Un8i!|y0)ES-pD#s2z6U}6ISWy4NPn71*OnA8w09Dse4Y=A;I!{mq-RLPOO&Wqmr!_c`1>ddn_Pkwjx-7O;C%1v?+LWp$dXW!6h-R zy?*;dn|5Q@L7rKRfy=N5(E6LB7m01qA`JW6pTb&!&YtFZ1h$k9z9qO!!liV3KErKc zyzpYaCG0ZFH>w}&QxY_vJ9PeNQTE`ZQ@A^c2}l15H{>2xj;Aq&Tx!Vwp$$PZ;Tnm< z-;31s1;~978UaijV${Ez)SUo>MOPi{ZtJ@ote{RK2DN~qoaoUrfv}zxh^#(tE4tHO z-5K!E1X((A2}VkS4Td2vf{Fl|ULYSgaWb2w*h)6fcT?y7-p(%c0;bYn>LMb6l2DEqDf_D!Z;Z>_U#uG4-rc=u zKD?-%rv2Z1@0&1;tw7aPS%&E?n*i370#NOEGj!_9=&b1m3j@I&T%ftQn`)I``{0w ztG+PBXPA1vZ1CV>_v4!5WM;F)xZHvBQUL4-_j*C>VW%fN+_0A_`)vw3wW#+C_1t0v z+RP)`nbwcZiyj6Ff8ae&SOy%1yL(!pM!s*wD7e$&Be&Kj3a?IbZQihVfCH*pWPy$I zDGL{H(!@_PmuUY`wTORVJ{Gsn(0zqyFY+_H_7opcA+7?9;MP&{_)xfV+HG$`V_9+5if16JO+(tEI`|zq{>h;Ap`| zhq8TecLF0d{8&oxArDTUN0uaTQO7PJ;Vk5~Q);^eSC_JQYjWSZ*!h=GAb4zN&;cEb zlb2)E39e~VGb;uG?|}9iCgCVSnw#Jh3jzGP*34qIwwvShu`}=nkQF+EcpdXSc9h6~ zkM_{KFMk#31wQP1OB0+O<4Y?PFOgv(B)`NZ2nD}zDi?yb=C4cxN7VlT*Ztcj1xFpZ z;zk`5FCe+N$0~tT!EKb3B2aDJkIrg3G6?b0a|u1DgvPyTev`l+Em3~)ec9D>B5iKr zh$HWTL(*gQkT18;FLxt#6d+sTVWX-gG@UYX=2VCNwje`~OtJ*$+C$m+E?_g}e84!! z?LM->JrXsbL;PYG6qLV%U5}?rP@4hWTS6#FFPvCYTft@E33h7F{aFvt5(DlVoFY#S zsAwpGT7i`0{N+r`qpn`dF%5y+nYquhrISfW*_7BAJ>*c}qsvJ4G*Rk1hd-&&y5FiH z{ub?S9^I*>np0Tyu?_JhqFHTvqq@*#)5_(0qh)@tg^d$0cP!LRq_&EgRNvbG^ntR+ z+Asc0hKYxpkcKoEHKzet<<=+rd2w072nSd?PsoTx=J6G`NIyiUPg9kEJbfw=Ib(^K zp|EV=>RYA?N*-SQ*9Obpb>E~a5wuVdsu7_YVD7KAJ(-K9x06MJ`+Hr`(;4TXFj6k7 zu1WC?zLIxp8kBVs@Ft`2#wXFHM%HYrvJwzL;y*H)(*YVuWzN2ug=bc~{S^8(DSdc; zePmM8u#C}S);DBtU@8v3{fQ4`JR9Bl^)M$si@9iT9o4(49!xqGbHX_`+N0Hyisoe>a%K7cVdT}5(6(Z zi|1(n~vseHrMuXU zsR)6~P)kVmF=^OJaCjg#m{NWS$6^`vuk5Q;+bi6)O=(8HDbFNJ@o)cNp`(LE7>*of z1z|>H6Fh=J6cI91AOBWsIZALh?0>V8z-pptFXzy@Cmw0NKy@7!C`X&VAnU6oZF?!tj;U`v|L?LwO_{bYQ zmV5AvMSSWX^8mg<^zcmV1n}%FS1BRBt2lhCm@uIemx20>H4U6Btx6pPAm{mT<--2i z?kRqKc1U+kOp*CJjZy;tlM%cd?{UdwohqjTf*%!4~a!mkl&T7j(#fEO+(EFbuia0hp<=4 z1VDF?ZjCB`1y#?~EQ8}Hc|IbG##C?NRvxQ?vWX4*-LzzyqOxRXKw;lh?8rUr-ymhw zl{@_yo|LpPhpEiy@jmts0n9>j}t%TNVw48GUSSSoH;Z&G?8Ue29#>vku>j^e-JOIf&GL+m{s{Su`4~0 z=O~eX30)eBbiqKls+mp1;GU-)gt>QUoyJYy3ENzh+^kz7HV!jJYoBb)mlCrPx8mto z5Q@dcg%$_JkawGp>9YgGSw*+YnsG(S3!rnQGKj1NoD?TvfAk3KwsJ?yE_jPYx>Iy$ zjNiN+pyYqXIHgH>s7E_)LEi20et_ps5e(V3?fBH&bsOa)hloH?QDvfB+ISSN@VTqg z*bd6~oilhJOYJq31Z2A0XSp-)btnj24T}6-4Tl5=4x0jF9ZWBmi3U>8U3!A0_}xq+ zNR$y%6|R+}p}sx~1>hAKRqvrT%wHGN?0X#sS`g~sN_DGwVl1RviTqJi^Mp^M|3V(s z)9lQ#onWS(TmzG+^a<2&G&VJ{3Wz4Hr>(@cN$}$*(Bj5G$cfyhCkrjL+sqJiS)?9} zWBX{4@BHDh@M$SNT72&g>`7XxE{n_u+hX1V2%bjdOTmvB9#4@%mICS{yE~h53f+G1 zTA%6S{59{G{%*gN56&=&Q>tT^50fnEzuv*J+{5w)oFHcRIdY(G_TjuyQg={?A;r)& zCfAU<1LZ*K6-*Ib&N3z`-QA464sSG{qe=BrdW^E@n;~oKh8Hg$ou8Z5n8`@X5Vq1m z(KZhBBUqm|K`;K!Zn(ANL=JTqk=yxfI1kN&*^gi5lSe##X>Q*i3M`YWQ*i5fXQeS1 zoGnXl!}7}RZUzeOnoX})FQ1Ln#XP)L?TCK`ia%=UYSqBahzZ2q1^>WvDTAnt1oTLDVxlYRiK%=`6b z0($N-M=L~Kn9-l|^UK+@r#koJ@?||6qHO*mC4Nutm}A9sn-5s*MmH4%!pxplb&`i) ztRRErD)^9IP8a?cBRgo=<74*F%;$?gBD8Y_r1P1@iHq(3u!@n>D{Q$4C@zD=n5kK$ ztMnQS^Dt~Agxr!fAkFr_?$1Bt9X1U%1OaS`zQXHfxkL@G#)i_l zukiQek-omv*@sv4a+6b;9iO9tTyc)2l?MH^ca*kQGU0dd_L<6y*H+kVaLHq(mK!cs_sQygsAl3Ort*+Kkqc46b2H%2Uw;7x@8M5)1ud-$9LLesLT z>J5DbE|dCto^oXYWNwChm|0nTheH{+(1au)#=|AYd;`T}_%&G?sJI5EB%x$4MkZlg z$=HU)m>IKX5AWhOp=kCw{oonQn^$}>n-wHfs>#;k|23lx(G(SszzqW@dRC#gzzwt+ zXe1_*Y!cNv2Q0XALB-|#>d0uYV!}c8Bb5v#zPP{{F4OBwcyJ-GCZv4J47RNy(-&ei z(p}AxB*P5rW-&osLO}pa3cC+2C`KWb#&DhqpwCg*T&Kr*APu<5Ev6d9L9(F9L5;)| zSMXg^Vxtw?!pEI-w;nZhmU;&Fh`QV$Iz75&h<6qh1en7^tjge-eSuW+` zl1d0>0t2sOtsO;uw>;TS)u~4BbK9)DSv;@Q@@yjs_Tw=Pu~itmeiRHfm`%R~IgwC?Dq`I|)Pups9VoD}htlK50iLn=qpBpHYih-Wjq z+b2Mi27Lb;9EK5!>?eGUWj1RMlv{Tn3&Bbt6o!oP)+d|b zw)QA#^G;WevOKGB#gL*Hleu)32OA`zsi=^;0x9dwS23)F4{(2PI<>E0IKRM!5oQzN z{40+1b+-qqlQoC}Fb#maHoyA&@@lM}&3?LleUSSZK#J=*XEh~$X90B8BD7|cyP)f| z=eyhuq`3g#iI1BzXuE|DdBH=TugF1aZOSW!0shtbC=johGU(na(n8bqxLNb(5P3v;Pi?fff>nHJt9sdOXLbDm$O-1-?@!3E74=|yUP@_w-Ml)J|)EF(+3H0 zfv1gF77dnRb7-qQ<2EBy(18~_vkbZ9h`lh-#@p!cZ(MCmt7!GM&t^cF)JJ%33!U)f zJQ_+GM5?mn_^I3b%3Q6Af`#3t*6O4d$Hd}0=hNE!0~7mqa5y^bkn>ce(4*6n<1FdJ zu72kxIG7Js9@7XSPo#e(v8Jj`80>DRI>vKID(#jcJD5V(Kn8Dh&w@6VT59Y(BVEx* z!DyuqkZt;jZlArio^a z|FEc)%A&}?zDufR13ruC72(pKoBJnePm)7FOU;W2H^sh=9Pq0ywi-ZwZ7>&rhS2w` z;$=&1k(b`*^Rg?_+=>(MyrY%Hbybx8orI1n%}8|=HxU%8^S=U;FuS9cu3u%6GnBJA z7b6y8;18@?&9Fe82CVH2c-uLYO0j=_1FN6$H6$&7n$hmsuvG2*?0W%2lYVL5Nrn~4 z;5N#E=4*IOzJPDFZO&;-ji#H7FzENXg$LQBZ=Y(L%ekE`?_pSlz{O8We}Id^Ja5CaG@t&jfRZD9mz{WQ^pr+3%d zM#_7|;y03#p$}QTwu?LC^O^!aDiq2bqSv>~Xo(>T9(eeDi70Z+dylM0kt?tJH74*G zLN$9`!ShmwMJv=lirhQ?Gp$bNif(7X)&rrkNVic6QgD^I5YCspx>wkj$(V(aFv2K7 z?w;T^o(QEpIu|G~?2(l?2dz5q&eU;SrJ^g|Z+B(ZW`82e)$)uzl^lR?ym~ol@4{Fs zP*d0SpfA^sr@%r|s_#Xk0u7r*+ON|I`nrTCU7ej6=5ebHgZ0#^(&22iWt3Q6J3Kql zo#hu+E;*~hV*<1Q50+MznrUTr+uWcN7qEC!th_xT8nQu8az7BUFA5H}uW;UF{UP zz5|;!`*{G_`{n-oVwhOxF=Vo3b^m5jI#|v0RT47@^lGB`MZ0Q3r}ON`^*EewIGbG` z%@#HcK(S36W_KklS6lzYH~b7=qI5q+iB}VZky|P~hY{!?e{}~h1~~hyZFG(Ku|*9z zHgD>oY$zJp9a1QGTeLwN(nRXS97?)CW4$HP6yw}(au#M-Q(7}EbhXAiluJ>0z2;G| z(fe$EW7<86`1k)(lgEHXn?NUcYU>#wHq$GH`g0QA&|mf%{`gxRDKY;4UntIDOjS*E zz9+<|cxjZn3wzlI6c)=k2e4?aK=GpiklId=jtl)0Ip{oFF15#*D$#(?)zzQ0iL~J# zEcr@Unkb9|Y@n9|A}0;-EZ{C3DF^!Yr%1z+=zwtE^}3kO?usCSI7K~=fvGJ@$#=w*R^L|0 z@F0sK0~Cu5jPy$@00F}MRCH&y)Jv}AJ1VuWzTz&ckMQW{d`2}U0LMWw1^LHv*9_oJ zxv#P3wp&J?8TET{?WLCa{-`^HErpcbIbd>gg2jb>sMvL1+?l*C!O6y2Js$*TX;Sq$ zl`sDQ0^P)c4bJ^5xsIw<&9t`HLt+1&T+1l(I6J6&Ne1aet7SPO1_(<7(h-vzwmBCR zxlUs`s}QA9L1!Z10P1ron%-Oh;^s-%nM4q|tGM;r6EoJWHa*_2U>}r`KWs3;!>f1)5V#uUKgVIx{scz0(pfKpeh~=uWr&Se$@Dl)#w-2K`YD<$wP$~2aScarE z6VTou$w2J}h?bf{L&xEDQVQmJ4#1l&l0qY>a}V~s*HIwie-+CC;Wqd!zNezt_!PzC z{h^LPQ`es;kKL7-jCX8bCB!2tfEKjVSQ{vuO*CO;kUhX8d!!+o$ey-5W`KLLg=JQUlcWtCEJFb^tLq(MQK4|HfvsICpGR;Zbsk?dS=peD zrzwo}WAsMAL&&CxVK_6J@m36xi(7!(L(T)Ur}M#dv{OPAbn2$^C7n}o?l;rU1QW>S zOp5rCgy6yd3IkZ=GmX6v&Vc5;rT?lyCdQJPmkp<5{!^Wf*hd495-7OM>4hLsyuL2( zQ#F*Qru@Ct?Fg|Tx`zJ*FmXdb`Z`lJnDdL|xvC1&p|_99=u({LRwD)4_!AY#PG9#aX- za<%|BaNtaO%3o5rgd5$XvYfAe@3GbWr(NMjF#Ag$-_5+d!D%xQ@j(QPkoi0@)~8|1D2^J@zCoPcXpLzzk zC+F)I?LSMNdW-`c!u)N)J>W&^eD|YnuOU#VyHE}%rkQvaU)d=r@4;TsC{G=0C`Y6* z2I;;#zJ8YxsjEv*7{U5ZI-XB5r&vX7OzU$%nFjwzrrjZ1R?0!?MJii73sPRod1A6W z(M;!(f~7M>DK|cm!F#$C9eZLT?WFbL`ExEXVf(GK0pZY1vt+y}(xe^#EjB*PGB#9^ zfYbCsHs`MQisu^d>qlgM34iEjbPz8mxPcKzrZ!ruJM^kW#Zof|=3 zHC$82(67ne20*o+B5CXUu?`_Km8YubT9Nb^$jOH2C_=|oI@LYm`RXjT2~5h`-USx8 zGJt+w#)+@v6yUaJj*RsrmY-2hz6!UQOXg^BAwEK*&fNK?fd}!LUh%cin3oIJ3gXJ@ ztC|NgVMyNa9-9+m3d#h+OmN@13-5Umy6`E%3V{_i`(n-96{gu#)c(N|)Lf2_>Pq@&C( zPenX|Z5`EVA81LzX0gOhmg4%n01F5?t(;B}xwv7g-RDOIpJAQ%&LBm3aAfoI3Y8d_& za@ae#c4McBb;3)*$zgQwOt?E^f(u6G^@cmV0+1b-K1i2Xfl?-G5SJye z{QD6&qffdSre-7+>Oag&Mf-dVp^Q@MT0i|@srsO`bC3k~v3+Fl@4MO!aJX~Gx0?W)U*ZL9^p7KLy!(?DWB-4~j9 zkBW{X*T|_yz&Nr9M!}zZQ94FZ4KMJogtbe=`BOn@5y9(B>;&R?92yJls2^l^rqBE! zLlbX1w;r<%H(C5IC9NnJZ8)u zCsMhhY6>Z9Qs~y4=w`eV%gq9^2e!q+`Fma$I@ z$d=jc>R79Yc&AcKm4XNm#btqJuH@h*J-@OSIjWp`rC%lyXWtCx4mdKzu}?Lirknen zrkQ%yp(<>$GT?IQ(Neqpx$Dg)yNWHBznBbS1$C(7gFJ?SgU%F_msytF!!I z@;rl+wN|<~BfHqe1zwoI+F|0?UZk{_BsO;iVzSO=rl0Dck7G z(sUdi9_u!mR38BVmEfemX2jpn%@cYKy7674JpR%StOXb4a1DY!#7wK4dQI2qEg&SR zMsB7FcR3p7MbV*#%2is8X6(h5RFVo%U4!fS5)d8f(&rQMj9E3)_-&B;G_|90>o;)D591IHmnD-}R?670i3|p3;Z+&4h7?heScVl%`wdp3 zAVEefin7YDOt7lLs3X_c?gFhY!lOq59z%TZAMwf>xL;F}XO@@Cnx@Wp*p zL8&atBS5FINjqP&AO zT$3A$zz}e#WC1~P58soujix)+tJxmq+}_DzGloF8V&|LoC5B!<_%o_J5WsDq>Lr*D zBb2ETKnF0BGN_mzS7S~%rvOP9*C1}I_`DpW14XM$5U2hvG@gCudD*g5)(z9*`MJg% zdRAbJ1qd24J?>ldb@XV*#IBtPoQHWR@@-U$4PGt{`uQbS9Hx%kNuUDKmyA-TBRWw} z4yCJ=*xrx4W{@DBe!Zjef4y;tp&~oI8Zc2yg}>hIwaTr4)nV1LrFL3eBpBL5c}c#^ zv#`RO{3!?UEt~r=RL21%IRa=L#A_qNjxPWm0YcSGApK!9?@-@Y4be=kOSFiJ%?ePS z*ZQYwp2I*HoHI#mcfd;dl7{p( zRn8~Wfppk2n64ZMzvX$T3QEN(FK@Ji&$0Xrfy@vy9HKaJPWqR>fH}b_3?xlWs0^8Z1qU6;2n)x0tWaNE zWm2m!(G?=HmA*-JV8nt^va=%Obe`jVQ_d}Id_+v|1CjnQAN0Hm+xBA}Na-EZ8?|$f zo{Jli@gNO8xBj!RYcUZu-J=iy)9OqyLR9b*^w1!lU4@0%2x1-0y=p{=+v1)k?XOp5 z50v?{G3nMEgKoC$(!tUS#qV3!_10*hw@Nys|3CU&uKm+raKU)I3xx#c;)YEbzgS6% zRRUCzg7(~o$+ZgEZ7m@rR(WeEF+X~qiL*1f={sQ!LhJ3;<|EW-9uQ13EChes6Jo@ zyC8*jOSeB!io9^e^HQag(J+_ppo`u)-iEy;+-HzjayQW5F?JE!B12jZ0{* z#19cL?Y}?TXZNo>7Io8%!HjQgKbruYt)~AEvbIlgfHpN%m{{Vw&@Uf4*8u;pdShsf zE5JoG_fmZGG38(Gi!N1(T5YDP+}=8$Pd$Q?W2zIkN83xT+LmB#k$$iZ3oPdda$h>V0LJTFeHIm9w0BJ zOT+#6>HQJqdh=6A_VviUuWd{io$@1xj0Kh@2`wVCct+wfOH(bWlii|%DfVE zvly%t@E1gw#}*r|>$lxNDpE1!Y%&g-;O_?j%wVnpeHiik=Q`=Y2w4L_EJy>P3AXAmkuj>SLV8P-6wk{m08| zaf_<2D>%#*nY;0LDQbl`aQ=C#Vn@c}2~vNzc78t0>?H&F%%I!+Jar~`i)`dF!>4fw z^Ylh|B(rF&?}trHgyFxS5u0@l?>-pu;H+b)@Wm#R3PmazpSW`@ER;(j?-%{fO6|rt zz(#^%^(aGdp9;NNxcC)WfRA)u`A9Oo!D)ecIV4qc4rdgO*l6h!8x%`K2)ThT3 zrhp=CyKGY9)1jl&7(8*ws<#RsB;9A_`*b=<+k(+y!a&kLoc<+&DvmJF07H@`zzfkz zBic*eH@J~%<0*=9Ox(?9RnN*K$Cb}Ao9+a_ zGA+4Rn@BxGR|JkGSEAN4c$4@latVl9N7N+{l}7xNXk!6JhV$x(zC*0LNCbC%hEOo8 zYh_3=1T1##Gu_=VLPScqSnTS?8~f@4y#m{p$v_HvS4=L`^nNd)EYi$NvRYKK9hLu!kWa8Z5AMgHV-+2iU6#scF0R#DZ{>CDa0(JFU(8omxk98Zk?t z!dQk=1gTFI87fdLXUckz+#b4#xTBBc?nnDiZC|VN{*OI z)_a7!j1UYbJJM9kAzsNsNW*t{v}NaG2NF!E0DM`Y(1b z6!Ht|*0QtAU+C2zgGHDEb&MxA2D?3tkCQQgAI(fBOyJ$W_y!}>Ro+0>#G0o$*H zxR`j>5Ose<9DZE$Jr5Kyofc?8BIlsIpz8P^;d>3}?6^8vl~X=NPc;(mLLAwPzuUxT z))i_wyyPO{VOs#}tsUxGNm}GK*as*pGm7_`{m4>(6Hfm~qIYZjK5%1zTZVjNE%p91 zdAdo~QeP|L>fAqa9N27*_mQMH^k`7LL|n1jZnynZBp~xVHg-T5*`-8XzEQ3%c;b=s z&6@}1SQ~&7kZ`|G4nN}UB+}e7Q%Yd&zZ$Q0$epHe zI{U$v`ak3e$iNa6CpNi!WYp+OBcdZ9(?Zc4;Syn$-GO5`tZQ5Gq%?VkZL&iS+Z4)n z!6PfLIx1>bRIa5;Fy3Wvgl=AX{!0?ohJpS@2X%&!59t|?knnxsY}5ydvB>zllln`* z;6J!rBolk;vT`_jv9|LxjcRkuSQR@dxJhOZLBGei!fQA| zST)fPNbH*PLJ17Iax)uxPTyKF5_Z2@hVyN9!sc6* zjXLL08x{BS%7V&*;YGg$#6(O&0wOc!f!c8;5)DMuue>`3RCpKV#Akd8UEt^J$g=18 zl@=eJyU|X|wrTNu!jDT;ZQR0g_1UihF;xYNPSIuI%%hW!!0N_6DNpbWKOZ@7#orSY-nHE(U(UFRsV_(-xU(IE6YEwl3)g<{arm7Ce6iYD!I}^6 z(qRq5CJjtu&clJ*Pl3ZX^GMz@yg3rnC+S_S#BkGr#G}+j3~28A0^x622Kt>dK>a&W zseQyX#v^b%qlPozJf|B=26;3(GV{e(I^rd|$CURMpE;ISh zv}wn(jNPf@DWJUTN-wWMK^Yh{i+uciB5_=}v`m`o9uztPb*obNF^X?*AuwX6H4`z` zy2uRc60L?zZC>In2Xsh6Ebvu{77kBZB90v*YxXp>Lss z+^-W^&&9p-(M#Q!#l?edtKGmNOTAUzy^|5nz%3--D zb!;IH$R^4+=f=^WCZDS|up)?+L2N9-_A;bz`WY6^!o^x0!r-Llr*ysh0$s*a`!YTc|j~L1gVXb!aDG!#m>aJ2g0z- z;x5i=vIj}b&v9$qheYkns2mG?xBi06mXh~=x3diNVdOSkTzgD#`a`3BO^VF4V-)0g z+uCKP1d$$E!P%6pgeZ&H1Kbg?>D@y=r`6<EZ5-Dt=WTUSCo$oWs6%rplkd7RSIt+_@INuLS~c>UMP^rNIoB?ahIYfwW^Ae< z*JGw-k}P&{-^D}Nf7cqIpvInNtL3g3n%t5Tz*9B`Zg@NiSDB!zU$S!ciA)5W_40D| zhb?rlh~{=@q%Tt^yw&(%&k5|O!#$#yB+bjXKa+3ZhSRXS-qVNEyrb4DSyan3(mGK6 z*Lfhjxs&2S(RKg$+GIQw>7Kk)^khRP+se_U#D{juW+z9M9bAMY`H4B5<9DG;BQTno z`Lp*$wFE`oMVKGyktC3!a@S(uC%rgR=5hbA2BVeU$aw-Hj$>wGPjC**`X8$C5sL;> z2WmN(-16AtNXJs$@6c%`8wfCu!)5&R^%&Pf?05l zs`#aMn)+;#fcio4=9EYV6!;W4xA2<}CHyX*r0Az!RdwNFC4 zRs$t69z%^2uLZn8+@*qEiyu50s5=bNx=?6~kgjthJ3>hB`x$3BiYhe%x2GbVfU^j(j%ibLOhKjE@RjQPzFP{L?!;ld&TnS^Hgb&%z$@g3TKO;a zb~wQRi0*0VH@{R+$_}}1t+6Cdjd?N*@@CNiF-mn`ekk+b;5F_ZIPvQo2$ zw6iO6A*~h_T{zONj!tcyZNr$wq7=)LU6>(W;60x4?D^(EwO`A94FsuvVB-JP4RwzG zM(|KYRNdXNg4p-OYx6EGoWEPqAWdUgY2^hC+(_%s73mF+&ry z;AC9X zv_tbN^RLPYRN|;l(P1vGdHWEDec`71;zM=~;0dV@IeH1hOO0;`MGo;Lj3C{MSl)x2 zdWgwX?r4K8f}G%tEROd8GdA%b>rMb7i?gqL)3b~C|14^4+LxHEE(YDjWiwE=6|j)k zdrh`^ocyV9qMd0R=)mkb zqkG|%BUA{tA#Q@rba5zZq_2(yp`zAR51V^rEXj?hXH=|rWZ>Zt@Ha^17;Cvnd zTTi=zcd41FS@#~iSE57I5_t(V%<6*Y!l>KCpl9k_6N9AOj?9*rcdY{yh@adnQ192d zWS92KQcV5o_n*Up(qhqZBCXYMf!?bnv2b#PXYZ5@Dakab5lX~X2zw@hHna=S(o||4 zVz|dMP>p{u8uiIJohs-!XT)0*V37p}PZP5NSO1?FcgC+i_Md@=uK0&)lCpbP-Dwih zzR#5|?;pDILrvf8Qvr>PIniAI{9(>;PGx0!H_rDS77YjIGByn$ZXPdpeFtd?9*i%H zv3*j(nN?c?`%pEBIlIEmD2|n)Q_zcMv_qrWfn834Fe8X603gaIva4-eMblrH%#*6$ z|C5q;l|hxfa#r{ItQPp2g&UV^@Q|Wn%Qp!~D=6Al|I0n+6BwcO5b4LgXFa`RaJ(Au zu!OMOhKR?-_;Zo)NVNhI1DFz8r8kXvhfpXKR!-5L(2-T4N=QjF&D3agB(ME~TJ3>I zM)hp9QpY%Y{DCH*L~y>uakG?=a(kb@l_c7)W0+bjaF|Wv6ntJxa7?zeC7QA{UY6F;mzHT(Bo^8l5*!Y z*U5n}|LGcsUrxHc=ho8+ng2Ed;b>9B^O0+!QpSkU^$BO*glw@WIF2@ zAxN*vglapwllA$9zaejsJ4q=88lG)I%dgUz0&$ z8Vk7{fdhAOd#FMOxoE6E5Bp4|pM60Jb9IDoO`BSfA!J~*q54z!@?fe!L8L)}GG$b| zww+XgoRc8{vF&tC2d&=2noqZ3!ys6~J-va7twXCR$ISr>%;rSoErdRb^SbZ6m8Ew9 z+@#Vpf*1_EoPjm4I1Kibe^lPzEnv#p1_eyJ_|iFI%ge@22wQLA5j+>wl&)ytTIQdq zc%5O)IG6U~$+r-al)H>9&kS+m>meEEYh%L+o%PPTkg_{$g30c>fQ2TGh$R3qPtDL& z5@}EQ3kETNm(3P7hz#C&^W_M}w#Qsuj*;v^am_?5mWpSCD0vg-`mqBb32be z1fTFI#ucPWH!%P<5+p@+TEcjZRj6FWRS0)_8FpJs)gWShnAQsKD-5>Pi;e`pqI++s zgBCmoh?yU!?*$Jy^Y#DAcF;YX*+N9ZYPvbG(?BIxU*dawyyJT42{gH^T@!E>xaHdwUFE=~y^B}&9;M6f z0!lucuj5NU%QoOe?z)IXt%np=AuX2WGi2WsXbMop6J}5%RAd4HPo)%t@x-@S`#2ct`l+6$QwGksAs)tO7OKfGsu~{M8N*xMHc#rgqK??oV0NeYDa zK^mCCbHXAWpGj&YYP0p}bs7HV&-mBYS!>XZ8c4eM##TRq{$XU@p7J#!{^+r6a@`p? zsWR(8EjJw94me#Q`pcCdJD>cJZ#Ev?`UH*J$DI&}OvY&##f#G3gR_Qn^y_beDp;{= z);uXC>{imey#P?m9baw*bI7u#kK=H!S2=xwSrx!Tepg=dznpMR`k7?^P|n2xV(VDt zcuFGhzm{2A!g8lr?gFv}SF0gc9rU|;L(^g4vc$~Y2GiS5VdQn*(&D-0A%7dnW;KYx zkp%g%)ib#`{b?Je-+Vh|jeHf(J8{EriX7JTI={jU^Rs!MZBXAi_H z%ps0&bT;V9E_TT&p@a2SMIG;mk$2SeMy@0TMAh9Uhf@tW)hBypMoaw5-fct`N?z>c zjG((~Le_Dgs5Z{EcnZ@-RkjaUlPSs$P)OPuMj&jbX59M}(+?%0djLV1LRBIIi=xJf zJz?S=MEk8o6=Y~U!;K%Yco>F)pG$3W+_AIT=X^Zh)n*cYEI-pOe1kdE%H^s z=BNUgR?HHa=?7uxNuht7ZV4?}ZnB^#)NDRrO$@|ZBKFe)0Kl!*@Ez4{*sUpZPO$45 zcc{cCj=0}GQ8#0!e|soHlaMSG{I?aE80Jm{wx={5OV=42=>1wGq!CeLOjzH^v_&u@ zB;xHU^MOg(R()2&FE8m6pn$;rO(gu@qf};`nrn98MIc2IAA*Xrqy5tIZ#jY34IkNo z&wlM0+ys9;ag$_!2a0_){@s!z?w&&KUb-0%l?Fx4zM#2=nyR#0haWc3Ysag8>!w}Q z|ImMMN*va`8!zieaB0;}95Zt4L!D6HsA-flX3k*svo9UR(|-#XK5w=?PnmozP*71_ z^tyQP2j}GzeAI>ob=>PP4R8*ix3Y7P7v)~b3vHAr$Ysp&l$H8%S&+#%WT#)d zF>rw;`qId&<&*G4GJK+BTo8w^=rpULGZG$EkPk!h%TXqedqBgGD2Lw(YAj-9*BEFX zB%;qZE`~G<*=h{joQ$EC1KG*Kt)MEaMfl=K_5PI$Uh(3dDTjw(whCET#3#>AbVRzJ zj|>~AvMG2Z@1fx%8pzZL==c!-TNavZ5#2s546?!?XSEW(b2=jLo9MLqeGelPkXb{= z10tCtDY|mscH_+T`EPn4G8Qodh= znU@aWG-e90_Vh0)t+_;jP4_`VuQwbt+aMCpxgzG;i3>!}XqqjO9ekxT>F8Ddpkk9> z`lgCg4a4YZ6#HN(M5xuq4pualt*@@dkF*)&n3@~aikQUN@! zEO{7`_9u|5+Uw6Y6^~=~NJHu}8`Khn#@BBlhnp4*{_N{Id-84*@Ws=??$~8J?$_eD zE?JUeiACiOK<8?n(s0c&4>ehBBI)Uy@^&z7Y?313}&ov11doMGgE2u`> zulv_8c-8vpx>&u}PmW&6&p+8hePM#G)5iKI-(vchlK~Y0IB~~0ajEx8oHN$Z*s2=~ zcXEO$d-GuQM^&wJ`w@Vn1K=UJ&tZ+(TBYo-poMXhzQ0S1%0xI<5PA~lM4t}6|9*A^ zQAg8WP1U+Nu#4dPbL`E;a{9s-yW3n&N;)T7uI*bg{O_u&Nk9ec_{{cM1#6^{oxZ6U zgnMGSaR+jdxZ6?ldidaHf#0Y?WJmo8Zfy=x5IiE9rTW9iA$RN|k_OvGywsZfpMKq6 zjl6|gA-88&jm9{NiC{B0AYBcA1J31J44YU< z=Lx&t=M9KMz87HZ9dsgZPo>XV*Ec8ORLB5b)+D4p4}2u6SLZMbUbGCCp?dHakt~Xnvbn*V&zU5hQbSzzxAdk+SMfE5ju84 zxURMi%Wp*6$f5CG#FNg_B?R@E)s}3$Ju$Jlc17Bj#aaUvncf2hDpZ3`olYG|E;<_l|OS=Bho; z#>#toK*u%O?7R3S0Jv}QFUER}PT0_MZXQHW&buQP(KHbbiRO%pHRY4vSWiPX>DsHO zN`lbpC8s7yjS@jnR@DU$F6+jsH6d&EgYTiWS*SPG;>gDATlCt33BM+=*Z^Vg5=NR) zjRNATLK_&F@1|-H>M9bDP>Re<1l49rUr>H-pv-DS)V9zm`NBRV=1*Tsx8krwY$1fb zQ_K$YjI8RtwRd0}N0VH!RtKl`z8@58)Y?0z!y?^Fa#)gxA8#*iSmTBAf^A zdI=SywRr{R2`knD9#KDZSO9gNd4vEmXKeF)Zl|reJ_WyLg_e|utfoga@pcoIAa{(4 zm?*iBdGqt-64sKu%lIP!k9lmQ4Qy*vGE9J0YBQVSILzAJ6tOp4d&&<`Ix_eWIeFev z6zW#IyrTZ~29W0%!M&dewmoriKc-;&q>&4>J<4{SD%M*7vX|b9dmQQePR+@A`P78F zutqCbPPSJNe^;UL-FUyN(Tj_Tgy28GK;9Hfh`T<`UB(I=y&`336zfyyt35Z_vUewb z;G)xYc)&2ftEO1$KKrVA4e1$n)#_2@;A+QV+A|4W1AXob2MDG2?LL#-Sh9Ew4liKau-9VOy*l0bt_ zrVCJ)8iEiYltWpp7|G1g!Kl)EayGP`$Hsd~_dd=o>2KtbOkIs2)_Pb0x9s>IV*DdbPWHYM#f>W$d z6I>U6SCcP;X3j8CCbt0}20%CUT7oQ^UWk7$K+#@^yXq+Aw?^c?#Fy^9i&q1Vv-vl2 z#gn@jHYUz#bi%hs^8Mt?UnSRvE4VF3@TmfB5^$r~^pi&7vpKmit7xTT6cwaDWx&5X zq5nW!DLy{;)cARy7MQ0!)tx%P<3dp}h?y0hm=6r0e;mO9_DulEaKwS6Bi4eVGHoK%u0Qs0Fyv6H*cY)y{E4EK*#R=h)c-s;bn7LCY2_4s8BzUQOdpT)2w&* z67qRz_#{KSV#wvK;_O^g7IbtA6C1W`)0n>nU2ES0xT1JdvpBE*Cppzv@-qo}uk| z5wjvD(|V7(dXer@b#zRTlcs%&26aUBg(?d4nBIXQW#W(+#L;HUuv)Jd4laJ zN(io3pXv5KLSV@|ObWNwWwBC2>^CsSaFjs|)T~`nT-=i@R{rnmZ%#*TPTXCNMihQ} z>U`sf>0BnS+%w&nZ{J>}9MA4Ub&FN*TXxA-ps#lB@AHNG+)WGn`Zx9_a}uJRvRh9U zp&&QFzOE5s-TX58m%_yZ^-a>I25O^Oy&1LNXSmvTD({sW6qbgJfr*Y9q5}VKDIA`H zxO~{MzcV~Y`PzpYkPN zif4;!rT6bK2m}WUXy{OnpdkFd&Xr$|P&$Hb-)s2#7C$FJ|41T2Ie_|y5(HH@7RP1Q zc(c6Xo?9J*iAswi$Q^&ZsBuQ|q`D~&y-^UxgL zOVNPhy})iIT@$P7m|^G(5R z&BblcbakTe4vGZBHAF;hW+#BRh|WCxr-U^bEYK0w(wLN>&HD9?s9NDqi+*{h{55(4 zrgd!4LdIi!?b2lg^qvae6k+7)f9EekDnPu*KI6McX?-1)5SwnHaw0nnW=Xg#>{Mp` z-M4s0-yYy2x@+dK0GkAJr0fP}QQ0K3(R36e$OXr-b*avZ1bO>u@{Fg~o|Lc+PbLA{ zkQk9cfx-TV+iSV%FH-J^=Hi8S8u#wADNbl1Kt8cF?PBkMk>;(dkQ$r~rSWF_tN^XF0vl-JJ=dFT6K0X)>W&B743M55Z2gs6lud%Rw)8$ zEv;-aM~{oOf7FndhIOH7tBoXVDjPHn(WPv?36@%kIU784#F)8G(^xRPC-f7Mf`Zxu z&p&FXyT!Ix9I^0J@jog938!yzQt{>H+N27Jl@Hxrl?onBKg>wj`+}o%^^QQthvf4h zhx2NBK&nbHNHmOF4W8{LJ1Q6Zli;&`wVesKcH7C@i`$!gEKu}B(a_+Dy%U}m8LKqNO{L`zzM?=`VGLc`Avp<-#mC0X+a?Gs= zx>`k{0s6UN86C&^l+ju_y3WR5;V=YkR-M3=XYg>vh?8bDJrG4`-?l-|sHbn9-SAQd zog@)pm;mK+I*FF8fO)S;g?=5l;%4`!p!!A#^jlmq=%a*82VC_MQ+!v$sd;z58!AUN z!$WF(-(-Kzn`&LyA|;!ymP$_kq+Oe49|^0Kh2 z-ok(*1=|}pY+kFP^IqridVRGh6v@$PNb5*NksB{3yV}3aOBZFVQM>muO~PB5DIu(XcX8JS9$RC++33z~zWP@i0BL$)yw2XAO&P^8{aw_6s3 z?^`oz6n2aCqr<}a99hRx`_ml#9Q^qPQ!@X~DB}tD&(wZ>f}i?dz8E~e2*&YMOrB-? zZ>x_8cFyqzvYg=&m_Dc(?eknh10X~6ub=$GTspM!xo9mN3p$N~>D3_#FvIvVQ}RUx z4!~Jz&JdI5L>#%TOegJFKn$Ao0qt0D|MfB^P1VHMApvfIx^`Y!>2Vy#H$T z^eD%Xyrkb%jDtyBx3>}bIL{RR{r?gofm%)p^OAElGT?6No496ZbQ(O>dz<$g@v1gH1hUeQ@;S2b!Xyd>shz~CC{kS`ld^01foo zucQk|RF5m;0H49L`jvb!qu1i4STAtPf8+z2voHw`{_0)$BYg*p#B3wKUWy1bW2H%w zg)>{YzL73eDPz?73$}0Gbp58&@&d;}Kv6(OU4WFD7jcwUDFK!MjrMe@3n!BuOJes( zQuFHNU;I4H0PUbt!k$+0o<{*c0{~`2Y#?8Fr*p#hmX?3A-&IL{N=nQ1i zi~v}^=W6wxtuNR^oA`Pn`N@IyN*K!~N>$l(Q`ZwNfygFn8s6}Io`?5SW`LE94PqR| zYE1vMMlx2;K z-2YxDraZ)!8L4M?gK+MR8&Q?{R-f){{W##;j8Ye|Lk4JZc$_M*#4QjCHPwRy5KZNW ze=fQYzzNm0SrB%BpBSKwhgK_cKu3MO1oNuZ6VJV4ep&O-wU@oYW>9vGHIqlsb*ilGM0Nx}r|C_csdk4firZ(KBC zv92F0_8VU{K<0Isrq0gLfWMiN3hdD?+C)^Vn(QV?x6;wNP z%39CJPbu3hayrICTF5*;TN60ym3ljI9i8ag36KHVrWoUxtn7LA5b_Gaq zoR$wUm=i%@3Cr?!ki$f&o(TJBcKq~>9q%qa@YrcDz^*7+t>zCgW~buXj>!WcJzo>n z+96Q9-QnIbCP}E>;OD4&`EP7$v<~r!Omlo$CgS7UCCGJx#8Fa4^d+ZhD0mRFqrn61l;H7+OQl$phUP@!qF~U7~VkewMKr3xyylS?*T}U_*dYBq{m|9v3V-%?000Q zBVh;JcY7`a89{RBNi>q0f${1<%vk;#Yy`8jLvFreaJJEB681VE&Uf7qVp1CFlnEG% zZV1-m#jAjoMu1xlbDYP`7IWUO)VSS@;UG;pH;xqB>|{mRL8n%|fIm16KqZk!)a|+5ifZ4-Neo2LjGhhe?6Eg(n$eJPyOAp9|^-~&1uYBBqB{lrHp zcKVB8R}>qq6iiUrO2!8qCOc@N8v<3RO4A$t_sK)PmpgI>@Un?XUxnbSQ(R&pS=A!LqLa`F$1Duwxrsl?mdpjJxnHCxk0Mj|(l-~@BScn4y(e{EbMlhTVvn1bd3TB&Jb-;w;{`h?xKX3Qx z^g4EKornMu0Y^g|lpC7-^8qsYdMs9RT|}yThdUmody5mp=x(DZ>F>)xfA)eDMWfRcht07aR;MeW+UG>N941&L_4R+oKrF#uVynZWpZhuF(JzWq@Ur5JEL3B z7|Q2Zl(**0Q<(TGsv=ZWcaW?tb(xY$Y-i0Nn$UYHd+K=27LLlY*d>Awsc`YE_3Nc` z!qi0q9G1}lYkq^*?I4J9K!cZW{h(8(gc2rQiWP*ojhI9Oh*HfU)iHdBZvRxRxWL?D zW?Lc{v~cZLiCKxxW}k^zO^{MRYLb74;Gd>Ui8+)WDrI7FB4gagSecHsl%$|tFLLcM z#PzA8fnK|>ThI+dJj5-u(J>eY6sD>0G@nc6I&+}``|C04&<2mR=*b(ufZ4^gzY41x zt3fY4*(G)8dY~^`o*>D$TY*J99A-SPj-au9kl;JuT7vXAG9AVGk7xg&BgS+zn_^K#Fy@FsXW4^e_Y@Tcd>pBFBQ=vV6Nu722f{YzQm?dj0~ zHzbQk?c0H$4i0ZniXmH%$Im4Ha|Wa}E$|tM^GBwCnRBL4-VC|S2orDN5ofzqI(z8Dz*%nHXqVxLrP-HN9)Dk{S@Ww$0Ladff`SuF!ml-29iH=}?jh$1t@G$XVO zu{q|Gf4Tiya*{C=eFao~K=F}uNiylNf)Rr*mo`CX@-Na};O^~51gT2ctxy}n-OwB0Vc+-#Xm1gpeufh@iDq7qdl9}}TMIsaBm%o0Mnow!FCiA7_+1&S$jk3MKzL^b9+abA9hXKyU>{JsdMvBp>`}+uy zYOLH}%h=%36uB^jEPXyBCw<-*@Lwz$4^%-3ucc_W=)6EEsz8@}yI8$QEzxAfopfj`G&3Q=bSVScohKZW+2w+84n zOJ1Fs&L3ZbpOS+LgJ=n+KN=@;5e(V`{r~RN4fPZPPCoy3b4Rn1c(dP!=46--7vSY$ zc6%UMOpMH6xPPtTN*v!WqE8($;60A>T&HpFI(agBQ$|WRYbUrb?jw1xtN~=2)Ab0X zi61+4tFn=)0$<_s`Ix5#G)G?*?1(XXR?BhTG_w?xEt~zFd^O!U8@>|P6Tb`BdR_rG ziqN+c=XNHojWH%YsloqQ12o(Z6Rl!?FBhisu1x$4vYOOT&?aQseSND(u+YpSb z;i^#B-ry8epmD;TtPUNDMA}GJLjcTk^6VXr1GDWb?Cd< zhr%B}^?~CEDKRXPCo$4#1%2nbiCb6J0^;F~`LExQ@X2+(y@&U7GmkiI>Iv~BnU1bS7k^A5T$}8^2&lsNW#28I!;f}d zWp2t(RQ7VvnGv0J+G|5H>z_l5PgP6NvYo@TrDPo@ICNvL)rO|V@N1h!g2jbX42e}_=1itp#q`=dl2F`I4~UfDwGnAjlw>O7HsOH zQb`JU8)w=Tv42lM>zDf%VI5O@AVpEk-RNOXVKEv+KHH3{aPybfyNZ_t66qg8l@_(E z2$Ni^&c;h8EjEBV>3b&@N5&naW60;4;l}Tl87>74ijnVW(un?q*Q;=nGE4DU5THMv zwfA&&+aP849Cb{|joCv#X%#ERR6L#!uMuqaJJtHfpB*bzoUbdKI2epAG zF3khdWPs@=I{$_9w%gs7FBA6SX7zh4NgMOBGb;u>s9-qLjJBUqA}!kB&}esU_9Er1 zt<9C@rFqCy{GZe8lnJ}Jm1^RtM1{$gKE4`tzG`<`zNJ>yF*mWH-kcfvM}`J}1cfkg z*->|*+xYL)A)p>?&YlmsJT?|IdcQ>cKi!fM6q)A0sD?w!UfEIM>hmXZ=1XZTb67CoEj(?IT` z-PC7}7~cr4zxoDi!VLgxvc&d)Qkf8tQeuLtut-O4_sL2DK%H?ZJ5X&9Qyr(_lUKD$ zf@E~X{G3T10>rh7w=d5G^60bz*vV*T>LLV;N5+s4!vb#rgxU2k($(BxSREK+oTe7I zyl7w$c$s6^aNFAfro~ zVg-p*N9*t~%dKvx4>UsKUx$PG8)>1lW1>Y$E?eyK787{kE>1IZIZm?P%7LN%LO1xikH2=02 zXvut*O()F2ob~TjxUPz`shZMw2Dv1NRc1mZ5Ff2Lx7sX6Bf0r`P1(}R=wmw*k*U6F zLVck~*wQ;ar>4GqGP@q@xV>>Qo?A%A%ABJNl8zPi^Km(5EUY3lrLH#267>6Vm=|VD zwD8J^d!RyYA3THBS4S=|T0Xhuw!wlWfJ0?bSWm;$5xo5 z;a7W01{)IuS4>9j94aE>gthP7m3MM;Eqs;Y)7^qP69Y5wM!aL}*eL&(s&%%pJCvq|DZ#Mm_TwRhtFY~(!ttCRIgbY$}qrXPXR!E1Uy za1KE2l;H!b!FVO)@VB7)YK=Ap;mEOx?_S1h`~R`;5%Uk3dtFR<(y?C$Ar9al3J++X zwkqmdA&_O3$zAsL1d7R8HH-1hniBl10B!L#xx} z-zIcF4Ses^n)y8V2HUBLnGEHQnOeyO5RtUmjmGf(r77=I@);R&E+|=3_e{&m5q{d( zpt9(}$Ino|ahfJntg(g*o3LhBQeEFz9F4+F(-2<}La)EpNUe-|rLD{|82I-BXR3+D z_Ps7_NngE!+BcxIHR(f=!=fjMoq-vT*NlgX7s|UeW*zqAVXa$<8W7(;)`vIJ@ffYZ z2gx=%kp{5^c62vlMvbU0!7tPN7|)CarJlrfA3KcJbZc;uOp$G?DFTUdh4-;jw4;ir zDsUxPRmw1MI}hI=46p`@XMm_t3?kER`u`u$G|aj%N8C3wJMQxz+sBgdqL7oeq?CC} z76yQ?uvcc0Zav4V)-w98ZeB&G2U2@@Mnoh~W4ran0a|O{DyTqn=96Yw%UXxdNqC#9|NZlh#QPyT9jdR)Lk+L+=QM~$ZUE|*jg)w z&R8{wc+QSgt~=1fR~=J{m5GR$c$NpYgsfJpN!Trxkf*CPV(b#@I~(~BuuQJ5!DtqX z#SvQ(PO8`02N66sM!njw?SW*9b05Iu$DG4uX4G_b9f91glNC*6RgZzs0hw{x;V~x# zX~gu7^;1VXIMmwJ`_r3$sHhLZmv8OHH zEkSlnjRDi3TQv^5Bl$r0Ob_3)6fVZ+y_+VRKEkn5BtfRvg`Pin+5lc53+RkRQ-I3# zdc!cP(UmK7<&V*=1tE0mqBSxInJn98BsIQejy$!vN^hr}Wlk%&k-TW+1k_UsXAWVF z+~q~7xqpojAnJ!BkI+k@R6{*k%#1J`H{Hh@$q3muF#nfPKF_`&Oif6i+|@-uOBnX>#8UyIe8`L%`B^fpB2WtcT*1W{ zanNCxRPJ%mRJ-;fp9vB5^*?-qtO(TdaHqCDFgTn6wfe1R>+v6t{cTWvWcCKyY9c>% zFbG{h&IFxk=K8EAh01&F-!!m?UuHO$pxsTHkUsSTaAtYB)T5Y$A=`${6OGEv+f4*k z)_QpK^Rf!%4n!kN@>uRGy+0j)ffj>irI9=lURLXIEmHt|dRn6(_wA?hqU@-%*FLg! z44G!{V1ifJdo9*~MBiXe?G4wR$!PM;@&>Mv9&EgeDU+QqRI?!OmX4aA30z}I$Se=6 zDC4;3!ya_K{g$|a^Ibh6l7>cLLZ`WqtTudpsx8XP)f~szMoy7b!q^2S-5Wc)v05kJ zJG{yN?$A(Z&`~4oOQsTmOMZrK{`cuB&nnj+&>q)CldB=$jA`-#TV7x4Ck7)+@|*8? zIc0G@O=_0zMkN+t9LN)qUqOo_M{7dPR`cDho51c%tDfUc{f(h&?csk^5Xj@j&N;Fu zv{_Rz%T&VxRJ!UOFGocwn7PU-GaZy`f#pnI^V@79jWQO1fEfb*gB(sb_pMM)GZb3T z2uUj4P693%01!7YY#{^nmr=!j7iEG6lOKAiF8OpZf=BjJZl#DPA}CWDjg>qZLByq% zN26Oo56_9)5nOdH;V>iY1YPNN1DhZp?g-p!zaxmCu+wmohXs7u^ML+wf3Da08gleQ z<_tq7hVr{|?XcI|p$}FUc!g4~PEEtd56WUJsYK-Vj-IWa+J9@if#bUyLy#H*wwB8+ zy#`E52RpNRHPJh<#KHD7;4xPc{~jm}dO?yz$R8@@MrlDEJo?bF4S_qs<+TW4AWix+ zVb2lA^X&G?oD^*tu-4o$u@zPNXPqYkLbvA3iwElfi)1K$k3e%e9xS+Ro^#4Ao8>_%WCG}sGHE4a>ADQoc`1CCI z{-)ArPNp#Cq`&$!&M{H{O(V=PZZ1FDH^1J8>MdXcJ@F5^^G9LQP7eGg>Zq5G@(N-F z;GPN^ZKT)RryH+xh%Js`x|4QPtk0XZB8&tar&BGGTxe|gW2jf;Bj^ej+FVgJcc`=+ zinBBb$O5$sLKX8!jCs#Xd{A~y1{T{}K9eDrFuzs{ z7A_?Iml(5)DD8C%js=Qz~+#&P!OzVOlIA=uiUD=0^Yl#<+Adzktg5Z^~>R#OslX3NPqm`HZY> z#-xa3#WpB@hbwCkfFD`FhyO-;6lp4)UbFR91^h+oMM~mmz29aQ|}9e#jqU?)brJP)b@?vr)$;{G%r+?>j72bgat;IS8B+lZNv9 z^Zwz@_h~sd+uMACkEl2Yb$1bdK{Orpt{dEZOo%yCe(F2s>%g*J%8Fq4-!?J4^eDP3 zt80Vb`$b2_zgnal6veD9c$eWi0(LT9qaNh4OdzEQc6IZG#rq1W8m~osj2&Yz=Q1{|tf0d4Y ziZ>(}qehoW)8j`;cbNr6O9G)_y;&H}oWk&q(Z$Fgja}}g>0-F2k-8y=_W|Bno;vka z(5oTj8kxM9%${g9z;cu`iOM`TGez|F^_HMkpF~Ig=2-j*i37^HTrKE)Mor32V1OjILRKG9zyektX_rsp3*0)Ms z$}4pe2{{pyvthPPJ|O)ZFbX9j`k!>K_0=52T-xAD*{PI-&^uNc-Dd_#@#5S-oCq%u zi5l)#`FoppPT>Z}JQb-&Z4s&Tr=U)n<1Lrci|JkRgq3#{*ebB!9a%gKAIf3`8;b2!PxDpF(MCPP@htWd+-3 z({I~6h$ZO-xhK@7(+$h*3CHo0z`R=d5vx0zEcp_;+c<&?!WZH>`D37qUo`|1h{F+3vr zKVE<^2-t0Q4jl1Uqk$>^(^^r}T7cYN@mz5C^KyPH_Un9I_~16>?^_NuYMRnpM=J=2iq9a}(q z0%{eJxBTl~iDCkxHh7(hw218k!-#U{q>i$F+`qTQ{YiMAD_y(*@^^xYP1)?qu+@GI zWKd=;4b_?>n7F7p!x;JMUS@@KFGc^$#Q$dFqOVL`y^MGx6^!tUiYzIVW5TFRb86q^ zyyJRc(t@_SVCr^zp*+!p4{dVIntfk)Ql@Eq9J{_{!H`YXR#@dM-jK;K9n#`2Mb+LT zeDLE7;sV_Qt<-S|=dgl?l(3Z)aN9TcS$CLDffb`w)4-!ebJ>B;o)gOy3LA4g3Y8wD zIwOR!S_||sm*(z$fN3(hHXG{2uuHVYKnsye30&C2a7zn|D(hUeqx5y&_Q?CKN*xCT zG~5+>$$B0|`4$?aUOOcd#`=JKjGx)msnX`4oeLTwlIH%T+Qk;giOI62o4K>&Y08aH zJ6}?GYdYK$cns`qw_RZ&=_{?!r~K#@AOM41G;tQR=nO}YyEQ1im|4G>h|{0|#g#06 zMA;%jsdvErdw0y&ed=o6{LWGP4jIb@bW^RH1cw*q)%Y{c}34{_zr}8FB&kj;* z*TceT_V~3Xnm3qfz`ldq!j-{+^!g1q_TFCOg}F1IqwZWLMt#e6_Hoz(bxeX3vbhXE z!$*a7sIVCcxiA2n1}L@*iaL^WXBV}-Vc%4U8v=?}s>pO)kK&gG1J(`_R~LcuO!! ziAT|4w)_nUGj>q2m&~7yMZl2^BV8%#YLOO8s4hU3R^%b|zXYWCi@|x;XiEGkG&W8! zC>sGZ=aX@+tFtPIH0XkqJ$wTZKnT72jOY)Hu7#|&m$+e0)m(T6eC=$51C6v2&Ck0< znSJO<@)H6q(g1M&oeN4Urw>Iyl|YV?=|bUud46rCwB|0ar?Z<3Ya_1eeoU@a)?jAgU|@%g1Jae67N;hrCNhC*O1cp`V zS4evqZR7fFrZMK_ug=Re5wmtxB;R>U+G|>}@*;D6-WILL8GEJg!4wOf9#{S&WWP`$ z{Q`6yq%U>k;1NUPqoqQpM;k9JIo_>UO{fzL*O_Q|(rxQ!`PTez7STMJ!kEr&(F)us zoRTTLLpTa3dbCXxSV%o>7{$rnIGp;!eC*vIRROT6=avOeKgs%BD?8pG z6DsgF>!yM)@nV7BEY8NG`4sN1iEtp?d^(+=466_sR2jpobAf>y;@V) zz(e3T{t$Bgb`L{6AZ*a~nOh66Zs9vh5$W02+E7#M8!+k=#~`Af+~%!dkTK21H~en! zS@t_8_9MpYV26-Ixi*Rla*1W{qmTLZ%wO=K-P#4F3mvJ4Jo9Q+=-zF{%kLsmyU_Mv zBr0%Az`Gu7Qt?t{UH7%Dg*=OSW=wmbOk1GRmbYqr;JTlXU_8QiC02^2iWY{V{@~; z+KSngwYnAM^af~LoIySzmB{lTZ1+*n`u~QC3QqzRQSm=y6YwMGAeS4Q!j2OYTGgLYAAByhf7A&( zOi;4LKm(U|Ezb~$ev3B%ii3$346JQekv;RdHvm2GA84N0V4eHP5UxXATfipEoOR>E z*V!ZW^?css{4l*M<*m9+NU-Y$|GG~`T&zo!fzv<|f0i9gg4xbmVHv#B=)r5BM2JQS zQ)~cb6e{j$bBgIhmVj#fah4rAfY3l8*Lo<3PaguBXUk}XAU@17A~*Htk!O0XT1bm@ zjB40!19nIvQ_avRFXy(WUw4Q4b5jD0SML1v)pN|;iA;*Ru)h;W3Ha(AzbbQ&OZ-HK zd($`IbO}g4buAaSq`DiCYQ_tW8C`vi*MnO9J#IfKga$RW5%uZF@sdwa(aMAKQD~83QuE8Mu=%+ zKsMl;AOEgwexjtYdH1Vp&r&j%jHSk4!T0p0^2`-IkWm^|Fu{Y*GXG0jpWC%b{74w# zHBMmu^3atz@2x780K?m$=Zu*;wosddCM`XdYU=~j03Ml=6NeSnem^845cQk9ilnIT)Z3l-zN-c9DE*uIQsqF#7j78x zSGn8oNQNM?4>y`2E(^$YT<6R%uCe0&0?`adBm~FjiJ=GLWOGKRGhx+tE|WOXjCld* z=_8#`tV~>Rm;8$IeMJpBpGkB!PJ3FOG2m;crrVQ;OgDH2E;hQCwJ*N(N&GLBREsEKzAobNilBdSY6(6_mVWB__S z6^2VKZaa*6xZYKqhBRGfa}#rTfwthx$S#8TbyGl%(PLaLR7I(@?wv+A{Z{cIQeTGwebRvEKNs=Ax&lh9U(!Smu`nJl{&(} zUmj2xSt_i*ln^yrp1m;z`;hwYKO$`M?Mh5ld=Qv7I}P*dN4YXXyq5gwF=aeoVb>$u)RGZH`7dhH~ZXn9amLUMB?fSX$k4ao*N zdky|!-;#2X!@a;^a482{Qw$`lj;Jks2v1EE5j|g#aV=zI4AnKZ{Z(IVgmOZEYqLhAgmp~ca5xrfi?Z3^X@<7XN`O{*zC<9 zl(>z!u8!zz^^}tzypcEmyxOwKMW*2CML**<%c#Rs2cqSL-cyfq1j$HK5>)66cV(}Y zGN*gM4baIle#q?sjHJs{x8JJMkpy;EhuevnOyiRbog;3UVUPQv=97`qD--8c6;SJL z3IL~GIT%LI>q4e`NvDCI3>)(mQxSZolk~VEt~rpSy9AXtEg2Qhanry6?z#m|nCQcc z-1=gyttU5L)i~Sb`g?mlRb{4O$Fjb}Qxh8?&;*eOB_UlIAZ^`vC0?LM{ z80h$fAVq%4Q#=k`n1Ep0t)Z4n3I%dXO6pIfx%&Q;6GuN;eB1&;$(9flRVlk`A&=UC zQ0lb_j|J0`U9{lbu|>y;N<3VN?T>0DntYA4l?Dft49_|PHPNXZpm+pyON6u!WhOwO z`!e2D0327zfp^E{iQm(F3&i+1a8|WPILE@Oc7Cmqh~Zk~bLM&(a^`RN3%6uJSNAq* z>acg=;`U+pYwDtH|CUr+Xf6`-FFvJCa&8c%)QixQMR5F4^gRW_Ull3es9ApmoKMAF zDwp%w_uM=pYx?C!w#7d}KIoe!=&2-(g*lzIfwF44qrn*ZB)H@n?({2tB#MU12f3n1 zdjI1GXO=Q$=A-1MZqm&v%$eVriUk!(I|-sR(Qho{+9)z-_F}isD&=S0gLq)vlTdYU zgk6F73zBy)J5hxd;j`5@h1-WZ>|#=3n~T!lBGp;37oXAOc1N$E{mj8)vq7mhNeETJ zWa#RE@=!)v;XHLqY(4n3laZ3F3mOhsu&|b&-2?gBDJk+NDMc1@N+3B>9^k4|q8bVs zmy)YVCZNE*DVjBifVzrzg${SOU^G6%b<*Drl&)L?md2+Lye)j#-D2cAi7@0H6UZ%x zqP~AXEokE+t~786@8l+5z#tojOZw!FI}idyhs7SG`9-h?(skkpbI>vEOfcaW=)Hq= zA|nQ-{?<|v+({7J&N;?EC6qbMb(+InfHc_w!;8$OcEHi-ZAOmZl3@}!oJXDBH#jXJ z`{Fnzw5R>7Oq>RxdmE84SiUuu|BKc7E)_${Zkipkq2 z=vnq3*Lg@?1GYpnDMM9=0#7fO#O{)PM{FF3hfjn@xbVh933UKvTezsCf~E0;H#rO_CT>=6}NHma=`b{4WVh{RD1{PWS7+A*59Bi7Wga^j?qR`j!q8nXF7Yb zRsaj0kk?+p{YAnxA5?dV!w!a+Q72b8F6sY+Fpe2F8^MX!H@0;~WGe)>d- zskW8a!Y2NLq1$hh7eW%{ivq6}dMV+D7iUzi+aSb_$Y8?Z_2HE`C&0Yyo1%Vueq0Rc z;NKNCR@CR$R%SZ+crdU~mOfhBf#Rb;R%VHI(}%;XMrUz?Gw>pl&EX&NJ;BG3mmn3y z)p5)x_8yrfc_}ZT=yMyeeBgpbOXKg-H$+zKuhr9YK)gwXKv5kHR<^7IS6WRbefMZZ z|8<{>l<1mwYsf(5KTfi$PP*cWr|D5zvn$)qE=IYOdt)eoB?uC>sU1vN#VSBb;RT7dnBtcJ7U$12j{?t!YH zP|#q^gIu#ewG~8)3)e)GruMz^ahOb3WsXS9==~bh$|=!}h`ICmy$j>I>L^BA&n(j< zQh5paFBtnVjiX1$?JT@|Nm98oN)mOb>tbZ}P8hL7a39u>)2LLhRt5I=&YbltO)Gwy zvwR%9(7G4qVD!JAv+7W?B>5ITM^6{V zV=WGJ6hiL%*wGN~0zn~_$JK4fv^1~v`+na=V7-8)%lo#60k6IkcPbsdwsF)ZH9ySU zaZLH-Yjq{5^03p`SKFLbh2MPOhm$I{PBP4tY)HzuxTgPwd}Y$s1~ zc=PGB%)qK;uvB0+6>zsKBLGwyt5|K=?57M@aI6YG{#W>g;dH_W^ZPg1cgKzbnzYo$ zu|=x=hcA6BE&63!O~$>eJG1f51>{qoC1^iD{LcqMP7Oa-Yhq?q^&O%AidIL}41Vwz zA{p{aaD{CW9-pyOkX~531VQpgt87KWh zTglPy!zzeN7<_pFycPXUl_TBJ^?J^9d8OMLGq^SPW2K!5wP7$+%H&h24J#5R%5ScO`u1 zdfou9b9IEa1)mY+@ee=>Kb(XfJ;;s-^A5Na_=%4;wVc7}!C0<1g2+VbtwlQG6nnW|UEc8kG5JHnPNK%JY zo&FSY1EMlUQaYP^7H+DS*R7roBtEn46r4bZM3c4G2<8S1;{8slSO<+xt=*Q(Z_L$4e-Z0aQG5a93CKLncPi;%rskGBu+08z zb@ub0H(!KMS5+ims3N~T9T9%O)nkq{XAut-NblrU4 zLlhs|dYy#Wxy1DUANb>&(q|pX$W5OWL?-wU^t{^&+N|Gh>nZ4rGlmG!+Xm~Gm8M+z z6A**9;{k0o3|o@R**EMr>LA9uno5>EqQh1~V4$PJIZ37tYz4ya5f&PxH~D zLk#BeppLl#MA@j9!6~8mC|lmVcAv?J<;CgIh9Ux#L+zW9rtvwmhLOWiRVt^D1?obC zH_xdN>3~FS7PYMUaS7cNQ@7g4*-_;ChpLe3+{)0ZCVn>vHU#G9#BET6hqKhCwbp6% z@e>K6^VSv570vk_N{pgcNEB=wGSwg4#bZzJYE)gy@KPw9b|!S*jvn@-2{beY(b@Fj zSUHzYhif+|)oMkj*0U=OSABdd{yb5&N>(I@4{|edqoz|(JUIV`_rbG(lVdYtwA8TR zBAhDVg(xS!J3d8BL6~_y9bSh&&YM-K0!~~vK4y39JRhL^XoI~6qLW9yG$|FgnvNn6j5q6azZX=S$9#d)LRGI4n zK;6PQ?1oVaz)>bSR~`@2~|$N0@5c6tANMTabLuQ zN7{Jo!&j!LaJ7K@@;P(S%@q(vpa6FM*hnVn<#`$C|Dq~SmT6UiI}vY6Qnfqthzgpd z=jkRH-yCK(XFbzZwUaT`nfT}$z=ZC~jhwA%-$>a_8~qi^I!x~eta3R?O)#;-Ece!^ zqc=(z-1shEd70GS1=ZXqk^9u()sMwQZ}$|?A$u1>Uq~wGHhw4BR^}V0`d_95sR}Mp z41O0uq!ah$v5$>|+|7n4LaQJEr)6-L5(A>25cj3Jx{q7UAIt^^dA{WVrXy2!WmQ*B z^CZSy&jqLwfgGV_uO|66zS~h%$&K{jtb@x2tb$y2P#f-Q7Uj8N$1Luuw67=s0k>_1hJ^>E70~Cqn|RujwxT(^aBXUj66^W zhZj{mZUn$x^#Aus+(|57lbWAV_&98*#q&`uOQ2fgV$q55EFNphFaI?miYM)^gjgT! zk#3C528GcPa*+psbvbNEzMK3u!lZzR>2j!T^HMIiQ381GmlGKV6Q`Pd3}$})Cyc$( z>Y>fV^tvhQk!x2NbdqB&as3Jm&%UlQf;cF^Z#14GH2zFns8hN8d9xG72HeGJ*Aw3n z5H9q9AP~h~TJzu@1X1mj$o~xJpF(cT=D;xj^|FS35n;o1rau$ojRuVp+`|4$EHtfT z8_?xzGVDnsfm4>%U*by&i4xDCXOi$I(&{aQOwJ=C7_ zS~ewwg+r6Zj|RhTQ0_KS*5?EEL$Ce9n&qJB8hzM^rs8aS3S9ts_cZ~fvsj+o4IPKT zwzklMZzb+0V*4`?(Uf1H7V$z>or?zSmROQUn{Zk=`ujpeLRnG?S6qgFIV%rbb)p!9 zBFFEd7ji-{?E^hINou@skJKbL^=LL~~9vJPW+-SH9nfAKYbAv#p>` zR9(=E2xRew&hATE?k9Pde?Faw;I%x-UAsYtI-f~}1eXgxVx>pYK$UkW(WVjgQj%Qxul*m1eZwKyrB!Xcp=`_h-r&c=&wjU@bE8cZg=+ncKQvF*OOBr#q| zw|PCdG2%Sw{J`)jQ|46o{YGT%gGJrUiC{8&`h}v973!vQ{$pu$?;Yl7S~E;3vMP;Y zmP)A+#DkTL%VF1Re{`Xi+a1Tus5HR)Dc%i9gRMYmKZtZeHK_#K*zgaf8nYQ=twH@3)O zO8&tfFBpG~MkqU_$23^zt8FGA1-IE@yp6`mUbh-320%gV)W(^N#ReYXWTL7Nve9~N zJM+~cvk*{MFK5pkgmt#}d{R2IBCX74$s%H<8OK)Y0GQODG?V5g-HA*j?GBK|IYfZT z-O&qjp1LQUvMM;LAg|dQzmTme&?$5~^;b2P6hH|D3%x}G_rWs=lU@5J@gTnI3I;vj z6D0mr4r@(qy2!k?NQl}=sQX($FS5EKOXskxy;5&SZ9gTnQTmY$wgV5#>?5do+M(n4Qtaq? zD*7=5ELyjUJ@gsmsPrTwrl90AniksX=IUX}pP_`KqVN3@ep`>)Th$K1HTd{BjLGN` zA2AHo$Fog7wh^_PQUYLmE>8zBo5G02)(>Hhv;vOfVblZk2rokzsE`7$`Yvtn*M0;t zn+rZ27jq|ZW~h6|jYA%_b=%X5wB#YeG&VOxj?&AiVnIQ7JmbV7k_Z-3(0_KjQz{(s z_8KcX)d$T?mVDTdllqP%DZ!KxlFZAlFcXvqp+pL|UPQZ_ntDXbTAYo1(0>_IP1oo1%N|A>^?&^>X-%m z^-FU;m8eRW?i=QF{=x313qGgy8UJ|&pEJNP7Zkz%->t2MqzaR3>BGr4J}`t(vMH+) ztNUR`G6{P{1w_=n&v9Q^$kjSofXo=34z@MQY;oR2Mz*M0(NEN&C+lR{XfqZ{OFECN zz%1*yY@F581`!l0tHHSax{HI8Jw4uH?IkKItb$jkX4}DsH6@R}%g?ub8={EHn;&>c zgJv~zjL?p6Vp#YnmQ7@ML{0ji!Y@w>_C5de_*}-&#ZYE79s5JIl!5a$qMQaE=dC zDNuY<$yk`rccMg_+Z#x77oUNIX-P!R>^`E_@jYwMM)WcmR3g~`U8qoGF6p|K8+#d4 zAD0SL8r=wiMF4Fu*GA{qIwsu=A+`ZT9dAq8%}hcgUy++LSCe}Pd4f~Dd+z3rbMdCK zJ6C@sa6Z4O9c8~??uj^;2#alxtHq8^YWJaR)YJQ7=XJj_Q%QfU~nrN zxU(LsoqX6P_vKHU0rngx3A5_vw!DI}W}m-@V-uFte#l|_YQhT!J3WH_=%rV);u@Ck z0gU=|Wq`(pDwoqDcb)5)E>zn0kjx=Qw^w5tj7a-C!!yT%U%EeR2-zojqJ(%MovTI49 zEykLwoF-k#BIRbGUxl3OORNix&Q)rn+pjpfI!wL3!%?xOm5>E9)O}^i6&RW!*xzfY z!m-h?bwOTE1^YZLsa7a#TDJmq!=Fn!V|tT35v*djWz}a?GAdE0Hi(z9*OpoBAqtaR zYR160f!!DRjS+onSqy;avwZiZEi<3`ZnRlp3dF7@S3bgx`8qPhSpRxv^w%IM8vOD2&N7(Y}> z!D=mh^b5;6g`i%1bxGTaL~9@0*><@8_e!*b()ZIHVE(}#wa?|)AY0TxFsuD;sPCZqw!-yql@yHv*u6iY?V=w_ zp5pI?vmd--Q)+`cb_HiwD_GRKzl>GE2AP^;i#Iw>5`AneFBq9nCEgg=ku%P23>p#l z1MIGgO0IVSt0IB>uc<(mlL&^LYg2K4v;g{_3rFu=6m_)p-rkkSlbKSB3WdS~6TAgw z<{sH*IkH2(BxmljxC2iDhxovUERv{7$|5!KR<{yacyWEf? z4fFg!;~gxvP&16h_AjrBDF1MMSVsw{@XthUN#Uy+3#?%CBHkMnwdY}!8LXLc_r??E z%`SgxaljZ&c%32rnpFAHWwqesev&lqW!D#{_e{LZb!9$-iQ_y}Oy9kj!v)rK+t}M> zu7UG;<4I1_l^x=2dd|MF4z@#XHi^&)3*o-$jGzmwheiKAz?{mp}rAgT}xVO4(GXpc})Z&PWOa!}!KIkF>6= zxk)GZxU}175Rz{K^H*aWj3b4K0y$M_kNO`d6l&KP%LiNl9i9BhB|NDDXl%rb z5F({}n!nG5MVQ#yI(|4y%vV~8jFr%DlSWB+#sOl{t{>~=aUbl>ex?L>@fTkNIaEq@ zDsuGL>OT?|5h+pV zz$>qI9y7i-&fc1SuxWy!>dzbIBF+)sTuK;Dho)OBG41~GNEu5AeRn21zj=Tz^~UYh z&kOXKighKPB6zTeKqz6Sf14<9sz090Yf}^_e&h$nF|wcpg&~pMCCE-=PDaFgpi9OL z|C-K3;mQdM(P3#rLl3H{7d#3fka;34d4#%B{%V~;O^m;YP@1UDv!K3UB{wLS4_v!( z0>JtY^BVRgbA18~FrzAu9M!hx;6&10|6V=rJb>u2Bi&9|nxBNNH2fu2ww(Tjp6W6{ zB)_wayqZy?N>|lPaOwCoeQ+xsGM<7=Osj?c9uACVSe<>}Fx-K;@R$VT35Hpc`T}x1 zQf^iHrY$tC<)|^NXn;KQ{wQ)}-Q=~(jj8ipV^A(&uhowAwOudg9s!$#C#>7Y1)F>o zB+w&obsPm$igg<oHtCr)27mf>rB$VwRyfso(h`k@>r=P!*^V)BE~-j6)`CNku2 z1lN-#Ta2fJVp{dF8SfuzK8HSxGvfhTtI6hqFiMPcpQs?9`5yTZv}tI6txERMt+_J@ zhv-4)18nDk8l(3Uz_Y<~ptiyUw?k^+6!que0m5J(iTvMgN4DJcnx}T*CLR?xY9O1M z4G9`3C;MkAx@Z|wNoEOX!d+K7pcUE>*&g@q-|R?SO;)%$m9U44ZI(zCiqeqk^r*v2RNFg)BqWk6`=RFt3ZB8xdCiT*V zaur!D7^j3B`Hu3zm}!P*a5@YaTyI&{S;+2ulOf(Vu?DuPJ!!I}$Fo}$-`sVCTN+2E z%qSEh{i$)2sWRv8d$fup4%q}-iVQbnB)1bp1A_PatcA0rXTWs{zKd~UJDj>2X;c$0>`w|F7`O?_cs@2oerk7}N;!4bhIBwg2{>r<|@d^qC3j z@TrVWBycESt`Q0F`A&1%OX&;8r zSrA#f&RO9KA1?U7g+8wj6Hb8ksHh5y*Ix`OS2d;CBW-}kRY&-bgi>@RQ#^>3M$UsR z7LtHo-Cd>ezFCH~_QFSi!MQ&?V2+yz&E{gEQ^h&vKCADMCoZ>aI5{d-LqRBJzS3~4 zeFL6dDXkX>uS`QES*NM8=aeTRtOTkkwSYRDZW7#8A)0(AlUiISM)w7*O%ic8yJ0v) z8GG-l>@415Ox0C<29QNc%)57{{0aqjZ-s~tcAZi2Y3?rP)4|X0mJj4V=hO*$j27hR zM6mnr401%BTRV?L{^|+Q@sEDsT zDaC!EeUe>5$O*LXVmlVI=raAuzlx;sPwM-tB95I^=se;@=jDk1%7wd3|AJflAu+kL zT`R2M^Ub<$iSD^N5p17flL;4sGsGBz|8iXOy8g`$_$!*?Teo||0Ea}VAr(WhSbm(vO`Dnq2lq`Mu%}%DKWfjQp|#8p z19to!A&PC+PGztbaHLeHps|fw?^>752rN|h(YC612Y_#N^rc6cxl>HVD4UD)g$E3h z*OdL)P->lTfd9Zv-={6oIc1F^i5!d6%a%f*W8cYi#t9-d+7XD13|;|2G=^-cohsid zO6~a@YZ4XXpF+Q$Oy3c6rEsbD8)LsHC_yM3;&BNj2I(TP$enUt(ErSO5M-B=!kc)j z@bHlt{g5Eg=EkgIWX1J<>)(mxZ_C{`*3hIX60xmM?*E+FA3Oz%Ss))_nj8ysQDN92 zPl2_2IZQmq;0cK4JlA?McswcCwQatAr+vqU{t$$QR8rQFOKR;hYoSz9MUOssSHr*R za;bymA{V^wE_F@uF9gN$K}w{Zw*Oz!j)G~Yfk4n+hFnohmz`13+(O$9Hk#^zSWa!r~gl)8#Ygw;2& zvJt#f#6TxV?3YQ#p|EJO?`Jo7cZvmK+}mFEsS+G4gL|Pj?UJD4{#75~yB20mvhrT) z>~hX%5G>&*Z>2bqM;lsZFR^TYUdFC@i5F1<&BJ6+G0vd}v`zd6Ap^LZ80H%CdPK$* zI_CT7gcm`Q=o#;vg)SLpZ&b+KPZCT3@BRBMWLPpHBUR0t?n1{%Ta!A3k-_9C(WCqy zPW`n-_`>6L!apS;M{Tkn-YwD0EDK}#UTlp0xk%Z|x+!vcUYB55=FKb&pV z?eU`df5Wg)_*VRy9TX4ucLA>XL4(KVTRa8%B#^$-s}A-y?vn-(QN+58$MUn#C81`l zqeXvU>Kd6IHPaazmLkXflXm0EyjOpBc|O695j)2sc`tuN&-h(4(r z4o;l!6|4)UQqPvhze-SMj{w;fEY)JA-UU z!r&m~Z<{KCeULZ1hYJhF*NY^E7*dnKhOK*2)Yf=-d)lkcCYOW=+1}Y&7Xf5LLV$I7 z$^@%?G@Eh;GBYw{B#6qj3e{xTz4f z^w>?VL5fV{)yY^r(sa8%Cy63Bs|rUuWq^j=>}&(+Vzb;$5-ERMJe|@tawmz_YFEgF zO-Cr!xPND`Xi^C)BSyP}S%6B8)odhSrc|lN`t7${SV(ZvZf0P8EWH~3-X1DgDqVla zkqmrMQIO2~7?RK=UlSm7X@#j6Ov^Rug1d#aniNj7c~LWH-$QLn&TF7{98ZL6rI66b z`qmh0PqF%9Z?kw(OF&6K-Ul%Bu|`D0xtZoDKbzU9waM`O-YMr#vbgepwpy5V2hoGx zcX&w8Yl~>q64dk$E`ac$K7Ltbs(=Nmar2z8FZh^;%(rgm$01=`-wsV5{eLrKw|SSZ zjVp6Xnt^EYP$G4`?U~&XX?)JMiw%3<*D0nkF$QewRXl3`wmW=&_dONN;?F<^JoC?+ zgP%<6?3n)1D#IL2mA2G~<^*D$Y_XosCx(}4CNigekn0r6?eYsh9L9ZXN-7>2!HDb3 zL#MYzC#}FNv%d~019{S1Z@QAS(BsaIJsM1RRf$RcguA1QM@>?|s$R2vnVN{1=^y`n z);$On1pMezezfyb#jd*}-jw?thLDVo()njuRDkJ+SnjJ99`%E5#KBjeXDPtoQ26`>?Vo!(9yHPh)R@ylraPk z^$4{8Er+%BB^b5zSO^2Y+#mDyECbBNrdv3!2LT`UI%xYFDACwmfUCBk_|(ceAtqT0 zq@6viV9QPsh3=pz=;;noJJeUV27d{|$VM%yFGqpP(F>kYaMrkwBC?GK2)qbB^==#< zd?q`e`X`U|sR=$JTf^1+=R2+vwsI+lBJs(mF%%soIhj-gR9Q{Z>aQ6%;;_Cufz>lt~PSS;DhS6|LJes$<; zo^L=&VZ$j>(wpy+r3azApYuj)M(ToD+MZf;o8`K;s#?P~Gs|p!?@g{3)r^gvMN&q*}Ia(MP8~9 zzTJTBJ9H@1dHTEFpZ5NQ&>>!$_1B@wzc(HjP^#F`<6?jeFBl_&tfy#h(C=vHo&B#>Alj6Nsln((Iib?nq9b8OD@V7Eb`oDOwnn;bfyF;f3X8 z&Vwe=F1+XQNIkQb1rpVS#N<7!pk5CKBo&R=Wc-3> z6=JrFRSrhn9$8SLmf~D;>J#I=h;=a}N-ejg)qC}VTwpyj-p4T_P-wfmrdbZ6305&O zg*jNq=@9EXk`=FWe66~l$aU165Pv@Rp&2}yTh;)`98GhZXM=j^25{nl%lOuvOF5=S zeX~Tk34?M>`nJ=Qfzw%Fjg`F0*ZtRM{}qu`G$mK$ z?R_^VWM*`a;+p2wbP`naQ5qMRfWJ}r*n;qaIF_^yPPt__Q*rZs0|}wKIM0RsqY*Hu zCI0?n9mnQ~cMRKoZ!Wz&N#8%=MBS0n+kXt_S%uBkacE06#Pr}a+k-4zcXJWDDzcc! z+YcFg7`sdt(>OLlyUH{KtExg{mQ%DX+=|nG0GBdbaextB?hlUulPu!FWi44n@J-Lh0m%gQG(}B)sG_cr62@Fo0z)OLT<{ zA=RcIt8iYLiSANw0=g|4!}jlwdvIMabuByoa~ABXY8A|(cQ0$z@1QdAGhA2L8aWwjY@=z=Y7-#OGFE&5De^f!^?~Qy)VEZ)0 zPQj-ErTE#af9E3JK9(30c^PD;ZVS`1`%tF|8Wbu?K#JiK2`#`wsE$GIOi9{%(I#;i zWdCy}S(GtB9ZO9QS-+h}@AuASK_0dMURl*o{W${=8=n<FTe#-` z+1_!$R1joVW%2HNIrFcs^t6$J%~rg)ImR3Hv*ZXDbZRtv3O?^f=#PlT!8H2gpDIkY zH~?fbE$ebhcYGJNb!F1g1wxs8(s)q1CpTK=;&C~L6!X5r(oTG+lc4bI>TX13ZGCmR zTz%g#AaK6)5mKBqRA(gPGf$u<&#SRHs9s8Usdso2D@BpT!$ulc5d;@9KKiw7?p*3g zU*hbt28z`Pdr)&zH{!XKPGpdbTQcoWc=gQYlMEUicg4voP$60eVsra_Mn!Z2?u##N z9NB$y*>MI&Js`+{dgJ|d##F4DbMV%ohSil~f9G}w0;At2pPjJXKzX+=OmipJ5)Edj z@gzG}qA)Dv)9<%(@D#iP+AOt?FRtM9588W{X4X9%LRD?5{rxp8piyRA=zRFm{>x;> zDfhW`aYBOC63cIfTMDT(3 zm)S(7I*3;3gc_Gb(LCL2n%zdl%EycY_R?!*OW}HZ{RkH5_}x|DUV`GW#K`gyqVclE$b2972e{HMntZ-^CH2KGs^ST zHK#jz)H)@vEb(jF`%ix0jF3m&{TH1L+SkcP9!|Ub?3y3-Su}+A0=IL&=%OIX*ed@< zy(1Oren4HNz$*401Mr2f706llQ9P10JV!t}^8Hx2$@y*v*CY$exnvB0N)c}%uu$Pf zrM@F8=fn`O&~%JP^z{*49d+))eEUHwc+;vHI)tKPw3`6^%|WFxn~-{8$>LC9J#mfOye>=vyU3@3QP>i3;pL8U!7&jddrMb*_1unHelUqHk=D(%D=OoWn5%96`rc zIKr&)m*_-x6WjyTugKD#pCr1V85|)wXUda`w(}yvFUy%EHJ|QM{?ZoLO5gza3=4=3 zJAz;aU4J!$9U#GP_OR8XA;8Nx89p$HKT~L4vi#t0kWK8N!`D*T#a+28C}tyDMwSEX zW|N>GkL;GSKh`GR(IO$=PU?P5DKV}{m6eb-G@WwD`E{0`49^&K#Qr_}%Lei9;0Az` zyUb=OA?l+j?)o9jNq$%%J>R5Xa(KNps-JIrY=urouQ|t~?pR%514L*O80U$|71I0Q5K!Xd$X@O2x zQRoE{O(UhF1`&uBeQ};TYhCsf$VbmE&(P50#WUynGB^6GD z+Qe!Du8HUGGiyte{Z8&y_SFPwu&|WCPEs zP1ZD8?3PYaZ5eG{+B_X^P9Wz;fCu)bp~Tz<&OFK6cEYWhPuFy2^vqSO;B8||i#&gH zlGg1U%HmaJlq#Xa3}}|Oa{63phBTRiS6XR)NIYU)5vME3lr{?OZ0iEgBHQE!TiYbG zSv~X;z9gu9En7P;djkJ%xj*ntQfRGzN-3t)s)J^KlaxcYk<{@#EC;rJ>s$Sr&bRG0 zEPn*3Ii_LFiU6JI_^#F*4ew0?ory4g$8tu_dtMy8!L*_FUAOi*-(ZBYV}eg!e+!Ka z6?)rQ#M6EO6@B6-67&jKs68{K0t~*)_gw*D53&NJwGhdE-8Zvx$S)6qE{9>JDm^Yw z_Tfs;)LX+QhWcBY;8%g9o&it3*=s$>9CB*ThEulvaz1|SX3xa~<6)l*fn=6WumN~m zDh}8rL(SYN^~6BSRM&>UIe2fFE);+g|8iW_4molGD{pFPJ8a(0?M>|s;qUme@JP^2 z&R~5{Mz-4tPcuHad-SrT*5ftr`e!9KjQ?C92;-HIOcyqq-w zwv6Z1C^LbUE6~$eU>bE2X|uTfDM6>hMN+uoniGow^)Hz{A>9i!8e+mAmh_A?_<~ep8pL z4O1q*O#K;%vn=O3=U(!aC28ort5j`b*~j~6niuYAD&fUeAXo^!aE{F77XNQ30rF@D ziPLn2+E0$}Dq-P3wuExqc*7p{n^0#vfqlW8ROih>zZhg5Tzu#+xYmZ21Z$?_jv(}JfPRgU~ z7z-QhCN~7W@UP+>*aG6>dovB6H?R)rP=wA;q-~0q#1Ntx@eQP42l#q@s7`)>Sj@_2 zhUW<}rBfOqJGraJy%Q+%t!CtN)io4Roiq!aT;V`Y-guIRtib{74?2%5H8REK!@VXM z4JvwOB$3>2Y8~-h;A+2%Fajl0ol)(4V7$ldw-`Xc*CeaKkHLGXaRO0uhIy{%?GZLR zC3t8#5VfxJkF$VYib4Z#-}6Iez@pspD^6wEuKhWU;^foqSbsS`)JKhVd9#}F)u zNj&%R->fw-+>^1bG4%STU9UBb)!@v!gpT!fk$gZ$segLd5Q>`a6d{19gr; zd`aWqG{J&ewX{6D69x2*8?Ffen=-_~zu-O2o!CHS6z`jz$JkQlAnpBZXFfs#*ym19L>ADica}fw=C` zVmKw`u`JiD_ThWPZyIalN;94vcr{ZQqEa;Zj~w$Wz?~_Q< z5cneO*M^sP-%O8cBM}3IkATWnn0=`WGLN`eu3De8eR9S1Hs$xI`f?SVQ1Z=OL$P_g1p@ zTi#2?X?(~2K7qb!B^~js8L9bjL*D>oYbz;uIP{#`bfET40G)qFqd1V2EYZhOnyG!Cry0Fq_USr?F}Hm;=i zRh%muD8hT7a+5M)K{hEO@iho`iQeI=>vw&aLU=E55lh+7>~zAz#$ zchRSIk097KBQpD@vudi>sRHuu^ivgQga=SwxPQUhM3MGf%lp*5aTU!+P=Z#Dw;#!( zwvU?pbgnxdP_X#l-wPK$L}-%>l+eL47r|E6zzcuxQ>gM<@h`jiN;`jj@d<3}(K!*p zP-zGTIUvWXYLgq)flixEd-JUk;~Y&BuivT>A)Lgn%F;ehOu(pq*2UGiy0Qs?35a`6 ziTs;1!5n0*P!2MtSnRfUiz3x)n%dzzn?=-RrmRMH?Wm8zb4S9oW+WzBEN7knubGAX z`_uWH>;$3ICZl00(@4akS2i?^AHLcEKx~cql-<|$)s3dVE4RVv%v*~b6ecX6Y&7Au zF9XDos=i<&jH$sh&y3v^{c{3p_zyvd>6AkWOP1B%N zyKzkCWfZG7z&i403)_tU?pxh;h_QHI}7=nTaq-tb^mr*2tThQMB2vJVx$ zp!EaP)J{f8b1ZitDJ6IY{2!Oz22P!v9-lZzxz0$-e~v z#u;e0kD~7OcGKR$120^ahQ6FqBXrl5`?-07It;U{=x3wVn)Qg})}VL7>NJ`hW3)(T zpfs^8Kd?@#1-x7NqTbcATn>_Gso_5@?JalPLGeGjXF2b5Tehx_3bD-*Hys9#y{tuA zF>Nm9Yn7cH_z`<5sU%UO~{s%y7-R41_2^=aP$7MUK&yLbU_~q{bSJTJRMG3be`3d?7CTEoM=mXNG zmT&IJ7|@tQM(LN7>ukQ{YdSTTX!P@0Raq6Zm!fZ?CyC5J61*?b7I42Z*m{>iX%bFr zwGD`T4%`H1D^QPRx2p>E7p6eZtP|!VrZ8bjRU>zzuR8xNtDyLfRvTnd8I25gaf2Od zPC$8id12tY0ED_+fK>U=DJ;hjOA4^jyYo>|n2GrL-0BFYM|o#4P(@qRX0mIQH;2|b zg##?b;kDmA(|m0#8RF~r2OdNw!I`cly{?sbF6ULLUSQ3|P>SrSc$`6(9QPhJp2qWS zgAkR$s**Zu;eLY!c~+`%4ooImsQkoj3pzCMOJDz7Tg0;yfFct@n|?>?3fZ=h@j zX_QS&DYYjF!KL}T`No^jzsBfb^&S}+Mf~lFO`D%mvtaRoJpgUF0e`dDou;`>yCV>= zdfHk?!BgKjmAqZ;CIHQ|_N?Lljn(q5KXYeM*Ay{)(ucmK73W~(IpDf5ZlJFl8{&N7 zvtso{)~5$cx^oHVP2?3%f-snklO4X7ko(u6JV=qY?%i=-GXF87?H=oW)^nezKav>J zZC`P1K;D-G3QF%{;uuV+&TAP--?Miq2mnTd&*WgTM9~dK9IEpPqg@|t41lHHLQ%m1 z;AYZl$+`p9i8#rMveSD{1?j*7B9&-y-)t>5q!TtO0Z1xmWLlCKZr4MH0xRIlZ;T^V zlXL73tX&WH;X`{5;`9%10c5O@uj+Krclg@-1S*?x5!|U=!3-8GqhF?LwKgp174Uj+*f zE)Dq!aS`=y{#%2=qAWb!JwJz{S_vuj)v(^2xB zYN_}MMcdML3r;5-?aGzxT0g+Ik9w#AARZODiS|%~CuTrD=Apl95^kAQf)nt^t7+%1 zIbgF*_GO~L_4=#S!+7t|2*I9N-o&Xm zZ4RXik}y1y1U`9lQM<&PHr;^P$F9)Pf3of(y>K(E!c2-d0WX>I46t-hpv z+Lw>ao1dbt$Mf!MF?&~F{}bEYlv~F;l-XcoIcgFR>atv~(e~$W^I@6Iq{8~j7_}Oq zxo?frTO@pUNr{ra60cVb#|0}G;JorxBqkN68JCC|{Ml}Zd((`6(B*v?G}1W+L7fdx z`6Ud7iJK)H$K#FITDodzJlnZ(+Nq%|cs#psB`iI_59Z5?^Mf$Z^3UfSeSZ4Qbz=}p zwM&Rui`%@G(aEmMBjU9yi_mkTF~mZB-f-z+RuR>jwz;Z2}K?-}?&exl7BVk!hR5j)QONlFMD! z>8wf#PUT!!h=G~xE{Njq9swoj2`A?+^}wWcOvu&c{{{=o3QJ;so$3=Jwbc$i+F3m- z%tonkAxXE87`Hmv%{554Q2xlR(cGE>ZLm>ZQ*eW6*Spwa?MP8Qq`g~+mmvdasp8vM zj-{o+BKDbJ0dE*OH?d5Ifq=iPi?4{j`qG1Wvp9L}5 z4G}-vt2z4dHy-9OA^o_s9V^Cp#QXzL4>1Ub@Av*Om=AvT+_ll5GaxgVcTgqIQUf=^ z7}717VjK7>eqM3DIo^z1`tB^d#H6xn4K(krqgfG%yiK9YchoDH%GbV!&Bi-L*nl5m z1?GpNb#6yp3fliCr*yU*D{{Z9QN$_R_h`=fnwQm&8bl6e>A{IMc>YJso$J8p7%}_A z&6fA`taVQ0dqW79M!~;Iqd-WDvS}08w&MP&Qce{>Dxau8KOH@B?lMP6$L-e1%OehO zIs4`)I1F@)Bj|rlvA~v>9zHSyjqPa5Uwd;bSpTeHUymtq)^PF`zB@ob!e`L_rrb5P zJ)AgnvKIx;I2$P%bm^@>9L=zg-AS>mw6?HBK#jGOamRO!mC=qN0&46>%Ua!}uT1WZ zv*V_EiRbsEgm7pADFi8;A$^J>5Ynq@*I8n$y3bCmD^W}g;*pvDSN9%gE&9JhRQbL_ zv`X07zOpUtjLtwX{960CR+2UqOS1q&S@dX$lNI$Qx2jXZgBc;(>a3=Z&%-0VVa`Je zXM=@?clsZ>uJz`kj}m-98jSC`43Z9H^bUP=R6A3fvJ;>1zkNGByL3LNWES=#M_d1d zpMamfTf|ZrrQxwzd8w}{Yj6Z;JXx+>Sm8$v6W}-PvutWbdl9Hi<#$7Ct3vgAKQuqX zE&bF=><*Ew2ftLE4Di%t#op;5HMh#1xc=I$4sF#7`8*JA-k*nqa324?^XHhiHS6R= zRPuBc3iIi^f^gDn*;u|v7g;kdV0>oXLk4F9X2%%d1{7j_yq_p;#P{7!zJ|=?(-L<& zmQU>#ilj1Pw5(MkkOBiG=Zz}bn6DW$jd~4&X`bCn+2S!ArpEv+T0D-vRlpjpb4i9t z+8kyhj(fsdl%3q(>5g7Uad0P5u%v>U@7bZcBSuI{Rg4C*EK+U3S;Wrd&ZGL`e|!iE z#={Sd%Cj}18YoU)Agj7-0k-)x%L8pa^bK6hM4k$2vlM^1vN)DRc~hD3s}=FAQnPk$H;Etq^fEzng0yWn3zH~w6=cTEm>4AIPSq#}TK7Gvz+c+d>>=eVb zrk(qJw|7uJO`FiMD+uj2DfP*Vu?z61~$`A9tGf z61ZiCQZw~PR%GM|2#^}I)RDL`#*td2GSRr_XZV<;nrvSPa^p0K+Nf#u>*9g zzgzwy_^sCkOCU=;I-0S&aGq02bAW(pWUPSJqVxymUPu)|tj-^(GD{HsA~fC)zc&*{ z6n_Ff@4?lgd!G|BBAR^9wqhZaAUx-Xu|jwu5tQ5NI7UgKhD_r4A0FTr~VJ*M(gcm(k;$RXG61j>BD}Te9Qap zB4S$2zFpWScbbjEP3gtr?kB8^0aJ&uV07R+m%e;`(FWM#F_ky}*L-TLoT_?z8#{uX zg=BJdY!r!CKx{mD8e^;rGYqtr19AK;A*7|2s|33G_up&22ofJcc6ZIbhC)CTgC zI=n-&c*F9z?Q7QbdbM@B8`Qf!CYQr6gD-HAo55mG>Z&h9n8`N!L9nf|LdbXJ9AG1^ zO2>ga^%-p=Tjb@T}wIfoq_Ou*EPbbCg4Xc&ot0q zc4tmaBOQ$%t<@vvwRcA<4C%N*LJrSoiVSk!taHWmrJB3%7Zj)4HQ>sd1w{-uoe`11 z#av@hw&Bz?OG9NPU+8TB@qK(#QI%I!CxxJ4KVtw0E@Zowh>JO(npxvlWJXAvw zyaTmtz?b0Wc|B8tj%L?P2BSjwHNVOw0i+rtv-Qg>*Jq_a`@8wer zcVD;5yci0$x_T{6z~Q3Z zTB%kB1oVK7Aba!BIb zRX_)ai#WLP|1+M(jV=HK5(lZ#0ayj}MPf+Eb|iFhdoXr$cg8uY_?2gt9~-P;F~Oiz zV#q#jGtj-kDm*LVml>S}7=xJM_q33w1hU1Vw!H=9E4n^~VV}zQDPBtDjv88({8a2n zcag*?otY*}NuKrf5lO_Q(`sv~CwR9SgG2sfg53g(&we>i?`#i4(!C6}sX-P>SLmaW zTUgw6d~P{M!?4DFo}*QA;n$_~j{xwDkw-^MznIYuGtSgibUgsiCf=Uu%Fqp`f2_|! zAvzrbnRV#63&$EeARSg4q3C~$B!ivT4_^k+t0mS0E*kp0_;9uv#f4J(*hXqbZC zHI^7_ucG9M$jA9ki)D>9t=A#kJ6YNhY_SV~nYJAVBlWqiL^=c`8Io_}X)`d7jp7)>hukhX$?j1sHDdH5^R zZr+AOq_GG((#qVC6+&M!%KQb0N&kUUF_0upyz{k{mFKZ1qmMT;1octCT|=!f!$1eG ziS%0l#A@Yg-6PK;u0%@W=0I!1vjDiXGaK}+C+OxO)KrA~@fi<*5oKFsj(KPZY61*F znB22Mgjn_vgphDvjO@pmmf#FkG#9Z(VHU!uhz?E~i&uGKm#QUqU-Lx#OlJGfz&D-j ztw;1%OWs%x3MVaTh&z(zso$bYIZ2et@Z90F5XZ8}z8jF{^kOoG)LH1qdW(b!GC2=& zJ{l8#LM#Ny zpp}^zLEiLQ&l)XooDskn!&IJT z_q29;3Pr2>@88mU_hjLN_DfxaEF7KLnc1fc8MWEcsB7Ka=7T(6ES$8=i9D>^4F>Pt zC`q%b@0*IGIj>n4Y#g#2;8Pm3;h*j59fD@w?T5OHOYTBE<8Pn8Z#K)`fS$Vl7@-0) zvX?_-0|@fJI+P7-xm8{Um|4g2Eed=to;*$~Vzb}bQSb>^FjQ6}M1|i~5s&y&BDgTgDaWQOXm$3#5!WcGBFSs&MWI?G&U&FFYKWMnrFkM6S3|77ftHTa3vK@}td8yDY6t)>>G zgu^SIueMm)xQECx*gO}laB+eR2E%?K4xA(BW#+@OmQ={WRBdu+S*4GL25%cc582I zIc-R6{ShAep8_dvQMrY?R`_)s=N{sWuPP)^n%^B zS0+U5mkTSP>9>`3ZGm=F;c=yQ-l4NE(q^d<;qHh{p7VM$yUsvQ?-v1Nt zzrA?1mP5FD)nsyTo-huHRCs!_B-fy6?Jw%{Zv6dt4s&XsKL48JalU2^l^25%w)A>G zPIrr0gvKoKzVjo{7|tiq-nWW6+uG}C&7zSs)xg$LU?tyllJlr*C6P{L|&UeRcNgU$TAm6k&lsyT_8h0T~7%KN3i1@ph`l%!jer2y$bHDje*NHg#uWc ziMrO+%!?VK<{nVUbmmfvHZPCbx=-mkAJWnlYo;U1_DEV8b~6e$<@0CRqnN{2{`+?o z=s;9wI>`SCrkoDQI9+Bg%!!;u^PVP@6D9FyDdG$BEz~85psc{<=Hm&pB1noM2Ng|LTH=-CP zyl!^k442}`EHgJ%KZ12a%m<=t1v7u*i^6(#mj;P2g)iY(fk4Bhsuq3)B$4F}9)A%um0<`Kf=i?$e6y5gzfO%q1)v9= z85s!TJ|;m_0Ug_wMSb7ivEDPw0Q>Q;G#+Lquxdiu zIwgYzCU_1G)+yg0&qm~y1a=qO;(=TLg?&=4TfGKL(~9V;Zs%D2$5D1n5>HaSjWtHM15{aa;Vc#t{!nu!GTep zaK$W=An;PP>#i^HOa_QHRE}jxkD&7noDOzf2)G;_PACeEgBdU5kdtfYQ)s1})~k z`cMpnl&KSyW)^&r25j6nr6pF0LVLrDkU?Q2qiJzH)F*imeH5Vi1pL;BFugV+^~7dZ zmn2J4BuuVpz&g)CPY&!1j6dN*3sQ)8z*lt(T=TH*sQ9Sa&CxHT`wxvofbresRG9f( z`!*M+UGBD%a?x6j;pcNxbd&YQ0hjHwbj&(OwnOWh!8jbL!$U{>qEi^|&0EooL;Zw! zqlbMtt1Bk%Qk&5_2=i|BG`66Q@o>gR{GI@VhLBGG01{v^6o7QI9TtMDx1j=hmv52x z2Xv8Zb%6Y?ftsb3X)gM8oL2`K@r5ONLZbhG&>yoV*IJd6^gRG`KP*F^%}{UupJ>=6 z5}nn`e8J)`|0s%RJOQvB63%q9ljCj6@9)0%JwbZj(hcM8Xxgf(d#=SNigeJ47)WGi zBeV~@Ix9NghybnV-o#qAQiTaBD&gd0w@YR=$fo5v1UQ@$iiziK7Ui; zoeS_@1#+wex zs@rnx(TShL=ik&m@@ea?%C<&*bzX!t=BGC3~Om9pyKM%C`S zqHda|+ZgeK4-cU!zAg0HE)vy0B>#VI7Q!EEJQou|aXzu=YY~%@M6XJbyLJ0&%vNts zP?(2^93(h0gnYwxBu*^lS2cao)9F_3^+434(oy%8zd~&!GD_3lKG^c>sX8(H%My+#Gt^l8!RHGkVq=@1B^HXoAc!N-4rj9e| zETk5#3c5oDjbN_A;u*XFA$a_lR>Om>wS09KzA1U%pqF)%{8?>pb;Z4H%(Rda_-kJE zCLF*jU@!i1z*gH<3#jDW6ko`v{Os~zvVff>c$tj>SkG|5BYo*TBDyicTVzR>z3uBJ zgwyDYz?ID4aTGc{5h5H`L_w+k5X^D6WEiCnW-mEop@O<_P&JC>8-q%yuQMZ|j7Ofl zCM@B^1bKZ)jVg~VxbTJbh74MXEJFsYaZZe%t^*CqD#@S5-vN2Rrm;397%-E!v8REM zO;y9ww{gOePeQS3pbwdAv(B$*8E~oVx)yuC+lA0?9qtNxT?vc9+x}DtbzLJ|z z)m#|Uj5m8>nDKQ>SG99)93eSx!?$-+ZpURtXXA#`<1F_)!!nb$WdpS?Dq|XN>)5+Gox+%mec(#g- z2GU9)zmc{VJ7vi{HIP?)J;GXj!YMHEBVvb4U{HmR$_qcxv)GpAr}Qa?UBQk+kkFHm z6192`tFSk3gX;{bHFuv^9g-MqzhE0-4)5CzNcTMSGrXpsLb^?+0#Zav)}B_Tm_H<* z($~Uy5G@89yHc^wOfd|CL2`roI;8Oq)w0>H&qJ`iZH5U;6VO0M*qiDXY+bC&{W>3Y zTXfqu{%XGzZ*a+TqX>R8Z#LC-h3&$JmpBE6$p;aq(ckC{^nqgH8Ch6g_MU#OlY}l-YrNI! z9`qBbxK@O4LCo7kg$Y@9&$e9d4D2P>Xys<`+v9vuLYdN9$Na|q;Y^6^V^wDBA1%Uf zpYY^BVjYkmzEp!m9!!OWV;OY5;;wrv-|1b=4?_Yqpi*J0vkKCrGwsurv_`ej41Hxo z0Xf@j5YO7L!&5_-CHlZp;nwW0Z*M>O55^Hc3hFz5=fna5$wJ+Bo*E;ZLP$Qby9)=} zsS<;sP}Pe@;{+TVI>E|+LiQ3-OF2$pbY7OQFEt*EEm08hO9FBEJ_uP_=i&it*b=IV% zLE}j>7=TIXhX9j!YXxEn;nR!?wiJHQyDB|lBUTo#`P!yvAZ68964B#r4ai zr>|y(#K~bX)9WICiDd$FI>CV3B_E$WeyOp8s-;q$9CC^$6aa(Oc=p}sfm92!;JuRy zLp@q4v$nOT+0PMUpW%o`B&SS!{tEG{?!xZQ0}Kp@Ck1$r5pkU1S3jGf<%3gQ#SuQ_ z!=Ym{BtEl@Tr+7$1493(j;$Px37y@^6V>s|-yXC50{bYYn-=1VjRF7%?U^+3-5Sm& zee6DdyQ=xa@ye>GqB5zrFWM#?7zhqh32_Flh0EmF*bUot$>a)s`}{ zTwy<5tv(S3y;_j{8%G^6E_5t~7r%enoKI$Yyi_8bPE4i+x!D7oVZpQBwq2`ROWu-z zk;9I>jjjns8r12G`a-B1nQTxFHC#NTG)-dc9S>3)jDe_uq5cZNY0GB`en4{-0QdhQ z(J{nJu4YeMoe~U+eE#X4ixrIFEDPvnzUt1K5JB(y4ocPHx*lW27x)(_5okrf&dDL znRsR9_3A6(rG}CU6O(4J0=rVTt7b7?U%WQv>2iRT1tBVDBM4|5r!aDDjN%Y936QY6P2BydGHc4kZDe1BH2biK8KIpK1Q7nF-1? z#1NLN5DmPr%M=iayE5Alh`sgY={39KwpZ%5Z5RWR>$-@E0W(_<(VP32!aCz=5?zo( z#vo;1%fl3=PX4QWc~&xtkt1>u4lbMY(0njR3g+m!`uXP6{sZPYJRESAK_^HR7aJ_@ zpyDpqieKGxPep&E|DS0wqkHgu{WIP9Z=^P1(V*r2=!NOZ16uJtSF26|drZxxpeGkd5040e>ItNW1=+B`_-GFjut+2!JZXK zg8$1^{|f6!6_Y0)sdIXJ#c^Frjgum2Iz93-xq&orfq=C^DrUra&`r-<-2eo+z^-PH6ws6sd=ly^4j!zp-wu`fIsEC6DHC)gvA3Yi? z%I#hY=tZHZmNB*ZhN?vDXmcCZ*#nH%=U-_04vy|Oqche5kVDN#;gU!kdhKslEi!lp zYpJ)+9?&?pUGgt?shDm0?+WQVmz-Ei%qyG6h}e+0Q;|uHVLo9l1nI-#(MA$_x5Y$- z1>-p0lJ?)kAekg%z31tua#>?3Z99dcwx1N&Mb%)wPpS~rQ1dzg&mf4nQ^xS&VB-{S{ z%L8Vvk3Jk{jUOvhex4%Dxk8D)(d?q1Z*ObqG^>t%?uz*^2Nv*#<^m|f-;-bKGc3u9 z^;nc=0XA&FWjNZV7TTaP*Hus(D(4sfn(MPwe=8a7Jrh@wWTPdl)c|~`)jAYSX%2p) zKn6&=syCGZ__eELczfWm0IZ$~NMJ6qiae_Cl;%~G7MmTVzbQ9zgu!?{!|%;O`xm2Y zzKc(6*doO9+kI+LKyS>gY~6PZ3Ji8S^R9ZRKQhdI-_XYp5;fXD9nDxxdi{tD_$(15 z!KIh1=RO_)$NPUsHFMQ+`D8P^%%loEwvQ4X<(D~c6{pJLs6KoJvh z8|`=E=DsilQXc zQE;Nd3`YKrQ9&JCPawsJ>Z=dK9uNeI+CbQoPVIPLb_P3ap?!oh)h!i0K z{k*Bu;XFuS?z4OzaPsN{Co|3bHoxrTi)1;@{Oq|P!~k^niq$&Hnl2O5X|=#c@Oq0z zlJ8AO3-w_3!D1_#XXaCnEYeW|ybXfKVZoWR;Rpg29Qd+AXa?z6R~KUphXP|{$pyo# z=O!CjdCa?nr_(koWxHtUyPh^lQ%HA|IX}F+`O67}yHd1?eMWBU<{y9PUH}XF7UIFK z9lTVpvx!iaHN_RnnK69_no*^Ak5p7P5@i~S7-tcgA{%W7QkulK!O?SDxMFR6vIi5I z78L^pFgCtfeM^ZToky+ctFv<>k{1>l9jhV02pB@jG7+x?b^|Dg1ED=4fT@Ru?@Pj!x5{ix7dk7OHCn;) zN2#dM)$C%6NBX1snH1=#TPL*OL64%HW!D3;I`9v3!O{5HK6Fs?7LNyh@?Gx*TN=c0 zNm$nFmX+RuC=cSREu2)K87Z?*KgWmutbmATw{T`7xbj;{RO~FE6$$G#yp+0UWiHRY zRy)6rtzt;by{UV9a9JWlnB)@{Id=54AHljCP*z_us%ATj2V?(1di&c`3Na~V6J(WB zR>7j!+M~~cAhZeHW5JhkAVxTd=c}udk=`(8ipQK$SaB@6EO=nFmio7i9-O_BrD*8h zj<3)mhtUF00ggU#!BuOMrSOhYp_O1`-b+CnRBvQj&AcF6fkVJtbXU*S7}RDc?5%BP zoFJ)NqB)d#{T7Q|cMRvegyn?TvfN zWk`x5b;qrAGHwMNC1D4x^7dd3Ed5VdSxOT51aDe`>J4>)0@-9y)hbA`nAxHy(Jg!K zVIiY2&vJ-QkUe|&t{yPzc`VUpd~1b~njlsj+>()*z-jFja6LAnUdTc=<1tH@DH4Z%{M#LupDOxUskF56&b=}# z5F{bkop}Y~Gg0X@^3XIM)?B5!`o`8%LT5PI7_`vjaeaJ|;A+`xFP{$lyfaknbO*rc zM2JkN)$xF{JTz4WdG^n2Bnm~1Rnqk9#CivKUc4Q=o&Qt(Z|#k4ztQvMw$@P#x^N99 zCSX|>ByMW*62c2Vep$=DdQ}H(?;5OKT=8E7XDGotsF1l7vi1-hc9J+;VOe0>sNKrsuJsZxb#O6Ft9!q#n?4~L(P z5g?-0@AzjqCsGR5H7P@**D~hG8gp&PeKr*Sd?j)p;9A+1P6r>%5VmXuM=p{)uve}B z*R)WG{p}@bz_08-v$L)Hj9vXmR{j6xfl#^(jsWWE)sfv^M%oO>p%CHg52RYRSnc>+ zV~(F=$9;U)?aJ1Jpu!i^E|j=olo+B@F!78oVryaVG&fV?lVUtfri^#1KWl zd5?7AsGk=C=`_!1rGrM2ylZZyeRP}YPB67mTn`c}A$1!v72SI(#6DK0ej3uXDE$Tt zXi9+#=D3(u+uGHRkE{bnRxzQ%F6}Fb4mebtMm`h9c ziVLx>MuwG8r>tq>svfAu>fHBi7QfAoZvq+XIr^5Nq3!BV0QJC@*5SMB$seiSoOPi* z;7d+ZBgGMIf5p|+49TodJDm-^{7*wgfN<=6cjjOiP#6APMoYN_kV_?s3jwA4ha^^_ zf=$Y&+2tU8kh@{olxY{KGa^()TkTlZHnO9%n2p+CE^_Cmm!)Z|4f}4vgkk{@4?|WY zg9W^TBTBQfxg_vktBnA|e?Qn0!lZ)Dt;pxWg8+E0n0*ZC+rs^W7Wy~V2Tb&B>7Z?w z4Ry}yITy3hWZ9HQ#QaC3uN@3Z!TIkC(WPMX2q|1uC3c?m=#^|BFbL!c>lgHxsvEbP z>MqoOXiK~pt^>JluHLoD@AebHG|ECA&_zXDxM~hK8kNM>>V{4o7kKq#;Qaqg<9;Uj zu?EEV%RQ)nBw}@=E-{|Foqh`y%TBFmPweS#cFAt(^zj|^P=W43Uqeg{?9l}yD~M0#&p53_?2X7;ALUnh%10&0imRVoImafD@@fG6U^hoEWhl7U~U_|#w7^@e2f2n;4 z>Zz+WopXz%A4W0WyFF+&7zNeWM|vF9fDDKQTQibYE|HG)v$?J}1fH5;ra zn}CWpK-VGo5tP;7cR1_Pr(lqa`neZ$=+&Aj;bAs&%G6GMbMya=SJJfDJ5j{%a6u@{ zY7?EGea2;THuhl5OP54&_qo`)ykebY7uoZ`8b2 zClEciHbK&Cn~K94t2`&vgWW%&V2eIyo=tzG{HC%;IJ+XwG!nPQgyPUdd4cbRUjq#b zesBZ#iTL{*w%X-re{;%lJc&}b6iYU#XftP}QTM0zuf-qa;K4?nfiO|^9Hz~<9c`>n z^iNRXR#2av_9_XL(b@GJygUXFZlP-i$dx(zNO%C~?gI-cjn{GN7h;>SIEXi%=x|nZ zw4FOsy-WJ7Y8+ z$Onb*S)|rCXQ70Ll%l7h=0d^SWs#W~K|~lSGsH&%SWukym9C22j4)8&N;YUS-deo? z4UpLKe8>AK6m1sY$aGJ?EDLy)%2$m=c&IEQvt90k&NcSy#={1mo6dCQd%6iN@Oiok zEohB~(6;9*H7kARK?Ol>ax$=P&4BO13%roEDVoXiErC7otjnZ2e4b|;4ggD}53ZmGram%{B>K^*u0q@m9989Eo`?s1!5-M;TZN>3R{{>71BOjSEpY8Um zW(!j!e^B2Ka*LLhp{wreo;PH8mvb#5@hiriHQwo#Y#(D_J7xDGzOo0Tixj4#41Cq4 z*;<`wyhyi`0@xssb+T?2vl-tx6M}XyMk^!_ac8Apw(?K|EgCCtICB)dBa- zSG(J<(bp!``lD(SEo%~1y>jFrnzu1SFA{dZmecCqMi_hewQtk{u#~UX^C?y88AJ^9 zSqr;bJga_N1d0a=W$Fv=8X$KHqrD;}jPV=?>3myqpUGXoD87dET<%G9gWo}tx7 zr`r-gjDMCb+;{}aEi!QaBFBsbH+(S9E+r0`bOX9;77vGkF{v3)ct^9PjO zP9m424lEz9oGMwL@;<$c5&2UD<$MLz(T=oF4ow~P$E=XCncxzvxsLiB;COcSt zUSWP6Q=BVKTd!h9XFBC_>kDM#^($gk=7TWL6$yrF;DR&LCAjL=FW7|5oQ(3t+odT~ zs-PSwfB&$9$H;-)>{?upLT1Hu3nXSvMlGKXLFotX5q$h>rpi@layHPMlKzVXsd5Yw zJCvG&vx!j2b0=DERpy|{AeaiQd(@m&7`px#@#8yCMF)~9<$(xK6_ zHudPM-uK)z;NuL|pb!+>Ct)mTkBL`Hm2 zMzwmLYMrOLz%IW}rTAk0>D9VahIZ0p)%hnT1DQge!zKS2 zHn{PHfUadkgA+sf>uaoeKJYKkhHPia^nyJDYJKp@AE~W`ip?UBo8eylaws((0mCkL z;qIIS1lA_o?dY8);Ja6_;yXVUD%yrr5MYw9M3ajVC1nW^;9&*AVMYcddy82sLY8M$ z@-lHUOVN?%oFCB~tV&62?hgeoyZ7zIGoLqmL&W&q0!!Xr)G3^0aAen34axP_QEd~7SJ?FmK_sT$4X%v_X%E9Hi^Le_X`Cx_~< zwVtC6baw_4hn(3z`a-)r^vvx5hO^X=XDG9dXG**!nC$Y>A&=P3L0pu9 zJ(bL+a5>9j$@a2xZe*4BOV>EQgQ=4P4;%@l^`HEWaNY}oUcL_VBvwB+6L(*0HIafV z;heow5KW_wki1%|g#aeK{Uqmf&gARRCxstKE($WsLprVqDe`2gJhP8ycJu`hPRT|a zA)2P4wmb(OTel4$1UN)@o%gp_tMH59cw^OqLH2gvU=eTKzqk-?rRV6leVRmyXSjS7yW z9gMQ8zRFj82ym?YyB}o?{%Hpm!z6cKY^4&dAxLj26vtJ(Rt^nkQ)Nd!8SrkR-{RT7u)U4`^l|tB=aF#F8j|-J#W^LzRhw|`U%1FyxHT&#e1R1 zb%5E01vx)9GF4GPy>Fg?xk2z7Ct~0%S4t~mcs_46f2Y`KsOenR1lbuPxyOKxRl3~~ z55OisXr>mm-C+N6?sWMKr#rBCsX#-A{A{iUoaW^vrG91Eb;mgC4r*OmavFLsm#qxw zq0LmgFPtD*Th9WfK-v$4Qh=nlT?dg`gvTRWwqa1`UBE@T%!(g&fQ-2W6b0ZMA0_(wyBOk%Nc0$V%{_ z-)q~6T$lHxhao9lUcwr*{=QHj%CWQi;MU1$p6*9y!URe-m-Mlhn*bwy*VdrMBQ>Oi z)Wm6IQ%6-uy@u5^Ub$6P-E5G`U_K}Ww*T_a=d=plO#)OL)vEN2L- zEG-0u0`b(K7%tPW7($Bjc3p#Hn9bOrT(Fp1dt{j|m4LDW?P9f(rU=@FD%Cd*thy+w zbf&GdpNBZQYIxRHPIlF5!=ESR%pOUswT81jW-goRoVV)U!or11$rVLbNq^hiCeqZe z|DS5Q5%sSeVi}R;thU_e6~}&_+!g5`8BC@chz9d)>xS(!k2nLVlA+zj0BCpQr{CXPuV=L4z>KDk1 z;4jbXXOVx@Ksu$_tRaHcI)5N8K6#sNPp{}L_HcW20`^=5eyM^{hN7u@c$V!F=KrXJ z;*!KMs-0+XuT3AT(&e)`M@IT+JeM*%itpFZO*nS<9hspqrHC;yt1>12+&Xlst4So` zZW(kHexW!-Zi{KVf!``*KVZ7q1jB`(d*pc5!%y)j=g3?^1IHS5X5oEG`|;;d7lN?# zgn&{{q2&~=hwU8uyUApxUTAN#Ya8E~DFFA-AnS-7Axd%x8QA~>#Hcnn2C#p_rPLC- zZQgW*P{gC7gE_NU9Ya%ON_B)Ara+BqM?xICYh=3ZdjX`vGCJy|lx|ptBqDNTkr@tp zYIExTO9U#h7$4ky%Fx*3G~9Qv5-h@+2Cj69QLUP@Ak6~d?y;(Wr`sdPG;6Q2s4h;=9IX~@*RCm8D$5(OP6?If%!*&#Yc zcs*HfIAf*t8L`Fw9j)N(^O%#lgko=$>@vOMG|=l3d@R*pSwRft9Z3B7_VA&!(7F@V zBxroXpLA>NCT<+%FH_Mjt{sw2DZ^CnsmjGYAoWmV+;4az$-_~T_zrkqw8`cy0ri(! zF|3?1W(G*E=H78pZts%y@N;&F%T>%Tu^)$NE;M)~=?&6*Q z6~Me8lvb-M-ql`UC{-Ax$7y${^fZ7}%7z8eE_;+QuNy`#lEilwPyuY5C$t#+pX7+# zTD}QVAMbj&RNO4Dxy^Lcz$~=QUKu3Oe%VOGjcJO`O`+o>T49TDhm;z0{#K&v z5*$w3gdK=a2Btgig?Kh6b zpz^MTHfP&7iv+jOj={5McIdW-)q9D*t^E+XT&A$&|KKBH&+<3Wk}e%TNGMt3I?RM_ zYd}j?VS+bnqu%%klUq)a3N{F(9FsEkx600)$@8f8qG!1Sb(Kt|l?BbmI(P2?Kqnj+ zu6M^p$&o=ikKxgpv*LQFT2kWdktYH%qj+mlFK{+UrgYkl=ACbS%zt&K3$Bg)Agc!h z!j!-tcf5gM)2qPh9@%gG(ZrwR`v7iX^6VT(#}O7KUjxYTZbDR5(Ivi109Un3G5O8CqcGQ#EyW(BfQgJMp5%EU34zM?OM6II9WvFLAu&o7(MxQygPRxQkH*O zlv=>Wqv0g}J|4H(okX<-*WR&x9{uTMEqKxgkAT&a2?wGV zgA|%Iz-X4D#BIHlJrQ}8Asqfd8}o?Qg#}JYwCSv06**1x(a!hYC$-?vI!r}`FFP2H zIk1C@$U=41&tPmMqs1LmsrSYE|HT0;O&@x69hKamLJ&~Q_#~D8O>{p{B)m{+U)}{& z14-&(sZTn#bk zd~{K3Cy~-zv5UI`g(Q8mRkOiy|998#dxQH*mZ!rdn{4a}5 z2_^aW==i1E(Gr^Ceg=-Cp0b3Bs2O#2}e zIK}g^9?l%oDh}V%JDSGBn;BDqSv^r1Ft(WbbLXE^q`|hZOnzZ*($Z63fuug2nFPj> zQNFb_xFwlUE^qtWsitYUoFTpUPgER^BAC(!&Xxk*(ZJ1~^=i00cBQ@?h4Mjwwi)jX^6HK$W?w_4Rbs4EKE+yCziTeP^=%e%9^P*L124;jFp z9a<1zXU-q>o?u$_zL{D>{M!7h>I7AGz5TO)0~=UsD0>%^Ay^J~GRuI##eWu{eCwMf zuSRYoijGL=ul;sn?OUjwYT3K|+(@DBG;qab`6p!#;L1}dCzwno z6!@_|m-c`0QZ%pmkx*{PGy#?=>5b5T`=fiaE(^!ZpzGXPa8DkmOM0t@o&Tt&qs2in ze^qaw;mD2hr3J9_bZjz1=42FjL?J2V+pOOyG>93W;R3q=cTxZpFoHv0c= zP+A(^6I1z@gV1Yhin3qz?8ON$;WRiV%3?FW+!9kJzkM0ZK62oPl+>3p4}WZ~rcbgd z%+V{3y{&*qDNLq!V&)OgxEjUw28cJqHHP*lE_A37&kC2|(B~S|mgm6DTnnP0%~O1| z{4i+x2wkvU5Umv1 z<2mbfO|*Ka;2q-|FJR<=1+TfN5i?R+CiGw?7u}8~%!;;bn(H`BnLe;$^ zg(16n)uv3e!6kCh?)LSCaPQ6zG=*hVM2uLnNK^Z?yFF9{@fYE_ z9AceuGj^yCl5&v@h^PIF7-0n!1|$vjV>@qd9>S;WNB|7*W0;J)2YAyB=Mcmjd2X^a zYEen)>kAVFc`u1Jif{m#>4ZI(XHIiAjR}ewrb(##`tyUfh*hyX<>IUpAnv$j>E7v& zdY??TlhmPuBvYBuiiAo|$@7K7g7aWA$uoST1)D0k2;Dwtg;OHsX;E$hrInZ$HKY4IISM zbS5oQ=5S9uGN&ygyTykXaZT04bLnd5ge{^m^*RcLPITb*73xNn;68i2gH(v`YVTR$ z<3N)zrWB4w5}Wqs4x_O*eqPJS3qB}oK!BI^dpI1btLpVXzp0n2FEV2H28<~u!PEKu zg`d!64gvplx40@$hJe;3uwGElGr-P$N2~EW0IxCH%D3+R?%<4ihhrnF5Xr{>Cq$lq zpX7Wwi5UAOfE*gbGw7GE5qRFeKiQ96jtH;SDSzrxWd?Pmz<;Y`82W9Sy!4XhS!P#$ zmQ_QkEH;CKzYqn}C}6oGk}9P}KD7b`j=6c4O;f*F1&Ne1Y$h8>*{prGdk@Bdm7PLo7S7>$OiP0S8(}x<64)z1S_)JuCDN zS4ZU(b*nro;Tgc=h!jQ|pn$6fZp(4k9>-e7t#P{vhV65tX|i_heW>=#wFC3TE|shy zVrhWpeH0yDVW5l!Z@=myCXj@K#Wg0O_BWCEv8;wwK52s zwM15z%`(y990Xh5aJ@EwW}(d?6g-;^zC-!L5SNUs44)U}WJ5aoUspK`vUZ{262TQ! zMEB}6_?i~YA$+f~eW$hv2&g@O@n>Z+ZfqQAH^(H zt-b|JYYcBWRGxvLF(XAl@J?4kef0jLjEE-)YW6o=1v#tdz!|$Fyr18$D|8^}+T=cF zshU~+ED#I^+`0!C zj{GxZe>KBvuFw@)hNW|=OcNNWLDcEJo_+zjRoGe*SuRWXaFJ`$&LVdxj9=r4DUTD( zy$7AT&fGC)gOc~W?8;JK;$@uy;EVc88b=Yln{1T(XZ!U&e(BkM>U-R&;vR^pt!b^L zq9Bq&G8vfTHaaZu`5rJha5v&!Pysw^PaWnAJ^S{KmVD+%Z=e-MfN4-)2~8Ry>78(c z_Yw5v=;?#+7?z?5`PmRWcYA=g|UDF`vmZ z47Wgk{lBD^xAm)6qX+Dr4r&GUz|AvNH7hW;QD;R|+}s>@frpStehnHT7`5EU zwtWf&lOGwrh>f{p9KI6cvPS6x4Uphv1PaLKP3f$Zsymc)w1%_di&{g?YoOxBS^9#SVR&mSFf+$^?w(__fr6oy62qd$*P9 zyZ@5s`EQJC{bH=wNYPewgE^Zo@{7H9eokvZ13h105>rnLdXXWd zgDNudaH>(X7mGU-B7A5CvHk=<*yV+cpMs|nGVs}(e(&wEYoSBdmVzM4jovxki&>$a znM@uPV_li>nIuRW1$i<375EP;#r16|U-pF|v5@kNU5Z~t`4614toBT4-V%#im}~e+ znepfcudYMGS8P?QQIw#=mjx3SdK75Xh4WPzgP#Si)f z#*{x&C*Hns>FMOplYSC-_wN#Is%kStf zxmFP6l)T+B>t6gqb<~~CJ3H3~=<63)5mUd9Q~QAx)L}gw^~fC=b{@>NAHYJ{oo=wX zWtl1y5qV~#Q5SrDh*5UuJrm4tU82W(&7yMV^(Yh;w!82;#Tw>>OngG>jFwK1g;1l9 z2Po>{OmKsyrY5H7F`DoIV3t&eBN{0U$>w`%Xk)% zkOMm`%E9`SVaYL&oZ z{^kae;_&9L}#BT zXf6dBmc%KCMHvUEWF=33{o>!AcvTx`EHAtZ7y zK6s&k;4Jp%ap8{~#Qrjztc^#{v@E*DZ<)8kUL!`9?F%(j55%vtY$$nK(B)Hfl)v0K z!+F@>pGI^+c+7IK>{Tpx(2+NP-3ZYlCtV9^?H%uIa;YZNLAy=ZGZnI>Th!sVIqWm_ z-!!7bTIF8rsI$QWsxhTCO~`^pi(}H!e&7%~#T(hm`l*ik#x7ZsEiHsoVkLyB@Tf`O zhYK}*(~zMs{@2eZ2TkgMLp!VmauJxUh}~eHk$TmIg8n;#Lq z%$P#b7;`tXy3FP7^o$RmestpJNP;fr$a0L=csV^VzQK^(`FG3osC-XVFVW}#$5xd^ z@>u%asU5}|Cd8FD7H)7?2UhDYk+!>u#hNWz;!H!jnmskhFzl;9WJ<02^xg}Q5b_w1 zVS=uznFU4@yxLP$uwc=~m5RfKN9_%ojbnarVD^AiG6TQYFn_@6ACs`f*rGKVDJnMI z{QT$r&FEwsAQ(i*!5>NFNvK{GwM$>v&4YNycIw_HT z>C$S?3|?&n@|x>*8!MvwIk{V@dBj7#)*%EnWf20zG;|iwPRlSS5 zDQ0XF@d~RQMausAS;cB~|Grl>qvAx*hMkaZBkn0iEey6@aDPC%xq^goUIf(<0eKMLSaAigj1yVq zqOs8vcq2bRwBraLK^O#2^n~HT)ad2Zb2;^>QzL31a_d-IumDMh!p7)mHuoC|VZo<| zyI#72|10`;{tYIRg%A7g#EeN93n0A58-CS2yOODsyWxWIIsZ|WQY%ok1ItoQDo4FOB3g?`dt`OHu` zErxxNH>V)60^pr$tmok)4y<59ramq>0;=V#PTvkfk(JnyRg|mVBeloq4?7TM>t4$0y941Vg$@B_$MEGUn8z<^DICRoa?XF9Znl~U|V z$0->d@_%Yv)NP-1vF~u^w5MiH)vMbmr+bTCOQ}GLGXSp!ueV%v6*S4TlCPZwGv2m| zz>r(qJUX96NTGg7-QTuy_KKc$4g0k#<7$CxWy%PO%HJ}WVIL|r45 zk&i}e5164UoPYj00=MlgM*gf-c+w5N)vxU6O#_a<&*61S%;L|X}&c_h&d%DRjWfX3i3}| zFG#M7hN)LI{eHEyZsL_6Cjgda)Zhc~jHc&l?jW6roMJ-?mBiL_mumxn#r zEKXr_X06$iRzGRMrxFFWBwK=$R?Ho~uQG)FeJ~;o_H+O|^{=3m*FTD7Qlf#T9sSK$ zLG?B}ddoPO!XA28V;QAOt+QFGDH0*hl4z-4ps1ApGnJ&PU> z*D#k^XNkQ*=iA)1$1h61l~@!|qkrgkMyhSKxjuGf@(=35e6E3I61q11j~<}J|OXNlpk0HL;sov(UcFr+9nR_;t=1HZzC*3DE^bX zuvoaGPU9LiC%Z9K&l`)D*Kw=&h>44UOcdINpFiP#;?C!`p@3x9Y+1I=}E4jXT7O zVS~Gl4>P+0zvq>x!b|nu-HUSh++^@zJkY2+Q?9Ea=VZ6S`qy8@TiOMzllcefB#%Ck z!Fd7%Kk0ofBp-l|L2SB!`JVI1lzIT*L*fp-po~B|_z3DdefFDthMOZn0&(IPqt_*% zA@!W56xI_ac?Fvy76F!5*&yADm`uRX)Hg*@WoAcXQ^Pt^o~eott6%-HB~;f)em`?j z7-xD)&Zt6h`C`pMhAvxN*7UKh>WsaR1O>D9DY9);OV{RB_@BKW=ZRrg14^lyg&#x!UpNGbclmO1d4EyYOV!(I@cS&Y^M&dN@sI^)Y7p^lSzPhXjz0)WoS{jE%{QL^#6YyMVV*sJSs*u50`N zIH}phA@Z}!R>j{N>ehPliJ@&H0yL@;`zWd!^6*vpIY&teh`;DU z7cz2+6@7#?w{A&P5W#D;*)HvGz5EFgo7H3{sMF6ki4qfacpdSeu^3foM}31b|1iF2Gu5FrdUm7$u#%YV@aj1RY-gxa-y6nq-|n#gq+!FwzIRzs?O z*=L=weyyA`knR9T~08sO8rd*OE;M&?%p>&lG^zmP3Vohx)Qx34Y?Qk0$wTl|yWLnum1nf*h;{ z?F5dapMg}HUtKc<-U&tgrrA;gNE&g5lL3LX0{Kp%j)NZ{ApZ?_4a@uMSSfk?8}_H> z?b#WQqqzry0&{xjpG^W9M*@DS0KlK0{Wq#e*pKT*oh+EZm<>0dBBG+aSS;9u?4|un z_bc;2UidRw3*-93qQg=U1*Q3T^xxU03U1qFyyH*DxW0dEp6I zM%T95!!dQrbq!giUlHXjudQnn z;F-Thf(NGcbU+YPyT^(CT&a4uOJv_N zKrc>mLm(bxVQI{)jfum7Fw2nsy9pPld^hPB)k9qHT<6Lrd}bdfJfeF3ZVQB?SDoSG zDs{Jy^nv9$ntVxJ6vvTOLY9oD%3Zg4wnLZTcbz)WouW&@@)G8n&6fXXNfjkma%C^I zzwYtCNlf^o5EM}rUKO$((_rraK_VAV{G$*OC2{1~@wocEbo{7Vt(5Qv23qwq2_FlZ zA$uvqfEdJpf!$}@hb6ISvYQ|zs2)c{n^5Hk_@W6QHv(rr(qXS;#;g?>TDq^+(D{-; z7~V*OeOmgc;IR3Eu@K3RXHPoIYXU<5`UXu+>#e>+ipTok+X$6JdTn$Mb+XG{LISlV zCx@U}YXYYwW9`7^qNKiWzA!4_*#M0RnNt@L(YVc>x`>(UEY_UWMV!`%s??H@*Z9Ce z+7(ew|C1$^sTfI~L&SeHW~m<)m%H%Bw?z4y*!p}9iyHDr-q#UJS1EM(mNeBxR`4Z) z9RR(r0}+qlAXLyfwmSxxKhUm6P11N+>&o3zU_to<1SYBf={Ll07RMc#5J^wBr@_pSs|m`h?1XW*=9pC_EtVHe1o- zFz5hm3ifAnAz|D?Gk?jcyhu&q=+;eMT+rNi}x@gJ^6n)Zs8`x z4XOr`yxHOVWbH}0ty$?eN$u8uL&T!=G7m6v5}z48d3|$ zi=~YQ``h;cO-j4H4>LBJ-(2)e&V+yPBGmQg5hpV4A?mfpb6mj`P{YRT+_3+SMxDO!B-%5tnd*Uj7v#V(c_jf{=Th$px&7x4$k@rD-d!xHt zr`V^{IZOx-@vm6}z1A?G!bBS<)y6HlaCf?3+Lfid%V+=){3|r=tIvO{^z&Wq_w}!M zJ1~w$H=QAE|9vXni8sP#l4?yiZ>^T7CyE5dy$|&0$<7t(Zu$Jbjzg5Xo0QVLZ3^rZQt#viYpN%0 zYpQoM7$F!3bV3Wp&t$|pn^khqk+~^rQTN}ycod!%J8KQP*5s2s8V!?mCJdpmUi(H? zKJLe6d)r_R13fk?ixy0IsT|EZxxDp*zqQD!T^{Hi#V*#HREHH`C#e4OE-c9}nIN<- zl$D`?$zZm8mv_HSWkQ=6DA#hiC%?}|Qnz332!Az8rN4pOs35{VcEe%H;u0YEeh3}z zZG(f0oL{hO6l`G&3iFWO=>nMYaYEa;C(|aZ`1VtOPG$iiU4bN)<|ft|wBAg}&tNG= zyx6p+Pin^u6;3l8y7E^(C^aha161oa%J@16krmTwy(!c*zgh9^^*&wU&mg&J@wU@% zk4Y@CPUbyY{4xkBp&&JLQ{R!h3rF7Im2BECJzpK_5Txw(+SIc~2+5<}tGv6Np^9fYcIe9&N(Ot1^qeC>ap}Pm#;oXt?VO-V+o7ysX`*GudRuv?6nz~XG5y6%r9-M%d^$% z>_=EaoxmqVOfJye(Y%e_fh~%$#A=MK9d#NqXx*tA((ung3J-y;yd6d69F7sirrELb zuL?g&0ob9UuXdLj)fezK89{K-WVfq0@bWZiL|}v<hZBW$6Y5 zY|O8DfU;VAkug`f3^b&eN$dqKRj6bg$AO^)c4~-Nw3CQ>DOl+=RAC#{WWlsn2@$AU z2TOqm>Cg(7*+x?A1aSjZD)Jxe&2}l6$AvarWY7}XF zRW{{4ID#YWhnfV1b6;GkKE$KaPeSoy)7?%-OLkk(INo zRydtBRSQ(5}Njp|l84kR#sCRVZQnOkTYU zvl~K!&^BHOVyn@*h+={yJK6?7n#?Zq<@r7Ri=Dn!o80vn-*G3-MAmu>^*>`kXv4qW z5r;t3E5*lU;hjJyWIjvwX7VrErGLc*X|2bcfqXP9n*`F{Wx2kr!patUct0plfp#=< zd=n31@Y_>G-51z zNIw9xRF95WtL2`>Q}f?HRTb6PmV1a$Dbm~g9xUfAvD!v*has6weGgb7I$I&vJ{#$E z6dh*MS~}33gU{)PdGd2Pn zpTvaQ*;fBOF86MmK1e;U4i@Wx0sW%4b}-xTR^X!3^TX2}V2?;o3GnNDljbPXjN3-o z+>e>+zJ|-q<%f+bl4_4cV!zw^T>vQ&2UJ%gRpOV=m zI67b^A-50YK(04Kkvc^A4_k%)u~YygjV%P7q^o%RN;TO};DEO@9>If*egaaJ6gT$v zUj9y{@@b6V4@Q|A`J;u#M=bK}l6q{upq;+`vCz@K5^s=pA(A6STYwS+OvlJ;wadVX z7~^|rPVFJ1+}3!a($~ceeqY06tQ9j3IkptCHzQ$}X;L@{msEo!TiJF!ms$OeXQ5fTP5kAP`LX2X=$t-V|MI4}qJ z#c4YqnfYM=IIpn>^UOEVahKPS(& z+v8*XuVvAi3W|G-mcP$Livu}Mr=Vt?%7qY^ejAv8m41_XQ`W`!i3n}6wpZ z(Sr3k&%8%=oMfnpgn_ZnR`Hw$r7)C(HeW1Y2Hj!}Y&XQd(6^wBIU-Z*R6rZFjht1G zZv{C`7CYk}!|J3Q()Q4s2DK3TD_~-A5u;z+U#DSP^7jKpg#xI~P21MP+6L%oXsF zAV&j`vysr&1of zk(OytPr2nnYa03ABJGh+a|~#=x=%97YD1Sc!It&3ZU6!NesqMtCPX@R!>YMAjMHnF zC~eY*Fwt1G&+8Jh9@z%#jYOw8CNh=uaRxjLX^?SUl^Ax5=VtUiKXLQh z@47m3hzt<(xQ-ZztNrEbIss7a;GrNMh0+7*`Jo5ek{k@Dmmy9oY*8a$k|(Mv<@pR4 z+rN$5kwr3>zjd()Fcr(Z@0=;^V_rF*%un*u9a2Y6b6S!W7K~DV_ z>UZtXPXPMj5#0iwaF)|2yZxXhPPyFF8m9wdOHxx3a_@qW5-(Kc5=-@r#-wr5#(7(-jKRy)=mzp9&2bw%Iv#}%0?XijG_dQ0NH zML$_w@=%a<9mZ(cn5}XTq|C9^1n=r9ok$ObfL$SrpNX$yh&}V1XYnbjsQO-yb7s|7D$6B?k1Zdme zvbg=w`!@_1zX#+O3fQ^=A?L$j*Wol_)635>%dqmT);dd~cbs2|lDJ+;4^08Afr4eJ zHeKui3lPQ)ldlt7zpz0vp?0&znSrQ2eb~r^g^YocKnmsAYohWvphLUgm|K-v(Z{qbM^QW!o047^DX8w?HQB{(-30+cV zo1q8t|Ii;TVC{&zy0R+ofDmdXrbc7p2<$G}=FYp)Yy<;gfqP7o=ljn6FE6FysTyB2 zt0MqYH$;O|M$zl}7HTLi#dr-S~pC>AKsP*B2ouFErz3XS<}} zHL6l-qpAQ`cp~@>qu2Qf>-t(t15UDd%$)49T)S2X>~r!^?YlX%Q-u%IYcy$edbsu7 zW3!ellO>?0WL6}78IY@1Et3Dw#$2d?BJI^uI(v;4MpWy05vW!dMl~Z*quVbNJU?NR z(@|(Z2MF&yGxdX8uTSIEp!PHbRhn?K&gY`R)`0XI@N>bZ`craHhE0xl+Y9klljuHO zx8j6LE}|J0-tjt#QGN%|;;>=>c>X;={YZNRqjSaNX7q*->il>y!#JJ6jgB$W;T2uZ z2!u1^WhvMI7kXy^H%q@>{RA;$Tq<$$a1;7lamXwYwGT2iGrZk=ar+&V5l8Q z*%E_ZKa^HAm*l)%@zr|>5HX&2pc#MDkz#dVDYRafil~j{~%VrFjzDd#!HS~pQ?pDe3~-(aBNuj`@e9V%QD z<2GMbEJG+9w3W(tx;bt&89l9zx%3Vejw}9<{LRP3JO3QetaNF{AfJol=k#~@xz;$7 z-(eXDVwwg+^irCxXq9gll7`qv6bHZ%O${#kZ-!`_0GU%rp!UHlfz?a15@TS*ZCpFcmlQxV)!heXu06h;;&UN0$^~tjczZ8!l|m6O%Fy@&IdGi+#I@@$>ZRLcCr}sM|H|FgkW;!sw$%t$Iuqhh^Ul?M3*lg zz1rcT`s(8f#T0M1ACib_r0tbI(Cw(>3rKAb>fCX_LVuLTnsDy7{amJ#l|uKW&w8Vz z8*gVhc#i5p0+f%jhT75Ol<3Yp0Or7&LH}d(1noe48`O1908shqti2|(>tO8Ze<9Zw z)ldVV8=6zpva4^ZGMn9Y-eQFlV94n|>Ct<0G@mO;!B$1B1_Vj^%q2>=kF=lgX3bzDnXb7y*4G-AS~vxPp|;eSRHrDBDP5bNMWE16o?N zu4+6}WvI%zrVAbojs>~aOXP1T+05Xt@GG{cfu(ly5BqkAxZ|;Kt&F)z5@paDp9Yu) z7iFaXQ8P6)_J@*<7+Nj6Al>lVt-C5w6DIXeAb;)DQOhdF>dynskzHI^5jJih+LOXF z@`pTthQMa85J8J9Z!UMSp?%d`ihWkpug?{))O&EpO&reHtLE_^e%mxHLrpDN@Oo}6 z0ORTv{Lx)W2PZ6>A+6{`+_PdEkopVkuJz4CP;yDW$)Y;rfJSh0kEk${va3Y0B<7L- zsHMjMFCP`ktGNi;LS;Z|r2^QJr2*q>&N>@a#WtZedZew3NR2D!X-j&_L4b-el50Hw z9dwXaPYSAwYio&Nf_*tlHjgvJdlAVAqBgIM-z_97?nQ7pLBNvLwA(Yw=Mn3P>yXm& zzm&8QZUjm63uYY~m>T~0dixJWHO}e(hl&N?3s-p8R`eFbuy3n|1!EgX66*D{NFacx zgDhYC^HS#wp>Oopeb1$t71ksE1$gBq$5`^`1t_>>=x-A^+7kawi?^h9+GiRmH7|f< zw;XU$ns52CkXHL)>9Qy9@kD245RK6nLm#M^Ra==+VI)5pfh8U1|DKG8JNDSap5df1dYX~4f;n@}5+z&t zGw@LF&7U5Cv1r>V5$s|c+X?UyHC7xzJGk}cPqGPpw6{mKe0T&soLfa13R(_k0c*nE z^R%VS8>}`hb8>~ztrNgcY#w_PY_O&5A+XxY)75qw#t#8L3IyL&=C|(rrWBC54Q8wT z8xhvqIaQoHw(d^YOETm-?@LJUbf*Qh9i%Gf^aL)TG$*mBIDR<)X%43X9}sKt`>$wL z?PjL^Mu=S^Jkbxb9-_tv`k8Br^%8YJaHg#GKQcq{`3HX%&uBP?>SkkO!@RhXDf>xO z$*(WAt*%~X@v4e2eCVE6o3p~Qcg<-a`M%#kRFe+l=`ntapA-ZL&yB*`B45+u`wa{M zM8Kxs0pAWBeo9)dqQaxN{0{TdDU%#cX(yg%AA(!$ET9F85*rf2xS0!2(&d>EtO8@N zU)J&|oiqDn`qPAu5x9AcMQ6CM$n!+X)ze&ttI=WOAoadhCr)|}4GuJS8B$%F@0_wq zKvCNH>BxoNF8+V}uQn06_H{Lb7-*V%!YAPVM)h{M*18Ofx=igAJM946@7ba2;Sx;X zD;5t2FSyG;Idz|X&R3AlNm6Pdzp%F3-BOFbS3tQoAtGy{(`Pj;QkBQBwOGPa+D3+{ zj_x9I_Wxb0yhhRum5nacD@%bpVPcirunj73C5;x(j8#FySJ?gXr1~!ih zCH9W=l;O2px{637LVuq$A?WpxOW$#AOXbhSYR%PlJgitvSY&O}iY#cfUTV0x2c}!V z4l+pi&=(EQ>oT5^3snJF-c1nA!pJbj9pnfME(*RDRC4AnJqP)Xx_-B-CHDamS*j4@ zS0Y*P0v5LgI1MP5(qG`cy&sP23{B&x$r+`x=xo_^sr&}%Y!riYg<@P&OVND#y>BR* z&hLlS>^v8$708*a+Kx@Zb=cYEq9jp{jfGe`6$|i;z@=b|%}f5^eGnQbL}(xAfX(O6 zHVwL;kIe4UG11dbbWIx48u0u?gFG8CS~(w2YT0Q9Ql(#d@Q4W`AWNq{pIZt&7gy|{a-33Jd|2-wC!oSe|SVJ(19W_jVOs~;byKz+4m36B(7Sb-$)L z>ld#~?TJ!o`d$)gB9B*>v(O-mA_PiDVobo;RrEe-Gmt1i_3T1_d~0e`GT5dw67W2f zOx<&JAEzpB516Y?A~ty3n9d#*B-$NUnFp(B)~D7aMp;8^=|f0-@Jp-gjkmtdQ-Tr$ zzD{hb%TYy2rUt4(6bhmq#UjsSFB~o-QFgXg;AX3onxo;l{a#fp?!h~^5EN{&<3{Y# zg~}~`Q39ddFr%Fya)OGVYIJ&mMpb~P;S-mOlqrL$dTL?ha%T4)pW(b-MgldN8!Ui`_*EvBwx_0?-92GIRh1j;XP1E z&hvf738z_AJeX(o=+|eIsUGT}Vpqy6J%S1`G{nHhOmlE|1#HFjr%S-*hLm67OOz$45pSPNRNULCqaLu`S(Hqmnya)8gjdnC zCWJ>Q-RWYxwY$8IP!#OgYclJr;`9g( zf_>seCvI=>2M+*-kkA05EmVESm0Nk)7pdpDtf57H;PK5~H^^0C-v&ayX4uFsCXtdw zP}X#54sorqLqFW0{w5{Dng!sQq)9_;@5dDZQfZ_D-tBU?2X~qaHA}n75NCzm6B0)T z`g#f>%YxZdTphpL60NCT#NOMie;xTl846Gr8Wkig&e}M^cNvXuetx7@mPeD5_=(z; zhyy?85KB50fOcUTu5i*AjIT1#VBQ50PbIFLu+@z3EmkbQ{Z`2a+J=-TdV8r1~r#tm-?rqge64alQD&ri1r~GFotjldyoob^1~nrTI+m1nJqX9dE+u@ zZri#C@pv_z77{(;lj#4I@(tw+h5+AQ^HhmS7I>?iKV=Ln92o({9h&GpKPp@U9=wJ- zo=cXK&ZGwcf}k*>Il!N4+&b2AAiT^me&EK-k46(YU0Mr^Pv~(hn%OC6CZq;1g9zXl zF)7=a9xhV=nlQ9B9=_mHtj_R+>Wi6NL9LB$GUpH968K>ftdhqSAYaNVh|DBt_hTT$ zL6YObc)_{r*vGE?;-$`~p7rQYO=uJ^aPARv@h}=!udchti zWR>j8{ME6r0ou-gR--NMkf5ejRlMMyb?B!R?dw%zvGmS zO}0sZmT{|WVUthSiR~{aO+NNrtzGJcUHv-ooi9qgC++Rn7yc7MKa#XWKF*{aJuGZ% zj3v)CVV87JoVY@1TcXs4p$F`}x7hUJ^gTPBCY_P(b?a@yTq4;e4D3;01RRx10Gx+< zD{bw^*~Rm9&y0v&)ry5jVA;U;rQ3*`)*^Kj{(wm0&yKQ6dlO7!L>F?TIcSIq+2XiuPC=7!H6qM*q@aBq!g>2pz(7i$du`oqzhtD+Of~Ot6XPm9TXM}HIlaH+ z!bgL;c6UZ)O15)9C}sRISFjpp{BGSJotF|*jUk!kFJ~RTl&qpJd2vdb_4mExv>#B< z!SxeT)91GfO&u*vxWi@$*p(;>B?0il#cvG?_=)eO$^#6n_R>j60cGGoX;%b_t&!*4XO(ZQz;vXFM5xoXI+GOw<*8IiREW7eaV84T2UAQQ$) zFSqvGQiARtFLv&Ous(R5mrCLS{^#ZWjK@l%3?#u~ret#j!Djr{^lJE-q+c)v#KlEIsV8MufKFHZ z#cD7WTFns>X}oHk|0_X5|Lhq_V*ht?ZmbwZ%xby+GFt0kb8+`RV8Shf?{*0D75T$XH znpyK=A|X%_|6kZocesd)$4dgOYz|g~^NJc$&?)~=tUNqphZ-ZdacvP&yJ1AB(G4U? z2(#}iLH)GjVQ2@SfYVT!j^Bs zMxuXZw@?{rk*OufQT3{K##Y6A7~-`o^?Eg$ep=!A`9sIkFg7zLQY~Dw=L4x0mI5X$dJ& z>1;Y8y0X>imC~=xsIg~7!IA+aq9+cnZ1hPG*R+6JF*zHI{nM;mJjF_z_>GUx{o{J) zc6As9Jp8ioXqf)q0FrG6c3X?OA+zh+Xg((>m-U za@wT*h!Y0T?>XU;9d=;0K@P5N+_y6MugMkZ?t&06cbaCzWiG^WuE%h+U8qbCPaW<< z-7XmLj7?Z%s z6{PxQ>N6NQ>Mc^c0TOYI$G{}5Ql{o0(fCe}P^w0b+heUY*cJayp+#b)%jDL`NMG*9Q#y*w0yhup>4(Souxt1H$sUQ2zKyhyy`?=reGp1Z2 zn^AAMA6;e;5}kZ_^H2o%x;^2|VC9SF^?;PSvk!2aY?Qxj2a8Nm0Pc zzvKEr7%{mU`rbMJ|C&}AkP~n1nw32VD#I0Z9Wq!Q^8T||3;!pG@I|eSg*Sy!et0HK zUWMU;KC4T^{nN7Xs$;drezapn!k}Z{ev_iA3oZK1)-{w-V3UA?oIAOPo}2U^G9KyO zS-q*{*xOOLfN;CH*z;zrlRee`m^oVy48e(eE8a}1I{NIILQR3lr^0%!uBN-*kX+)dTQ zEbq9E@9{dIcHgahYklUD8{()-vRYH0o_r1gg$9Do37Z)T6{osD-mu0F5Jy?QjAgSJ zy>aQ^bue2#V$wB8OATwK8mY>amekQH)V6Q(Qo!p=z>cYJ8pcSQ^s075A=msdn17#z z#k`X?YA=W-kYg7Q#s(>MmgKHn>qj)Yma1?P#v(*fRbh~+2ne~}atn&XoE!2ax^;GH zf>s#?WY3Yp1^NDYovc#uExH+gjrPcxvP9b}V(R((`adbFs8;Y}sn$GPyYb3aDmL+- ze}kD|(@qr$Y+5amx_!EZaIFxmtf=yTZ$yq8)S`OJQJ2T2x`vD1z&fZXaqS_cL=0@Z z@ldR)Hrt~8j`qT>X7~0iN25t)l*0eFWl{nhYc10Wvv8^p4yCmf_f48lO>mu~yc@@k zMl8PnxtlB(H&^o2jzs_*F0BDDUT%pk@W@sWAZ(o;2XYLQf5G>kU9n6IDr((bw|C!z zo|pH3QfO8oDan|#yfVLl9B_hfdfLpPxnc}dKECio#KC%bo%8Z zmWR5Q^3rpUTWnh^H(YtfA~D_3Ter3La>&nID_7!N_VBG+Rtqnvme7ixo2PRkg%<1^ z?e9c6#=?kWZYF%TH@lQI`D05Qu9jG>Hmz!<{>Rvz^Ct{YPMwFB{weBL6`et&yaemR zVq^EkL6De>>>b9>#E9%_sZ7sZhvGujqnHle>RIG2H-XjzIdkSLGNb-j%^e14D3p{x ztY2`G=%rv+ko;`i4;7TOno!k;f&0)%Q0t}#V2iCcr?wf#8o)rnTzrWB+h5j4tO>?| z+YnL%a?%l>dW2b7TN1H4ZVIPTdTrsj7>UQbz+IDU*;XGNDme;4# z*b`j3(0OrKCNY>_6ZnIx2}Xe;HB^eBc;4&&MAMQC^M#H@*N|~_rNnlHt+5GKLMT&5 z-$yBSUO0H)|6|2ns9>uD`PEHBAjXAu-KY z#^ffo(Lc&U%-y`s3B*|jkr3ha^q276n8TLGR-ce#HU|rE#yrIsqSk6)B4+2UnqtJY zj2hdgI2z;FHq7*)oLJlC5;pv;>ZRc+(T8)z5+D9FJ<$LyPD%#U=5Gj1X5~L-hmOOA z_wAZI^(GNiXeWDgwc~AQK@%dX?0!3I{u>JWHW`TMUHqDm63ae$G&u_EnY+u;jiI*Z zfXt&R=U@Q+&c3MlcBAqcYhQHkNXzac8^JJEdZg^!wwmc+SO2uy#3$OAkiTjTs8HWm z6Bw?jAJS&5ibmAg53%}V8oo{%T>gSZApmeYV9aTwgZK%c673N+u)FE()rE};9L#ux zk!jI$c^zXsnX-9?O1Mbm5e~Z11ds9LzNKV~9&HTM@)rLiGfnuP+*yBUv!h&P`;CG+ zII%eXfMjHi1u=$_uoL&D4`!|oTRwmr^sgul`o^*e-X0sUotc*a% zunkv;j1ky_Zdl{BZIQbU+ZL68{O}&{&cv4s)mdB*(HnJsO0!yJ z>Vgte{W2MsJZm@6s@L$1Y>p&gyg&Sq2 zfQo=|V_M%@;Ux;n2YNWnoKlf$TmE;xE9M!V*&a$&*jG`OOw5-_%;vwpNcpsv1P!Q_ zW*CAYGcNALU%a&zLCj5T(H6|DYrMlP_h*Xqe;a}9_*$H#0YKJLlnzz)P>A40QkF^r z$_Kf@!(uggc&hxnvfi}Q^;eNI%B+{nf--Z&^@>?%SO4yLir&ldNR&otRYR?0fscX^yc|8S*&kR9Ql#2QfxF>=+M4FnK#N|TQ zK=9DMo`O@SG&rrFtpvkO%C(1x-KQba4?Cdboa_|VFk+m50_8?iRcl-ye^sW`YvEt1 ztjpCJoH*K?XqI|9{%uW?woix8Tdj6r~Ehfn_)bvbW6t7^;l*Q3qh#d6fEC^3W>yoQ<8JKeN_`5xq4f$NjH}j;5b1JrRa|ME}2AoqG%P1oEs08a{LGG9?4Eu-`Zu`YJ z67**z4M5k)-u0AQk{j;8UEcl|IP^(Ruh$cT@hH3%Jx%PBc|C*;>W^HV7pbGf7OcB` zj~#*KnJen2Q+V&Z}U$6aEuaQEX!rvhZ%T6 zos9NRw&5|6EBy$f$X7y>>+C?O?*s-s0eklNpD3frA(?u9*y8qtNniB)1C+7glaQ_d z6W>^?0*~k6<&d0D zJ7=+(%z($SM=q(B#N*WI=F4&P;*iz(eBkMdphD@ie5tYSSiF1*<=(+&xn<2sRf_<8 zwy!>MFR*gZM?cFuZ;{ask~9CZIC8$Nv4U=dH{L%&Y-z-HJ_|f7Z7q6@@Q~muSjc)jB34>MY z-{Ijf83sK_rs)9MQn#!s>2paOzW&71D5P!M)h}*V60MA*^Q8BFaF2CO-09(0xi3)u zyS1&kfAw(piHC*q19V3$OoDSB|4iF;T4x2XZwF|1Q~FCGa()2cOrR!b;PF9(CVu(c`@ zUIf3jeL>Gl)S>**+ptB_n)~3*pvXlEXzfiUv)nu)9XnMt-4m&zs$n&p)1Fko&u#j; zmQPh9ytdKz>@ZIVyyZt@n#m^opw~rx%un~AlF`rV(_n}$Vpj; z*RSBe>SKTxx(A1h!z!nucNMCz0U_F7@5j>$4Lu>vV9tZz!u+*mZ?Gs&7CMvZS7zLjePguSu6%Ij7tY8kmXC$*-;9nI*#F<+{5hQdRGktkVtPSjL>d@#F2xh*?Rry@`$; zksU#e=Z~oCrLXi(Mu&jTni09%c8RRDgOAa3T@)L@E&$j?#p^(pM|s%FhIr&i5ZP&9 zXVY#Aq5$ZWV$>2_KT<^3$0?^T;&WOtujTzB#BbQ0sbtu;``Ae)HffeF?W_|kksSrznrzA_zyA{UAsO1-OS zz;?w)xFKmID7XujZ&cP^b++58ITX5v+I${Q+hm3yJP0@t=o#oXUKn;h;8~8WTN`LF z#+rOKuIqsxw!0j3cIh@{h9ZlUuykM^ukU?D^ogjQ-@KIdRPGgmrh=aLw^$Fr{u9-8 zp=V6IV?#`^_aa3_YWbMs^As+m5+<`%Vh;h`dMz{>kqE-IVE*GaNOZTzngUrpZ~Cn; zk*Ut;mS9my-L8ovepV{4Bq0i|At+0pvXc81*zE{%w-&ErrJBOWdk;rzVL~@Hv_NA@cKFEh6*6)vcn<5;MqG-P6PhY?C+L|# zCV3MlEYZvJYRQnU+Ccnq} zh-H)EK_#bk;!6!-z+Ofk{n!Z&M5=gkr&-sbm>Y!H&?%Ej5A9TsQiQ|amWV$xrA0Ll z37FABHMS572{aT>gfb<*td$lVnDHRc9o@8bZPqL*Ca*fjDhfZO|Gi#&B(GB^aVrf4 zCyH{?W7>j%qpU8{{*Xd{h0^}y5E^@5(;oz-OmloA_y!OCpsxn+jeXFZ6Q0tIG;9Wk z4m}*_z<$J;3Q<^hnGP5dPix952+p~BMQMjkitgT0bBVfb!Y5$1xzD(@kFGM<0&2WhmNi78C*MS+(tyY$8G#A!6t z2hk0hBIUyfpz1<{t0*k5v0zsgM%1N*Z2`Ws&|G^6f;twZyoylMme=|ctUO5qw&%xi z<$Pg(!I@j$QMr4yn&3@{Tnvs=|8woRf|fp6;DOe6*RAoBz-as!yt8pT^eK@{RdA$^ z`1i$zH-`arp<}1kRJlpa&%DQBiWVu5iUEeUCLm^kTcFMUSM9^s%=;42M)`n|&KAH( zOz$9TU6K>YoR6Y;Vp^KUXw^I!S1m)WIvO~ZVN0;)cz!40h&1%(0XXG(!D|GkMri17 zQWtH>6498U43h3a-K=f751bLqG_yFpO{qCg+W~Hv!K2Rl?vu={1(-Y2){#a(laZL` z-PHcJ8f&_M@XpOw=1Iyy;`50Se=q;K)B=E6c4;BEDQJ{|erJ!lBkL+{86sR78v=p4 zWl9hwmlcB6wW&`1NB>zv@NotYXjCtf#^4*lhF(a@4EMW`v#dmtsi!Vn!VGR9Ya=_R2?g%H&We9Vr~W?(~~eDvT7B82Q!zY>OTI zWLcym`DGnv;VfG=iiHpoB?Bq@k4S>CBS!p*#`Rd4OC0A=lod2wn1dF!e!ORkzsKT0 zU2HM+qduJnkLi8G7qzm=79N!}A)xhdf8kN6?u)6NfEd{U0Drv)1qya9%_K{Bgo z-2(ULl8?Z~)gSp`X6gbCxlyPlv%h}Xm%U-|v6(OA?6pv!Lmz~$_Hd24P*rN)LbVag zPD+%hG%C@oy6m-G4mXkB@4&j@`%KKnE`*0>rGI(UyTm3<@yXrj))#aw0$@$6q#ygQ zt8z)_|H$&H2*~~?$)KSizYIXaf6Bs+?H+uuXo-7r|2{v&-zY3c^Mmoy5%F^yns`6< zj@8ky#ei^jo`2n%#(5h_WwzzPq*eFWsQUbm7ZiZV>ap4O!`kNfuf zVW*dxnn3$L%^Qnu90&d7jW7_Z<1)+R?-#;aYOt?7L3c{&p|5DzBEO2P@a#z970pYO z6aU~ALLAD(Duj)Zcc)dQHXFB?bxi)_7_eXSAtM4F)JLP-6NeZeq#@eS@PYicCE6{l zFfQK)ceR)OFu)x|`IIao&qieF`Yt;FD9vU;c&whgN6(|H$ zKH$_py0RxB`ZSQGrga*2%{8&Yl!=J9`sk;^)O|+7{N8M|+nbXS&(8>|4R0unL51FF zT?BjO1V$}KcGB8Fbc~3$L7+j_&~ZM9VtzaweQx}z%ezRJF36ysdf!?W9f>;)n$$E{ zZ0g}Sqm~z^537tZSqT~tIEC{67od{X6xz^pU=>su01}6YFRe%7+aQ+W*)wEIVBwI( zYE}dCl%ouwAA*qfH5FaMEIh2Gm1n*PUa2kn<5Kw$CL)`(mr~FMJ#dH{XIY1$18%Zk zx~0ZSPL$5j2b$R$tQa=Qf|pBNlDL^GAp_`V=?vcWatj_B(vc~kSRsD^1v=0)P#~db zxu-XG87ce2UQw~ax333H($&g8gIk3-+L8*OKJM_px8RiEIhVN*7xgr5w{7SVxAI2U zENR!uBTrfNTQT#kiGK$oJ~(@1j>S)+qYh*JXe!m?$O?q%BcPr8RUFIh$tmVXw_a6i zKy<_GqFDtuOdBw3&}v4{P*_4r6nO&h#RaCOa3 zqB9>2J~SNMNW@lkOT+20M(dKcFTQL;y?~%jebZ0op~A>rkHxVOK02N}+Ge z8WZ-Y1J4$5Im)=YN^LL@hC`T3z@)m8`F3b*gBO}Hfko?NOtvs6(Tha@W1|gwn;wNF zTR2R2OX00XoQU^i=-g$ziCI0zdc5m1M0m?W3%3E@dC^396>UXy4cZagsk{52yMs5` z01>86E^{~wA<0jzUB(%x_Z`AXLc293{JJp#O}Z9{1@x;fT!Qv7L!unL{Wy}r=|Qi7 zg%oA795LSz?cFQhL|zc}30S91VCo>ZmW;&PnT=|aPsCvq^H#AWo4C=G6=9%SuX0pB zC`bN>qTVDLgC^2gyQvqAedEvkwiMVp8oOC18wEv_r#UR4aXh2-njBo`jv;WM_I*PTQfJt-j-5PNQl-uILzgA$n#Oh$Yj?*WIGcjfsAaR|VBRTl~JW=VFxg<=6P`2Z4wLSbk?bwlSpVT~V@0 za$HC(RxBf2YOT{xs-bnWDzy~U1f0b6QX%!>+_?$$4CXJ^bPrnP0qx@hFahCEA0D_RE<9M@&d*K8cYya3KJ6c+q-K+B%ESNm{sOX>IvEbwtbY^~* zCJ$m^U}VRi0UXht+iO($oVu}aT}W=0vr5DL2Fe@zz~@rtk%aPJI#BQPQLG_hUe2w3 zIfN~s{JK!Y4DzRd&V#+KUVsfR528pnZj`$h(I_S(s-hX)PGFT;r{H79OIG2|Ia#}_p<>XGNYr_Y+4Vgm;?C*}(oc%?XF z(PyA%Wj-pgF=$Lp#pq6wSQ`8;0FPO|DAbS_R<0Q>dY!BbfF_ghqV3%r9eFA%wOY#A zOq$!HzAM4~MLpq$p?c&$vXE2o_xN7tGfVBQbyL`%PhP+zdxL2P5|2_j(e+K}P>pjz zG;%zM)rytu#&##=rmp--9iLLLtpz}T-f~ktrl1Q%d`i| zcVsEFS2;K`0u-V5Dd>^z_})!oW291LjF~3Xa0LJIr&J+ENm7y~03zV9@A2d-!*Dd* zcc(eB5qWAp2kr?jbSIsk9r_*%k{AYiH!$51G%3f2cfTctGzo%T0^Fty%fx_ufNXsI z`Y;2AC1A0AWdL7un0QA)&0`m|(rNMHRwj;oh4Qsu{oI8*Q9!Zizk4g*9)<}g740sJ z=CpCXmwf(r3MEI7!{DfY6o?gbDroXpT?WDvHr=}Bax)E$CfdNsG0ns z+Bh@wlWi&bEJwn`vo#N{-5+;SJPull5sZ4xsma^BgBqiAYDypCZ6P29oBDLHyAXhm zzJn4Lr9qHRWyW=;9t)M6-J)VbcDQem%UvmI$|WuhHE-JDExr{a=a1m3!=5JSm$2s^qJa(JgCrTSNzY# z+V}=n#)%yrnpTP(98_e5Vw^4kc;p>-UB@jB5DG0C}hS`v8i*`Y5E;o6l=wi zsHj;kS`C@r!J!*SVeH0s$766sh-BJWu>0DQ6>p;PtX?6s35m4~&gR}f$f$&ScpVJK zGKPK12q1-Mk7s^B-oMs%G3=Z^BLC3L>CTA+X#=$J8&UC~-MAN){K&!qAzXyD&R7yR z4}GR)Bpqxb?BC%#6*yT&Bg3@S0)3_93+0ea?n#3Lg!ATZI&Qj0Sk7$jCfxIryX3u!KQe@Cd_dvq3s% z>xjYt7S%M&3y|y(R;oOOWOD4E4KLga&wm%wn0Oow4$~)H)0TGhdEQv# zZS3Y8RztCb_dPC}*0KB9jaHuVJdF)b+35xQfa`iLo zKjM%|#wW%R_L+_dsYH%jPm-DBfl-t_q^BAbPV@8FqwpW~uT7O;ai?jJZSW}q5iJpO zh-86#N^my9GF2DHSfUSabwLs27OQ2e1;#0hjwdKSmr8ITbpn$S=G@Tui9iv#4xBv@ zUkQ#?nYF@OMq5dVApQ*my%1Mh||kIW?@+lsJWkE9`_no6sW>*tRo0AyU-+6+J31GaHKx zDPAEjoIqVp^BuIr5xLsSTna0!%)3{u&-;h(Ff<}-rS2A=FS95kLRfTYcJuU7j)bQ_Cc`b+)yyVm)Xk zQlisea8CS6Tc-!8QQ|N^A&}PR&nX#yHC~|A@QJ|vOt&FrY_GYU5j=)UYs$#HoL=*L z6H8E&s316ww00u-X_CWjpOw9Q&7?sN5m!IM#F@-KsrgMIr1E+O`Oj_=jsA}Yvy|9*&y6qFk7SlmqF&7NsukFCZ{96?;TzC?2OPu72BlSDmTi=u zR$Pnac(Erron4F#{~ZK`n@Oer9K`~EoWH-iqxrGJcUtxXK+Ro_V$+pWkFT($tCO@g z3R_3RzF^-aO9Z|&Ca29gFia3{03$%$zdmIkC@S#CG$7CbQL>LJlma+n{XM0D|CSf| z%>bv@-&a4K$+duz2%-z>#EKX@1CD>_rBBRZU{WDPsdcWJ)@CQftFno;>4sAh*{aIA znEMQAN5uh)l-LF<6?Z4_kVoSJC+OvN^z+4+){N$kRSH+YvybMKjK9=BP0_w#{&1HN z+n>C+X`eI>ONKet>f3Pskr;H>tOqy)F&+TDuxj3VDfJ+!iNTnw98A|i(LLv+y zUw4awK2hFd%U6(0V}lEd!6#qB^}VQBRK`Z2X+q0K0VLng50*9RBH9t!XbqO#j7`c$ zHt#|Qllh+<@I~9JbH6G~q>2PApG%>lvJJ8d~ZS>DIt$Mf*w8gOznejNGDOzeYu zI0u|=5jCr8;ioPT*8;s*vu^1&#q0AeJ$u!|89Q$FuPqNTE|Og4cM)G_ZR&9saPY9@ zYw%Ez-VtsP&MiSMhVuoMVOzrYvd;{GO`xCAPn&s4FP> zY71+WKvq~6!A0SuU|8)~9jx%=W-1A+%i$ky`XX#&Ab5mNCRgi|?JnT3y zP0U3ERX*NjB`3L*-M>vvnd~&3%JQnBNFgUmc@iLUjSMlZyD}J-)o-r71)l4QCWXD+ z!^tTk1J)u@NrpT$9Cf^n=5d1~Ur$*)p$xW{*Aqe-5}4V8XPHT(J(eD=1lc5Lf; zvu%U0n*f9ow+TFEwAX!UYRNAl?sr44{Vg2@tZ!HjHxeQdqdW&l5V;4Fbh?|q<^WUI zG#Lp-bDBz?&fx}wZLvJ4ltav?(xbcPn-?5^n{{z{s$PPJ;C#b80ray7EeJEX6K+C6 z85T~LW$2nfd$3m+Oq_1K(VA%d4qRQ+c zJC4sE(ALG2aZLBWz~o^Sl*ho$#ca)}dHoP-`)I)`g`B0;C>2tSdCw4Z15(r zFUHk4E(2U3637l*uDg5!C~(& z&?hp;ueETy+&q^}+Zp;lZbvc%>2kv7WM9m4d{jhTQkVzelq47P3X zRrB6nt9Cabs=^-T}NvI&?-lK|yTW0Zn zVl@9`pj}8nU`XGD@#cPh1B zQgBXPoCB~Ox?l#}=^sjUuU%-NFTwvKWea4S%+T_YkRMCkyn&$-;go*1eHTfvlQwzN zbRZo`V~BV4uLlQ{nzrW9+IEI$G*BD&%3~?bLYhx$gPe7?T-yX{&eD2PfU?=o{S%>3 zUI4coQjQ`TRZm0DS=={Pwr@g}aE)C2{9jZfOB$vD4+f%7uzKEK2l_)z1#dp5Ou~oH zhRsUTND;a$qgTn1{2WXu%ONtvW%12t7+fEM{w4Kj-k4cRQOP9ZAl9zCzwzIBr@JjH zZxc*~Ssr1lE42%|kLH&!Sc8~fBFf;2xWA<&ZT6!Wm`9Y((G$<|K zpt2Ib?Y*YI|FyRB#EU{6;8v53n#=dcPv8`*6%;~arI3P%-k>}Z4qv`E95f%m0dwk~h+`1tBmBvME3`1XksBdz0y5{%1j4rDml`h z41Ewr9omBQetH`;;+0mmDD2!c3{4gy)fCBML!ajph&?W+-p-7c7G^^tVbg7T!I^KaeEF)*Wki*g{jc$9=*Bc=W6@|El+Ez ziaK6;togx6DjNScGq+~Z;k`;4M8JdW$wym;@Ylhd11$EpdWrp3`+M zIv^nfLf@&4&8_s;o>Y^7vCbyge<0Ryl$0El*saG;(8uysgfv5hc4{7mqeQ+WmU)K_ z1DO;MhZ$VaV%81-K7KlhAS(h~(`e^Yo8#AekX`Vf9;7c=b8HA(MMlS%)}!fPR4XAD zHYU(Q5S@g51nvOL#=aqARVW~v^56Rm>{5?;s=c*RBN&OC zWj(xr83-rLDkyS}Lr+{+E*x}Xv;MXov`R#Rx2QO$d-1+E$dXZ;S{A`RuBT}Yf~!jR z_n#ot-LXnK!`6GDSynyV6c!)UNDfnqAM!cS-MN^N=J%oNq#24GGhveTH8pGq!_IWM z1hw#j3oXZawLO+)!4pcn{!`&fXy?Lh0ke*$=mdfB{{Uv!Bqs@mB*JX?q|MpSq-Gz( zVQ2z}vkgN_9zqUWyohu@(xf38OY9J4I}Bjrsymq05=cW#xUF(b5gs*3*V85vG1ZMb zcCOU>5>Hbdw~B5`vNm1B>l>eJ#C3`m&ChjZKqzyGiUuW4!q-tq}n;Cu)U=?HXHG2PuYb@xdi_g4b6g;C)zZ0K}jL==M)3rB#%a+|u>t zf#F-0@}Gq0o9&|Y`6tZDC7UD2^G&xI3qzYzZYy(`lO-6z?**6wxK^r@DGI+S58IAi zIKSTzX>fW!j3{P1(;8>diuQ=I(>R+Z?Mt+YUz4`+g3Pr&Iz>seYR@u=nT&_@Y3G z`VuI-A0xy=eMJG*hNkVyB;(KrDsfQ-a>;JsWqhaw(0}nFsEV6m-X=vXxOQEQG#|fw zsNnT}whg-Su5htTb)S$fS6vaUW%(_*MeQ{3gNZ#IUJ?D|y;_*~IVK&4@}Iu@7FbGD zJu|BoJ-n@KuQs?8Pie-*Weu3 zUe>D)b1d-|$g&uaxm$SY2gbhY=hTQRed|ov&p2$U}MhvK3^KC4s5y=1t(s4EqYA4d}o9$$Mw#+jVSY7`-T4EqtOt@$^{=A@?S3V9p=BhU{ z&D!&6n@@ApJx>AWv6)wz?%~%ePP*uzQhLQZv5reTIUR*P+)UC=m0Y>lA(o}J_;4P1 zj`F=jkW7ON+3Ay2+CCKqP|XS$IC`*-r;hSFWzEKD8@FH0gtoP#}v#2;-^{xBnyjw9}TawPW734VLWS1#Y{4kPd@Jl-m2 zluuyE!y>dZ8dD_0qeUcOp2r)7iz(YXik_2U8d~!{(Uu*&b+=s3uW2SW#V7b@Xu=zG zlv-LgJ`ja>u#xXIN<)413#>^&c33?iij@Jvl}FJDrZJk51B9F`%Qm&;N2hb$4D(i3zJWwHFX6 zCw%N7-7@DaOM1=f+U%gt#@tDO?phO%=q=jTFwW_1cMR^ zP&obqbg~bMPGe`n6=i-I{V~}m$9-y!s?C;CGa8fO1^V9<4m7mO|m7|B8dlw`C%1fHbe$l5fDyw51l+5|ndowh~XbUBpG*QbvUklB8@? z!V$RI$os{hnR>tNJEYf5h0F zSvo-j1C9S{+f6GM8MjTF)dhvR+Hg?9-zo%8DgH>XnVv@7X$t9M2&x^}6OWhGKIXPh zM62Kl2-A&aS&0U^HbegcH=*LmMB}8enRp)VBu*S~F;&RzXX#JS8;yruGC`ZZl08}< zXF_)9t%3@eaub|0q`1Adf`Ky1x-ga3ECiN%7j!npmn$9U>)~*BRT9fOmx|zO6yP>Q zASpNsnc*+Ac@DnoxpPSkQ}Fygky={r7}MAt0xhO0%eNn5v2ryFPKO>XL_PygEI)^M z1mBe5Yboo!b0FZ799+tx<$(577P`t}jBvF%l8`U4asR=a?3cVHUQ{yGXZpH7%N1u( z2O{f($*R9FtZaT=+|29T`~P&YJ(U#h4u*2uyDUZLsyZyPek*BiSbEm8r33=^3AMtH zhL1=*<$U7s<2jhQZSE4?=|9eAS0XQ>ySH;yOQ?(af`+znueo;w#uFxjMUc$5%8cj` z&{C+!{Pvk-eA&=W@~F1bRTfy)V^X=H9-mpg@p2u44&&nfpAhB3nf(rsa zM-(;?QeAcMv!3fRVFCoWsP=O)DMNI=Q$p4gyyfS`Th49swDwt%oB`Ad0G0BTD^7Nh zo8Acz7Qu-js71vS;_E=2>4KFI#v2o2nJHbW>&1g6V;6rQ(6tLGWL5ZG{fWU%yI*h0 z(d#Z8*zP@oogZI-_ViYAt5cxX_%NfI&o{GwoW7i%Ev5s84_C+rReK!P zy$Ba~$Pt&&Z!m}~wM)PoHfB)}t0UX**g2gt!8tJpX3b?s%Cl%#oeXM6e8;R+?IixI zEI>Vzi}F0xvsj=dZ*$He@}F-Ay6{Q@fR=T!L(_6AribLTg-p|}; zMa4D3gFZ@=~3B&FH+ji{8!5!a=`gHr%S`ZDCdJ1A~X{#~s)Z%e(b z_`^3J{9k|~gKUsliF78cXVO@EkVvhT^0a(n*DRUG67-Lo!{L`IZ826?0cU8ULbW_@ z`gvin+>vtOV2eV0v;KD^2^XA+bJbxz=gpw)$o(9TiQqW$c$Yd2^3APhi|H5A`y zK|GPLhN649d!&_W5%8PotF!CB0Xl)ebBU7(m*P)JHBVT|V@Q;)get9yE4e1*$lOyZ zjp4OtEt7FcF9wtyMvU78(=%aJW|O6urF>)esvTFpfefGd(@#042X7Ohv3uVOMZwdO zY{v`Uk0gEF&vGL%dXz(+nyvz;xgi&K1gNW{=1Dc3iE&i{z3441v$PG@kaBfF2W-9^ zW&{T19C))e-u=;AFoJLSq+febtB(MnwojXkgMI^q`9(dg`MU+<<NQ-?XIANQHXN_V=otAg?)c8Z>8H1xk9>rY2+)%!&UgO`A4x}STZqTlaSj#m z_smRJDpmZBJXRz98Q$X9gYXx`OW!1R(W{LGucvSMDC1V|iYWc)D`)7XG&qO7USir% zj{)deu@}1iBf(L`VGKw^EH^nEsx1_qEZ@7@*bMWT8{h0~%MVsI0r4fw-0!$GN!S^I za-p3mvc@zS!a{Z`2S6qC+rtxL&#w(Aq6Y8kqwG)mQgJ7?sAFV!Z%$iZSyV8Q26yH% zl92BH%Z6}Wxf(R1PEpU@L=cM2c?`~I(bq>W_;vosd2%+V;yxSNmiy>u%9GOm-16o+H}I8uR5V>96WUwAWD)0~L>ByzZ21pqLPMs5 z1P^A*0IaxKi&)}xV2~oy0w$`>ZlOI_s3=glgFhu7O)#sMx8!7wH&(ZTVe^5YODKd! z(guoJ#Ip_C0$=`r%NV70rK~XLGz8dq8F?1>zuw&|GwUW|VS>0kPaIe$5j%W^(nOvC zS32{BN!=lKT8d)mL>vB;Gt9HMP&<3vZdnBin5GA%AXN+9XD!Ak!>yTx_!r9`GB$*Qz_rGM8QXkQY znk0Nmwj;y*2pzB(a>PV*-jG@psjvDMD($VI4Om#nAJ_=ArEnzRlQb^FE+zQ{abz6{;>)AG88GYUA=jPl#hB#a5m7SG7-6AoG)_)D4x1zn^HCB|P_AGiP=G)D5 z#ev=ZX>cOmtq(Sf{0K(gQYzQG%*9R}i0Q>bdg#>VVH5 zg(YI6Qnyd+-*@IzlGHV}p4xaTenRx>+K>b_u1#TNIleBpMIz%S2PdYNy5q*iuS@-3tYyT8hM{3mP~eHSir2T zhC5~2fQ>?WlUTE5RQaq#2z7^(vS|mWhHjU62V#HJ#>#cj;DgjXgBW$Z_OpN4WD%%K z%)uZ^vmcCJnLMGIz4a_*?oJ7m>xJ-~Zar#S8ps*?{P3@z(L ze_W3aFu5z|VX1xw__iFiWcLjx;s0vObz)I_qB6ayn}POb_-$&9np7rMWeq3eu1^lTB~I%k*?BK~@>!O$dw`6qHPpylcX_c(?su84d19cpBZflTksnGlFT)mHRoS!GEajVD7DcAdUzA zm9Weg=hS+5u>20zQZ_3?D^pg_ZC-8ubepjGH`AZ#bH!^5U=rz z^88oOvCSa8^5Fppia9&l5-J~_1k{KB+sL}oM8K})7X?GDsen@DfgB5R7fn#s2kegz5I)ey0O+81a#&k4$khT#T7i?m zXcHBM+w^mgZ5TSRoSOV>7`5N+*TmLm@Wn+)-(fegEQq8E>I?RKx#*vI%B4+g*1mwm zNBoGhj@}-Vd685Hsf9v{T}H9^7AAHI-RPt@iP)~I$VW0SdmvLTL)U%37B$w@lg&nEJ+E0bzl5--rLa|p#@UW7IXGB>NRZEQT$?Ih58CpyL zW@V0Mv|Zb4^}PH|?74}U@IMEwV@Yh{58cI6%Kn1v+)`n4R>F#lQCE(ITLsNF)fxXg za`JS#%0onl)&TCBsM3j-0t66))^OR#?0+};9oxp%q-pJcpQm1vp|5&*wnMnD35y_D z1BLGbBhJW*JFx8wiaGTrq%IsDRQ=r@c|IAb9h;U7oDlO5Qu^M!{9nNWKcp z+w9Mw^=T7R=&pci7~3JCJk*v0*xL@NuhtkrhT!nkwRi>bbc7izBFgd;D&n+-DtBvC z$uSfKQLjz2lese}BsbMjtF4YjgxI}W7N`eZowCpduei@3EypE#s&b1fM|=NunzGBM;wVW`%CBZ z8oxUP5x_Hay&PrMGyF!FK@)=xUz$`WkU0I#r9lRGAAj6IF3~8J^7I!o4>-DL?;l)x zr**Gtd7=s|LMs@p>{X=}&~4#!=W3HyVDY|w8({m%xsfxy%>6S`-l|T$3ihqH$?;~L zV?OzPPK&K!=|I&Ug;FEgb>$S8FalgGy1gpvU+Eom`5=57tNr|bGQ!ve9de2c6!%~_!AdW@%%F+$n8f#Vwp9a3=e77+4r+zu z)2$!kh8}#Ubx0K)8%B?-@qG^-5A;!tfk{WE$dc#Tb0G`mQ#+EQi5+SLA&BXmgII1+ z<9)tP+Xw`eY-a+xKA_V*UzR{2mi? zduQoVsfodBi9uu|2Ml~x?9HR!^90dG^I(M5F~rW8KOC3j2{Ayk}MRo!X)} zP_6Jmku1-%q`(&wdFG6FDww_uV&rND*@6Ek6iA=Bo5>`zTIJI=q8gSqSG0F8VGXBooou<@(RqgXu}itL@V$$I(l`{%L6&b23I4*R7~2HPXtn8 z*bPe#R5$39jNPYTcXh<4JUdvKdrj>WlD^Bg4ki1sfTW48b7aS?NN|aHQ}+5%00sbN z2WF}FR!DDiuIjw$BeWwZk2}uVSv~FfjSY+~?)GCP1|IFv7pOvikyH&I2{sL_X;3hN zeVy>H_6P)BRiOt2xEp29q-oCmJ`dN}Xng$=cJHNyeJB3Lj*wH~uiZM<9qxcs_xR+z zbPFw~>1_>2n$?W19gvw?9ZOVPO1!(>z@oX+r>DWs5LvGk1n6&?UHQ@FT|qRTfLo}Y zsw$K5fx(v$tEJ$ULo9niGURbj%SY-3Qg&Pb4h@uby-y~~jd%0o z1Le{$BC|F6a6PF8Me+-?_tQe@2>yH$!aTG=LBXb%c(UmKMH^#|sE3N3e)HUHWV{~j zJ-*c-VAVTuAGsWVTPw9mjgBD%enPVig$j@E9hkD$M2}-Hp(m4Ox%)`9b)?6MS*uS+v6&RS(LE(ze4P$n95eE< zw!SN&&iRu=AD(~zxsBOC?msf~AG4AT(`SXprpcGx%g5h@y%)l7t)fI97;)s>(rP|h z^%)Xvk!}JS@E}Vt?iy*K6?16%PBVlj#FK05^@gI_2M0+&2-*fAC$|6c!5*i=w-_7h zv@f{7^4}l%Gwn9sk5IyQCiX%syQwrwIQgAWhu9!akD-&~uCr$}PxLo<)V{=_oXd=r zKl_D{yA>Z?N%$N|4877-@B&ib4jX7*X4LeIbUXMXu)@2nude$I zgE%xsD%OF7dFJg()1jNS9Mtguv(BlAs z>#dNZZV&{!=SQEC422^M3jQCiDvhKSDYS5to|*bBYscYUM>O*ecMoDRIdzPu=!ok6 z-+I#6Jb|ompT#}ae)9u41>&K7nG)iw9PjhA|bmMBl37=H5^rl@XFdlI6=9C?i}0ya;O zD2;EP;ynjXO+@!QB-U7L`|NV5Bh9j!RM6QNS=Q?X!3EvuPXV87n{XDe88Wtme4z zyioS-0;^N5?suZSPJL~^N<^iRk?>_VhAQcHcCfZNf)~)? z6bJ$D$NGo*2edabKnsX?5?>q1*8oAYqnmTXg;*ym3^BxW;4h2krvhA5wAuQ9tD)?( zA2TmaVwX1}jJ*UgK0Zu;!|O*n!?YWxi$T6rAFxa&z#>u25plO1mAhy^s5nj4yzuj@ zP!_h$4{rXmsnWG~6+weu_4a9aNhScs}5)t`Bj1**yL%s7TD?;;iNx?bM8 z^bzE+0uTo6<9x^Spzw@~IRwKWAO?UOpO$kjLX&xH$EtCOo(ct#P6tlaSfwCRDA|Yj z&_0grM_-=$4!JgxWnjw=4KFee?Z*gR{@4>IMn?adnyavFtAcR_M9haxg@HD`APoaD zJ~w`4E039`|5t~W#mIn7av$5$eMw%%tk1J$9DSJJ92Vmv9<4fy1)K`8%T{xlHQtZ~+`D+B~(@*?e4# ztROzxR3zhqB->bu*UX;C%@tU7>BA-BcxtTjZ984((yDu~k&o;d@BnI3N5BnHwHNuv z#|KB1$FvISd583DPH|F8jMf~fGhkGmG6y@uWCP3%Y#j(}kHuW+#Gv|gl&*ifaHUrr0X|qPg`&!sHWSPi~~NZ z-f|6`EjGx1g!z>-4icabn89T+b`$l*ia71=SZ(CR!|XT!}2x zIKp*!>e|8f;!q7K$uo}G^5MUmw0ewdvR=@IM)T6O>+BLE|H-L$su&^mb|`N0j< zNMYSASbv5Y{o^1Oy{j3CHt})!>3}^~4Uf}V0E4MTRvqX@kEtp(kuuRru~suczVv5* zxdQvwnSCnTQ@(EXAKz6@d`%J)vSm+W62SvL1()D1G+AMo&_SV$=v)h|SI9*eWjr;( zYVFE0(WLyNwP%=X_>OD>ixKUIYHw^-Zny;*!IA1gZAxZ$LRiUaR&F!fUbHh|tcEhM z+)!!VIt^Mjml~2z1W1na75Pscmd%J2h#wwFn4T% zlN_zyYp*8Z_@zMNytS+Qh^TC;Efj>L32SM=v5mxz^iscc;I% zZxmcD;y`@Vo0ahd|EoKHT9sOz(zhAUuolg@#E7Y>&%kskpk&D+gT4)GlFA{X=gGKr zf(U;dVNCuqOW0Fg(}jmyX8c z=Omglq|C}H_{HJnidj?Df=I*)l`&U}B<}GF>;#WI5}0!yLg^ z)-OM7FE?(>6gwe19Yyn8-7`cJER`8Quxb2*<5B5j&)^N87J4&lKQ;A(kdQ*mLCKe(kgmXl*R1(%B^T+tp^VR2wTPu3d z4uP`Q%!Y*$-M$U_>RY%H(Z4zZ>s=a35*3l3$k{V+6zu2i{!LGR4S=@G@kHk+=h)^j zhhbtB3xF!*owvbrt<f7ey#Q_q5@YxA9T%Bi?Xv<#O|MG2}FD1Y$8y^-0sZg zsYTFmnZTy`ZS^Z06t(L*f33=0;K=6%)a>0HA50qo=sXvE zAcW825p?ILibGci?ay1ZZR4d!v|CozpOrG%b@AU+jW?|-chk}SynvQzr_vItZhnr? zR^Zgsd$!fiot50beZBo$m z``(R++wuIq;%H|!%X=Rtd|B#XrN$wv$K4R|&Cvu3n(%&c&mbIr=^Zt6Z4~D2ruoxj zmVJ5Ft1erV>M0K@s@RTZ0QTC8{zlvyK5(qYiD6t!$n`m~5SzMGQR%9{-i%X(9CN2*DOQ zueQh2sZI-eyR+>mGzvpRWKM70G-Yxu(do8k9YyCwN@TzYQm9`F`!R(2npPmypQ^Ki zi}d(>8B=rVMxlbe83aiwcZEDII;vbc@lGY;v?i8tezwl#s>x&oH%_ny0SfcVa(Gcg zpjOG>zRt7uGIsQb$0fcO?iZ}|ah1Tv4G64d{%SYwzT;@smGsN(S zYy(dX=1|&9LApmH*iXH+E;Dy|+IS>)2*77%OlS1k;lR*PftdsXhjCXQNvX7Kl`F)8 zbn}bz9E4iXuu;2NOqB5^ptv@&CzFv;r@$|$O$?Aoi2y{oE)6wQQ1CvkUFY7nfLr!H zjHQU_cOyFmiPL@;SeCoW`ulOOxDgJiB`V47ICQ6+s!F9$gA0V)Pk4_5?!zONX%SZW zkSlhI5qK#F;IU^S8t`PCXB>-sm+@a0gj{Jl4hV#lXy}+QL{V{W%Op!VP&B^3A3!@g zQnX~ziZXgpP#9H#DD;`BxEhEp(_XGMIHB@uC_9{vpP!#qus1V^Z}}$m7R_BE*T46e z;Y<*lJbQ064^~g0$g|Bn-7DaR`pQ{$tQGV+`LAvvJUj8@uzAi3Vhx9F=vjU8dS|Fn zE#L2rosgrpV0dYKmlbC_l6d-84-oSHE0RTw16baMbIiFqLi53Z#ef)jMPN<*l-2%L z>UeA+NPGVYdV2~kYW~NNZ?tT!#OV)Vv3c;Z4P3|SgxxaLJ)P$j&c@az?I2fIyeiJN zrq&-yBqjjNKf8-^z=+}(V;9N@yRn?E$ng53gk7YCFvstR2SIDjj7{}NRpb3nOzO46C!%8 zlTIleZJ@p@8o$aI84(NsY^qbZspQ6^t7;QLQJXE(d)=4sSdP<&LA`yot26o+InH?sGPQ?Y{vh>cn*Dek4&zfAU{#SWtK8~HIw zn$8y~;T;36o=Q;SSG(>j7$&@JLpzTu!rnOOi`t-hOTu$$D;^S1LHDZ zD+a)94#gr6lFnUj9Y_84b*WY!KZ9Hje{Qt48c!CoYdask02oz|W5!zzjMrsPfU*Rv zU^*PWco(UEJw+kSnxBfiK@UnS;zlk?EcvX?A8sa=q*bmS&I^7l6EK!R7-yId`(4~#0n?^v?;*|27k7&F@YEWzhlM{?iZ=D0C zAD0P7uBhD8H*Xf$1C~CQ3lV{;)zk}&^aW{(iNmNw85e}sV^~&7xabrDNu)F$tU~8r zR*td>8_O>1^u5T!Y*DcM#p&oZ&T_pQ7&yqxipE|ld2+LoLmb6v(&eStau=*^;sj$< zhNOSm09ytb7cA3GTgMo65SS-9D8@HYm=r<%^iIqS(Ly1W6GHk;m&@slZ!?Rjss`jB z@Ddu|A%%;E9jjloKwz4FZ$Nx zr92(?;$dIonSDBI6c!ivd=~4q!6eoOI9g4QT=3! zcbyv2#eV1h{=dyeHxIskzwP8^)VA ziW)BCCd2<6CiE{k(?J)R1F@J7SzO;6f@Fmkb6ph&7V(^v#*5Y78P)bU*V8} zpFf{U4e(*Bu}`$c+B4e;f&QBZ!VcRkC1x&^D>3Ec6weJgIFc5Um){uvQR5nEpISK^ zMo?}^33C{du2i(rFPVFhoLw&DX6X;Kx7e(^V0qr5!t0%r7GNw^^d1B8p-NonZKus& z*YG`Ar7JSW7UZLKpTz31Fq4VIoP+E1LlJ0dD0hSmqBko8qXHT?dNfp-p32q!@we&TZA_ukds+I9y(1^HRY?t#e>F48iu^7x?`e8#^)X~+hUMl#+ ziQ0&rPjZO5z1L>bP63`4zwEOpa3tG>7x;>lH3ZGubM4mzkX^z%SPfn+zVmIr6`EJa z?y4ahxzqq~eULCM!Ye@t()@A`Gv|TWU^BqBeV82%UJUgDQ$t=-_>&_4p9}8s8)r)M zKV`9^P646v6192q{zAH7m_KPJBPN?-P0-OqJh1AQz=8#}biW&ZNu#v{_~g2)Y^$pl z;o;G<-y-$iE`q#Y;LLGK(PGsd#u3h4d@gS3b(i>2iG=tL9go^AW0vSP1CuT!Ck7GK z(IM?fQkUz)=Ig?#2#6?tcH=gX+i%M2g_kXSzg1OR@r(p1kEU2<`^}tBSid=rJB)?v z#RD)B&Uucjd$|#}fb9){=M(cY{*`{{c}ja&3n)e{Rz*mv;+Q#50;{%f)*SK#8u zG^Y1v5uM>*Ezbp2Ms(j5RMgkQ(dRz$Pl}$(-?uyBD97(HYnuH?U*4cqr)L;7Y(I;y zCV~g!RB3ufj@P)ZkWsBXdtG+v+d5=SWVYArxJ`398n$9eNTq)n7EdmVLz(DK<=7TN zDw`QF=%%kN{O6g`%Q|z*`c#9-XT<|)EAL3H{$s;fG5r9cV(F3&vND%5c2qwXqVCO3 zU|lxAEz6t05l2PZhNJ2fh)S<%Fu_7h>4Et>hXWH0%fCN)6(mTJD`FJ;jT-u%ZZ=}y z!&Iw-t6Sm}(hNmy-X_3(kR}d_sHw2O)}h6Xypera8@5AtmSEIxsT2VS>xXXkr!U)i&l@EVS6un^U69+e^TouVjB~l1 z25s@Foffw_M6JNu1(C5XCppmqiUE$MM1Y`cXV4T<#jGTgVW6=ndaVY8 zT1|7#9rTR(^531G@CD_iM1U{yOXG#3(P_X(x&YV#W!z2|S-Y}fJN7y?CbWP!_bieQ z)kmNIQ9kpN6ze`WppHL|oFnq)lRjJq2PL=JQhU^eE$-&Sl1zaWCYWm*3bMGmlrxFFC>Iou9{84_LE7W$&I zMue^s!@?4uM4Zm|Eo%i1qsh~xBP6Vt_)(|k-0N$X?^iz=F)84tTEF%|MT2@(xapfF zD&0FE5jm=G$Gq@F$`?W`CFq4rZ1;@drGDgGH94H(nob1-@w*w2{RU>qlCI9<4}|?$ zy{bpFN9avZ^7B%J* zpy*^}-W5lwv^d}nTv7Fdt8sFz=0fwL6!3|sH1yJ!j7Y+GLIcZF{Ca76>i6kYHt^st zo3}B>$n)CCC5SCpv=AQzSCVN*-DgJlbt~k+Y*e7%kwYPCYFB&L8-Pa7i$y`k*){6$ zMs)YJ6nMNI=2I@6TuN;;Yx4QMC5!-1MJI|h%nXD`W|kcl36~NFS_Lzi)G0+S^(85Y zvPBm$oHgc0p@|jl8{Er9-U`u(701Ml0U-~P|IW#OFGb}Gj=uxz5%;6Oy!y*zCIZP5 zIraYHs6T28lGKu%XqpM5m{s)08&A$$nQcGN=*NpB5zy&SI0m!HNC@fyk>f4y*wLL# zJ=v#|@tZiQ+a@8UYK29&;nbQ|*z(06by17KQf^U?lp3rByjApn*|7vGd%GmdesPd+ z>`&r^#lgl#{v_4d6@SbcrzfZ8SO%You@`|EX39x!5a;wRyupC8Vu%KCde(+!qdoF! z&{#=7iHt4?DcqX~whvu;v=_!oAocTvy$Z%Md86$@$2sr~GY`jx(+1|&K)3K~!1s}@T69dwdZ_I=1X@y|Y1}?Akx#6re z3(~IadX|3U3arVl^crFv=6F>TtqTh!Le-68r#eu;tuYHimpgwiw9FqoEG)nrtSC-W zt}uJIW|wTw&VvtGb{K~u^@RQ!eA@|x0u!OncwDNBsDEg*jbcB)V8wOVYkwg9`%g=8 zahFResrgOX&3cKYMyExU%uZ)3;>ve_;DuAN5YzFqx~~YHI8WyIY7u)rn4J3fC3svv zPk?%qK3=@B{Wr6Z07XE$zkYp7v|%H|*-q!cC$>vsL>R$xh_FM%7-h=PS)NdWOcGY@UC$&^o5A=$MaM6?%qR`gDJaCubQ?d-mh$lZ{FsbuA@C~liP^Dp z$ z(MbxSO?x-TD61d#=l89}j4$IIoz`{R9IwTIeBzaG@hBJ%rcwF?B@qIuehXL)!J8*u zqcp>vZ}jPNXJ=v562wE$-uTbAt%c($6#gyhijw&rfuN22@9WPoxj$A?Rd$qY@Q2;c zIJSz%4mWkWFq!&DzVDO@EkDRG#VeU4NFx*>e6DW#<^~E)nH>}rEqQKvL+3MS9TxY_ zYOWXM_`@-}#Ni!`ItvRevIeN~y%bhDxKRTk+NL=0yA<}Gy1%l(9Wfh2dO1k0y_3Qv zII}NEt9$3O=iy-xw&wsjYC;hP%un!e)47u=S3*(3*gR)Nr*<_}O3-*GsGmx{It@T3?I92E!2Oxd3Gq3a*GQe<8GDC7{=wM#LB|66pXVanUho-k*Un zsZ<9DLO(qI_~9=jO==lIWEbQ67>E}QuJ0CBpWI6ctRjn!x5tf&9c6K%bsgk9?rN=- zBN@TX+a!lk5^qTsf|hT^H>J5B6rV-(alOIEH!N_HhhE8ZNcTVd+=`W?oN}ym3$h$Q zsOZ8NC2_nME23O3K&`Vu=)URmHi${#tW%cy zM+mGwKuUXzv2zesj8wPN&*J(>N!`7{6!1xuH)aR$t^BzFgvi@DGGf3XA2$dROLn__ z)6Qu!$-wdw^gnc4(lQjIsy8F{o5`_A>I;V*0u;xKQ`>NivSJA7l2wqbX|RElQ5EdZ zZBF#^1)7-#7)2Ab$mc)b=lbgV9(7|PQ>bsBWUCflGN0uoaPICYE+KnF_LCgyE#bRj zrRF^N+>Hev{S4*7#5(?GzOk;?6aQp;M=$tS@U>|t27IVcSv5gH!{S{B(wxbDC+G!U zG!Dck#P{N_;$|IDezQkVX)X`LX9_c#r?OK}|H+4hV#Sgtw4-fU>J*kT6&77R!L2z^ zY@;~01@14-zSoh7t@w_k2Nc@=>?)n)mmSxkjdZZW!5b#iEic?ThRD=3isqPcAhzwV zL-!ME7*ce9(@1|!Ns=Ngo4mj0t=1M%V=iW52;>BG?z7gf<|m(>mS@X_TE zJ+I%yA$2Izf1d}lNi@g`oF-993R;l5U|vAx)yQ1`y^Z(4@98!BryuRnv%m&P0!P}o z0WT?A8^Z}zNp0A2Hn0FFRvjO;jbz|G>%-v&3X!~4e+iKR!*dC*IYL)XJ);hX0fcrJ zy8H$OzF$z2C#Lq(em>oT74v8k(Z{Ya$w_PO?Iu@Ca~+VGb_={*EZ3bl1hZU-|e^PPQ>?ocy-_8wf`3&gIMwm(%83hdwexJ86obDMCVy7?#e z%kQ?bm3UFN@L~`PQso=U01o4oots5{@)Bt6L%pv;n?R%mke132) z<&}z!baH*#CpZ^_zF!qpoR1=TMd<_0)UtMJKg#n!I{tV5QOTLu8Te4{6Jr<_pP@2w z0-~z2H9$5AvuR+JRO5V03y_HidQN=%J!WX8pM+fiVgDb3Tl<`yg66ljY-LKIq|sAY zE%5Tv32G$6-q7`%2X_44&ct+MDS9NMhU34Y@Y*fI+OCwwMb@Rdzq9V30D4G90A2}a^^xeXfvBs$yk>c0)Y z;lm2+G8m}0dsF;d5o7Pw(OyId*_xCdKe$su2CY-kw3lGYjmr7N#doiGh_6BMAQtUT z!WSke^~1+Y0ib5NO(m8q$bX3_oLV}QZO@PI4owC-drGrx=$P!4GinH0m5(q5>&i><*EM+ctDpz%{He@PyFRexP%HG1%9syVA4&9bes z?EHD1GktpbqeDOIQ?knWf3TGGiC&4a3_W|f)`F$KW4NM!n+Oe|=s-;@K2LD3Vs8Uz z6uE=U(oWJ2(*oKD5=bCv%QPjwM+4$8&4uAGfwq(`H50+Ifjcc%SXZ4So8$R}TWf!Y zK1Df%Lt&oyv;|Qz#~n>?CgAL-yMQ81UfnIKN6Ui!?eQg3mTnpDw1U9ELD1iuJ-SeP z^OZ7bxM)v_Hj@B7xc^Y414z^Dd0-XU)2x6rDTFR(b!;xmY%$DQN^(~0iKeq%luQm& z2qdzRO@EmURUR@!@sqdPs$0X3&k$tN7)F1MaBDXfx*wmrFJ~1i}g@1tVk$w@>S(z z_*z&CVV^s!mhueq%LZZloVU2F_#B#&o^P9pv!(N`yfR=h@CsdXKmu@qS2c?fM}87BmRAe1wDGfwR(ZG_EugnC zyqVF$Kk)FYuZQ|2@XQ`CxDt2&apMCPU`!nnUorlKl@MU2n^aXO#7;&YM@fD`-9lI_ zgGUfKeJDx*(<+PI2m_zyRTwj01ebMC3^VY&h>ebS;0X!fyP$Z9Z4Yxd%~J-bR`YcB zyX8zV3)NTw*5LAXrYmSd;mSNN6LAd7j`3AcQ@2N|;S{A=2aQb3Y$oL3iFK=4-JaO$ zuh-+;OFLJu9l5sy6{PEmCN>b9aG=ISi;C#|`b?oSCxRQI=N;Xd?71i+puaA_lTdg* z0UnrcoW2d!f26xQ?OFte(Av}nK4^^Ry4XKNr9Hl`&`sbcTgyfZUU|A+fG>&W#%kJe zo$CE({Zj%njp`=|6!sjP5(hmP?0vhO#K&O+FxY{+#Sb?o^=B&?3514qOFO+}50iGx zV9xf397dM1QAhbBJ_dF%{QVmgyY>7%g*E4`6T&%UXjUk;2bZ^NA8CEqygtX|dwAOv zz7b5vUNb319z_8Tk8vS7m;AZf#Ue%D)TgX8H_YVvs0Au~&6^#!XZF^d>)20(Mk6a@ ziqIetRy8a!>L!cvz-&snP%$;nL-9Mp3itlJf&TeI5W^&;^VyKFD`iG>Y)wLK^fC+v z%IIFtgdx6D=C6@~>LHL*VJ5DU2kV-&I9P$=LZaRWa*+SX>&edGKe+nq3s6#SE^@`2 zlJ$StRa_2#F-df8oXk}#;evh~Tw^P5BV)Q2rU%ICSyHz%s@VpUaot_lK< zS_X|>efJPW?2^-1oXeMw6&@o}U*UQ%{6P^@W>6HMb&YMPB$#Zq4)dtz^GuD1>=8dw z#~HaNa>{CD^3dKSM^_W6$C>3=r-Zm9Emqr6{!Qb-kJzJ?{HGQ>Y*u^TH=%{)9@b+) zmbh~?cmQ8H7Xlw7fR$C9lG&Ppnvr_f$n5!id)WJ=B2v+P}%vl?kOwTpp&PbHdD7>W7Z3k$KUeg&ir8J zZBU+!^ISmh&MA47kcqDDQUF~469+4VQTnC!?R@}}2e&oUx}tNC$6`nPs`xLX2ft(d zcNO{jANOfcwbbdmZ9U|v4vs)Rua=1k3`I^QIhn;qKrk9i-hSMBHn@_HKy;1t;3 zrE1VPRr}J=PW&U`w^j;GTO6OsbEjz!Uu)1 z>U~KJMOX+i-PgXkI`M~}#2&t}60k_<|Qwkqz<#}64H;B1mGT<4(GFa(YF-le5 zdMMOHf#5bWj3+o+(5BBiyCG{uT)s0&;v#fpUZZWkiQe*geRRtEK`q| zuFZGl9$jxWABKiRFy~zt{|+ftW54+zqPw{>Xna_wwBHa-dE+rm{7?Hsv8qE>Qvm@x6pa2wYYFi zRq7^}E4}RXv{AF;h0hAaJ37^SPXC~XO-f$eogv2R$R&Lf0uxm5n4X3$S-DJBkV!)%DA_maKf%{-JeZ(C?S2p&?kDotnJm-0 z%rmv>4Zg7?%+T~;B`0NLfJtA7fL4`kw`F;PZ~c0C4)vbl`aB%?k$YFkijB#XINEHG znnTKi%DY%m^eWFD zw22r8oda1ITy;P7W@>JzBtp20Ltte4>{1;(CYi52ckj~$LWSoou7i>KY;Q(t?LdP& z%9pmsI!=H*-6DOzp$fVh%EfjbdYpRK9VLff`q;g4 z8I3)GnbK?=Q2fMgc!W!AOU?rUm}cs2*&wR`_`~!TJV=n8l-Uz!q23mH{!{WU()U-a zhi8E`3ik>fK?bq^P_`hHgQwPC6bAF^D|G0hjL)aqoONOt3xICXg)Freik_u{0{&an z!*4mi;{_0VKy{tMZP?1uyP5ngk<@E0z>uRy(MD#f6feg)xxQlnFV!#F)3TCo#AWSl z*4-odx)T1{in?K*Xw!GjH6E06Y%qG&Ai-#kX0i&1lB9GVZG$2X74vDPzQhz2?hf9r zJl_Zk!Qiop#h(DJ52552NKu4C$_HBaSfMaz(pcNp2f9d0>)%bw`fnPJgW7jF zl$B++0rSDg;?6{)rOyHVb7dgS@xFZ~Hx_lKvgE=rU|j!nYhm257*8Fy^bJ1ngvoVK zWq>YL3cj@RQsq2Eomu?=V`dy|3Rw&!)OG7xhM{L8(5L@ zW;Bl7-tFvrp#(OE7%Kaw;Lcrx9jo=YGg$P(_QNX&(j9mdt~I6P=2W zPIj;CM!B)^XaQ=_SLQav;Z%8isT5UpHo|9$x#5Wys$0imD0Ho#;n4W&&fk;n@y~k7 zOR>gXERPIEsY!#r<03&yT9Q&~&9wMI29Tjh$GkGu+cJ2O=8lQE^P!=ZP!GD7K)sUD zX3FHsN#8pSy8mIPqa;q}!j_4%TwV%!KNyev$+!2-lUFCRWZxXDe{`;l*9K|du0`z548YjEi<|w6&MlJdD3a*&3x9$aL(`d~Z=ZPWv04LQq z^55UTf{|E64c_`$nB_%k8g%cMg+-48(*_Wrnzj_@81bM=WK(m zVGPJV%w~$-&JA!%98?DnU0LB`)}~-S#)NB{TtYKe6UqP?ED!2ieJgG~!8lQw{!Zm% z$_zpeYip~*Mq9-^-BKXj4|~t4Wp}C;x6z3(ljfKgpeMDg9l^|Q=6JnTx|t-d1dw-e zG+FLm_uE)IG)8(HbQJ7522Thto+|_R%I;%c0Bj;BYy^|SP$;3H&94a}MjZSeFwwHS z?LeHXtn7jG8k!g%8@mFy=?qVZ+TB@KE|5je&p1Gy@CwV*{z}QM;9H?Mxp^UTAMRSv zPnqd(HrWlxN<*y5e4bXKRXyGkdZSJvna**PWWxCqp9c~jGmJn!+jS`YzL_~%p9$SZ zYHnoqNJabiY)48tDew?cVrK(>iZtpSn7vE7+$o_bmldvZQb&p>a9}lMjuLyu#JZi+ zS9Hv7^}SiyFV@Mg=%twXRf^91gq(~#>G85(cAuU?6fpCV)k5v`$5yM{yrRdJc;&FW zG$9SApn-Z1CGr=CqR=aELYhC|m1UdF-uo?$F*dL?ybRMI7-Fp=Hyq8w=>A z5SSXg%+dk63&`c)IFVBB{9iC=Sd&n;l!TqcYmzRe?0>Qm2mG8sr8W0uRv!+&-*ApP zjlzoRmX5Cwr~2>r!kZOfzMkD0qYnbrYyPi(d?+z&YZIIeJqe}$Iqa6%V#j0Cx?S;x z#Wr|OjAa(L1kPOEcmDR8)ifj6Q6JVFE+kgPhW;h-IC;Ntz8SO|)7DQm^ToK_rp=OI@5vw5^@V=ZmTby7k zJCK}6>Qth#taQ`JCjtc5G;)@1zAAn|a-Fr|1d$V^7c9`N1VN=dL@TEFJ=Y=cXsTy;%x2$u@uFv=MO^YY6WNE<-N)yKi+|tZ>*j} z-SQ^gW=40r;}G~MIs)&G3Nu~%R2V^pN_CO!_|$=X6LM^R0nfQ4Kj{&Afc$H7HD~yn zgu?%s*cxRwPEGfbbp&c7+%NQ|hwzCJnC+jbTA1qaup0bZgV(e~VEzt%E&2wQwvul4jEk#;@$77(t_i&uEDr0u|*;BAfU zNpvT~%mT^(SxZ8T;?}6Kg32RlJ+iq#4SeR^kW>i8{CI>O{Lgqt@370bZI%yfe~lB( zZv1FS2DbDQQYS3k>>Cw7X~GYuS22QWd`y}kPoahh37itDOOL*n`)SlgDrp5=pcKkH zs1M8Llu{C|jF=%4ahj*l=-)VPPx_?i)kb%jM`UnnX>qnF#9X6Gjv4{9`b^WS@hcDk zHF9y)gUB<*Y#3p`xN}b84_!c{kz4FBDm=9`RVQ`1^rEgeWICMI`KqhJq)5oH-=m6R zCYtO0K6tvKArep@xHft9yZ1l-c|a(CBEdT@+LR=q`FmnyXhwHiW?G zfQ6S-?9u;R79MWQSC2oLn0ZV5f9|z8eU#_UYYC;7dTS&b3?|sk@diealR~hMt7WP+ zhsBkO(0zb9gw{jZK{Jjv*G{RBtd(jgox}0C_xdxMNyI#p=$Pk-g2{-h3qOBU}*vIB9`X{E@m|kq{m}-&#L7CPNf$REv2IVL7 zTly}Dk0JGt^sS!e*ONLre^&Zk0Kj0I?a9I)5>xNV_!+Qc+l_*b?pyBOJ;et;4B8d1 zD?60D%uzGltmwh}lHX_p`6W&F*^g52*?yvYJ8+h*MR)A2yy*eg*L`))x)MmH^Y4KI0KsN6ED^+jbz5mMB}p|J$UV~ZePA+qM8O{`GY~|!TZ|);FQ!3 zDa!~va=1lioUfLUh(WD*pRKG-Ti-rGegQFEz$R$_Ft(EDZh9}n!RF^^`|^mYG8Qc@ z3Y8m0!>eo4MpZf$-rdXH2?tDv^?(9ZYUQ)jSCRP2cqFZBl4Qu~l4}bEsH!}uchPogb zr##R{53-83m8aT6eEP2L8^}Sz)A5Io!wsL@biH5VcHja07qLu>W7sFvwzexH(qgSJ z6rfQ&+pv}gn3o|LLmN1N%C%IzHy`oovWFQ&!f)`Jjlo-!Hzp0~n9Kb^X(xo0SzMwl zVq1)KnTMZE&8uM(WG?mRxIm^DVv1)(VKs%=$1bmm!$f_`>5{7lQBjv2oTZhl$;K8JdH_jfp+=DBy9Izc{}*b zk}-DZmhct<>H_@fg#S0jTt<O&{Y;mKk`r26RwqG4@5b?5c7vZ%hQ-IrhQL_kVs~ehc z3t<31k15c)5|r5wu)C7FySB*)TRm!{ii*jtI@Jte_uVpzr-h1T6L5@8x)S_NWR_R_ zVC4S_yPly^GV$iTn}dz7@;aBFYv7D_e>Ayg@YrtjC*@Iv)Q#1bD($Y$YYZ81JOg-D z!lVQc4HWg`D5+kOwWna5z|6_cHa>u_!(c;%6DS{s0+cZf^>zEC!)a;H)fd8WnwH!_ z!9uxwA+WZrn@Y?${!$>4F$wzS#O&VCRb)F%vsW5#ih4e{tl}BW#Ls0(db#Q{piLoP zL`sP|*Tnt`k*F0jIY;2^;*p9a%e;lEe=IW0-zZUFWVpMYga4o)=jmAw4BC#@=#4h< zZC$nRU=@fO6(RXoEf+YS^QHN=vg3#ho{Z z5n?3{2yzOt2x)yCM*f{tfO5aiQN3Vfl8r)VsFxveGPH(L_nOZF*B-<&8h-P; zm+@VTHhlUasO(kDV-EdQ*sw4F*bcXEnzB_4HewBq_T4@}cMShPL6 zdUs|fnTBNl6si$ep-kF-mPE87!lABW`K3*1Q&4Xmi2o6}#ZzhV)^Hqc({nG73s>YX z2+1stBJ1w=-2uU<0IVLcm>(D3l^6B%HjQGJ3$ zX#B0n;F`TX)rVFsWC7C9k@IYh?~sk4u>Xc8Ix5n`uJPrqy_EUG#km8Ql#&#*Z~Q)r zC-hj@kqLLT=YN;WU6(|8up08)8?Xzqf!m}d$|Vk=TO()Ng5%oK9vxJA?$YY@$1uT1 zDm=k;5U(*LdcVEaghJc67$^F3x|w(MtIM@5W+~a3cAeT&lbe+;znw5#A`LMQD@-KA zIII`BPHj@dppDTAhXpdz#3&g?_`LjkaAPZnS5gszj~(r5eEVN-MAx>;QOOf6x4Y9{ zQ4GN6)UT=Lo2))-YUgEn%<6b1ES4!n^O25?ve4rgO_}Z+@6pPA$VsySfua%817siK zS7Ebp_#7qIQ59SIu0?y#+CkL2vfT?)%>yQ2gKD7q2I^;*reD$D@15p?-JmqJMn{2? zM_(^E%yXH^XUz+>dnkLmRQNnDQ}gFx%O0QfI>PCjVG>&S@Ba#)9I>W`AjBW#Sjx1# zqRzn)u~WoSKT>HuGJ*b#zT92t@tmVLo3rDoeJ4@~b4xy0K(n6rp1$qLmE&*W4vkDQ zj#pOfFY&He^*`T}GPCsG!A=i;;u(psE8D#7v+j z72V(_3`beZM+N^G^0+Zmt|Ai_JX@(Kb7QL6x425U0f=maMIM(Z-8v8M!l^fyGuD6w z8^4H0W-N9p7CMU96;kA;bZ6@kfzD`tDKQ$rtX@V(%T}5w7ovS72Y% zBREUl12i2jEF(hmjt3;`T4xdH-8kK-63L$q<q zNfORyrd(A%ZeeUF=vyzw4aKsRoyeqK3bi8E{IU3p!AO*)2OpYZBI9jv(3YlO)Z|L; zRL|N>!6T>_yq$@K1)3t?Zd;pxY&~?dPjgHF^f*|O{Ss@A?2{6BpI{*nbM^W&>p7YR zslg@MRYu3m281k9Tep#Vs2r4u3DGxRhxoW`%|b*Z1gvc#hOwbWJ4E)Lko4+-u*x_( zen<&6I777PFR@Q}Q?q=PB1Gq&J~&i&0UWTiPg38Hv5ujeVEE%=@&l`FwaCtJQpJ3S z6;>$g&+ot)AI;6sM``Y?9bAzhj`ye|lIfX_2o2fJ&55wQ=%Q>38UApEhf;xAXzF)3 za?ul7WWmOfL%*_ev2&GgrKW2JR;2)U^MP6O@4H>8?!ZtQrfVQXAnT2pR4mwCLFd`} z59x*8b)+-vwoP{vUl9MeH98-+&1GT;;?rji3NM{N5^Y9=$xHVAxyf&OhcT5N@R*DEv2{U9N;~Tc(%(5YMoCaG zjNF=NsN)vKL4aWJ z*NsM0P|j5mXa0ybYs_0_YbAvfnMic9=I566upQnyi0Q9+PH3^Y3pb#k-?JYc3+4#R z%jD&%*QzlM79Y*pkpaCUMVh}=#2qG}I|UZka_AuOV0811mm3DCi9H!&!*lL|JRY^a zmVt_&f&RZi!(bkXpqT2$=|y0LjjeKF;7qeZyhl{n!8@kL7&K1@fq2k{dV8DMENj_c zIhX5Q-yP4YeFmy&XEI9!K`d<;%f_E9rngp0GA1Xsk*5TDe2J|5!DbcTlGR3=qia8q z2@r>K2jlQ)g`JJ?0%z7>G0U92Pyqrt6Ow87rnyeTdN8;7d``527~KRci^QRa3v}Ch zr8oBc0KW#0w9fG5en-AqTnj+Hiyg#%e0wON`D8-OV!vkP19!GBU+IZm;C&mWPUWnP2*HY7z z(xGcd2+b+BX>Az@hYC=4K@sH_OVBkPJOL%|8Sx_K!SRBEeMCCqV{!(&DSS-T7XQSL z|Mw$~l1QjEi>i}b;Kc&lGpweFMtD$4?wmNPoiDBcQy_6ridQ0HjFe){!1U4ehO()b ztNE4VhUc$@*TR6}1oJ5v@mGwppe(Lc8n0|*Jj%eqw`&|->@+B`+yl@9SqTP=QzRbS zQNh)w8(pyh+b%A?Rc95fV%EL7?0MH0g6O0YgtsSc4_MfDiYp!e3uA;Pssf*G+kNm} z(izc@WtQ;@LvS&0H+jR$n;sY0IA&A9M?W;z4tnqHk?Lsek&Td@SAl=(Kp_z?QI!ER z%=mHw$U^7K7y&rCFGrrs;V&SubG@NMJ{J9c5z+ZY)nh^$5BfT3=IT`*+`t2gFsdP#-E4a84L`0}(+)yhRcOp-@7l&X0!VzPWA>OUcTQ8s2vGIhIuZ)l)8=?yp9 z(Lj>n)F2|Wjt;&M9|=dJmixByw?B#h*1;gUB^LRlUH4|3x;Qf9q_x^%(FL?(e_tw} zt**Ud;s0D;Z1~$39`i_aW{_VF51(5%2WEt@d(EDQCNj0&_kiN0Sj|@1xy#;!hyp4V zOkameicE~g(kniUb%Y*FY-GZTHkVac)>X49BEe$E7@Io2!>$4t%#BmR%*Sz|5=#v!G=u1SqlhN_I$r+H zU1yk{rG1TwQjj1EruBsDZ9iuK*l_`LT2U2Tgh6On@Q1CRedW zxD@hC&no1+lIl73s2fp^xZ_g)Vo@Bye3Q;?F0*6q75;~ToujB8SU)Yy?hB(j{=WKr zw#KLa3K}TH`ZLH0QzT7iNbUrOmS8GqYhl|6r4w^gw_`WBzMLoWrgB-~I8#8ucfRkE zaezXZgaf7Xk36+ifWjDZRVS!2ScK6y6DZuY^)!BME>bi)_Gz-me?*zZqF8_fis*I8n>m+L&UL!Nsjdo4}Ar~U#{D?}Bkp#AJjbb@C^XsNYjsJ<;PQ{bd zpyHaOEfXCLu9v%@SoAC>h|M5z08q8hE&~z6=)dvgc4}`L|L0d>B9Ce*bq@kG8q7NT z7fjGglr~r#gy|(!>UIG5P0;caf?d@NrNu}O1?S(#$Hd7xozA9FnrDd0)_1! zhTi4O*Wfem70nQOA|0njqUcVE=^QI+jBn*w)}5W%W6?FB3a@o4^l7FgX2g{j+^jqz z^Y27`h#f(YN9r7DD0?W?-VW30_ukF*8-1iq?0^Wx!R>lsk0@NWp)@;=U`Pkf57&-! z#t)#;$~zY3c_+=DLZM;nsKFz@o}RI z!(cJ{rDN+;bql-WAO@??5?V?)xH!_61656yQUmCF|10mPaJ(%ZC}@zO{I$=F9b_q( zgIb)gRYGDq*Ms4B2hu?|H^>~^cW(ed{5d|BFI94~Liof8Mf@RHI}G*mXjSKc{lc^D zg5S|F3wbG9h;dfM4V*Vdh9WZmog;yl678?8hAC|jdMBtJ$l+aj6aq}YCnG2NrZkz3 zhI*m6v;{s;rrNhck!u-!oFukPCBL(oOyT^v&UvCa2Zy_T9rGs2mM}r|QEUF2EZ>Qp zDgz&od&^Bc#TvR$$PrO+#Vby@4Viby;<;I()4BD&pU=Ec)cFIReu0_NN#DXcSw$wu z+22Afds`|Um8hTbW0Q6j2vw?TOGi=jmH0AjE4D~*;Y2QfZvk8tKQ710ZJE|zYx0+w zcCH42P03A_nmgM#_E$s5>rg?)L#D*2&N>un5e@l#Qyl70(Z-09LpgDT3}5vUK)v;s z&*kiX!44q{$^IE7`bc^jmlvRQ8TjDYQB#Ci2&qf?w#t7hC6_|fu8ka4GzOo8|0o}q z1YkK?e9(+|CO*`!T%vb;7ueC73qGuaOYOi`62gAqpAL1L{i<7zhwI+fnDQxl-n(%I zeuFBN*Zjic8kq#a;Jns+Xuzh4Hi8|QbZ{0d7lM>}`nJ?_wc%qMr-vA-yqPxkQz-x5 z4;*-`^o{St$k8})BonM8VhrO5pzPo^4Ov$h{xD}Z300_TmC@hHzN zQs$)Y-nJlfqv;UKV~rQ{Lg%>#!j!Fnc3OD_F1wdBJFI7xtGY=l*>z^jA$L{!$GEq8 z@82|r7Jkw`@Fa(Y1>9Mw-%-1Yq3%p&yA#7)#Bye`s^00nm}R6oK=Dl_5urboXEFd; z^Tr{{oP3U0@ zjNzx@hUhH6f#10w!naeTgTccV!tCWJQL?(W_<#So><%_>&$R5=>)l;Y*<0a(!6{rY zsl!1EQD8V1*e*GubndD$L77YUql}JdiUgK1Ht`$%CZrBk;fO5%I>sOWUK(!vtq* zIqyful!e689*YMzM|)r-$byS4&O5@QVU#hT%6k(6~h0=P`d8h`Z&2s?Jr9?40vS(;?Wd3 zb|`LCJ#R|*Vn>~ibP+h;+9Q>5pI1uG4>lVJ+DT8jPovDLc`P#Rf|MuW>@Cri4{O66 zbgvUDh6m~Of^Af^Z)?#vpC14ysq#Qe59b(}uhuSXOZn%!z@89_M#m^;S2N~|iLud# zn_SjK7`HxJIHsH{gE&ZGha&7=(Ytb`s~;$d?+t`s=y~C?Ft}m32Q0t}{Z?;%vM&j* zm-N#Dffd1BIVX$&sBmsn6YUxx!a8Bd9NN17HG2gDI8*oPVj;1i5^ZvSQ|T9DENkq3Fpnu9gdq+Ae!>7Ou9 zv<#GX2Lw0|nV*;i!Z1%k0as!=5!In&dah?aICBMA?PvitM`4kr^FO{gGTseCHCv8Ck(5F4DMaZW1wWpNr9hZ*(&`Tm# znpAV5fkqyj;y!uP;oo2D0b%~GJirnvXBoAG*0c?$(!s%DRsyK^TFAMLRxc%qvTZ?c z_)cD)@@Jjf!UJJ0jy3_hcvOSjdJeAASoG>Y~)3nrn8&%xz)^D5fY{@h%YDc zcuoPd3-088PWW0RQ}da)EjeYFA- z{bA>he9~8Pi!Jhy!O;qgj@?;dXg}+rjOhP#9Y3I13HA{zY zLRHQ&r8IkIWKk4)k84)%28BrJLk?= z4`Z$_Q!X&MmnvIuo<()#A)u_N zrE^TbBFc@sBl{Kw=6|^I!xfBqpFCop44LeZK;a^F?gMH>Gea>y>*|{1PHa@HRvqDC zG(9b<-*YarcKv9f*ZqTSJ1qb%HqQ4 z3T)_ip%Rv|c8SrWu6*neFvlhDZyM5nW4hR5atl7-Lb1VNJy$Ux7YKH1NHFrc15A#= z=>fGT%AEv6;J=|rhT+?v{MfBFtaP4q=%THy(8>I4U%X1)dlo3#QiF#ZETQprWE|IC zD2|NBH~x)qGlm~|P`?;Ip|)m}gug?vbAs^4UYM+5-s~@+P3q^fo28)UiI6`d&3Iq2 zdM+Q*Wl8W0iUHQuuipC50mA3mG^jyQ#2r1KiZYDYst5Jef+{>%P~7r>#GS6@DAuAL_t6A0>8boPde_l%KG#nP_ZS5 zU*S@5-@4qF#sTi9V2@E>4$dlhbjmVLA7zQ=s?UHMUrlPbnxVIx)fmXZB$Z9FIgLI$ zZU{e-OYV`+*nzFpQ;!UKlV->()BBZ_&>dXv$3{vm4Ife?@KU`fRPh{0$UW>~F;9fj zYazRpoG#@ZD~plogw3OqA4XQxq0UPc+wN#~{q&nYPT5XDta=>N%!iBeUSyz9Ob(5# z)4bdyyAj-3;-d2DfEwAv-L-}4$|XoJj{389I$9o4GIhUdd+^bP(xGtbESoc_V~RSO zoILq61!_;rUGQw)in^a83Tlxd;E=iqvPjRE0HG=3Sc)UoX9BNLC_{5hT6fQ2AEwbG zSQlh*nn-dnCs&WyuBhb3A!`>ipmT8l5bs!)O*66;$`@NT zApR+Z!2&&SI?6;s^jh_?-gXjgWm2mPcdb@)yTPqDyoRtnEHIaQ9EppBRXV0C2{5Ei zOV)kr7H&!Gj;xEvc-?7eT$!<&hydR~Gp@r$R5Q;pkqmfNWP)C*BrIfe8uDVa7|3zu zCU&_urKASlpLoWrUa=$=&=e}l2CUdm9teuX>j+x>C!nE&HqoleLgq@Z$-uT|mnpZf znOAt;#$nk<%~NL|M^Sp7BQyl96JY=Ov)(}R4YzCvE#*Tw3gdtH+VO2np~}0AbesWd z071g^ELy{eHYJP;R2K*h)ELS!bATkgY%&cVM1o+}{%_<3&P64&!6zi})Ty!8*dVU4 z5JAij$QD@EM`Rr1o;y(PJ`g!V-`%Wkx3y+@5Pe!nw!N?@;gd=;>Y(Qs&>;*+anYhH zuHL0<#A8b1I7Ybf!yVory%@xrRdyw8F80dJi)@0F9Z8F#6-Y&I(Dd4aw`zt)@33A0 z6*qd7BJ}zbf3<3Dk!Id8Yg%>*fMpraZ1U?1;op?Qbbf7P;n#!Jd)JYyxvz7erSYqF zj&ZH-!{w6CT>_?NKTP!DwO7m*DkYv&8kXkV!JUURLIhjTN=>XX6n&7ePHSqgL?sw0xl^28@$~IWmK$k)kwYQ;Dr6gst;M=TPSkP*MU7B(O1jquV@uAiI z4Fg@7-BX3JT6$a^O>5kb%hnx70u5yIs=rvPSazLy&1`_?T=rb(VOr|3>amFVrp*cKw0<_id3=@wzbzpnSk-euvhOgLr#@1i1|X7m-tXW;(@c6qAg5dG z`UQQ`8z?v%Ok1R-@hYZ&xts0MiFy@4m0}MpHZqrs0+x0kh6}ruC+@;*4EgJ-^K}~B ztzjZ`N8qb_3j-`C~L1!$UmQy9q8eq3LUU zxyjjV8+E~Jhn8_!X-NAWE$Ru3lsnULze?1 z;hcFa>fIcO9pO5@0ruv~JKJq|Ll>Eg)Qj8e#5NS@Z0I+>?A}%i+**J2|KlM2j~b4( zjPjuPl~;~W5gUf^dT8e1ujzR(vCto>;|t8Lan-}4@zfM86MG-TtVFI>U+|X?@i%-W zQl8uY;w1-vgqB0b*0}rBLABpjUaRB+g6qq9NLW=GRJuKr0n~;7u^~t7jxY?jQPbmO zx|t)m7|(XZhn6z_mp>fCdNeEcOPwyvwIrfU`4-Pa!G4Dp>T<&Q9Sca zCsN8;`iqnh)@%%hp#)u(k*yhLrS|2$|Jh&TDZ$6N%|g!qVC!pTRIl1W$dL31N%P~YtU2ts#SQ>FK*YZY=qE;b)@W{m zs{$73WEuO*JV90D{UF5RU4?S$KmsZTC5{c^;t#z(pv|1{Hnl>ry-|F1^Jby0vy-O1 zbNRRx1e2o-S%SHYZeLvWA_R0e&_vr653KzDE1oh$9fJ2H5#`JyZ^^7Ek8HMZP(FG1 ztnUBf$}rZHSGWSHT?+9MUA#hu7gu^S;8b*#fp5W8*I;P)IT!x*hy`gm;!oCEi_n`u z3)EFgd}^ken?MZsiL$$al&XkJaOuH#E4}tT#AHxZL?q=q`w{0aQEpy+PW8e{5xYN< zCB2GkmWZ}a5<2H+=)YO(IZ7K*M6PMlWCwm~zRi+0@2A}`K$IU0hy_m!INnAPmXuj3 za9(NTNKYxCZ1h<#J>6@XeUh0&(MH?UWI-_L>#5ca_&WVpm-cHLYJJt~zbJxu*)&1Hy~nh` zvqc&1K$;(=QS-Qx){QnZB8q~QwzQNsAgXw&zP0Cr@7)uQ3fm=1CgXsA;bxO6Kleha4FW8?_s(w6XcP7oI;> z&>s{NcHb3Uex^la;oRiA9u3(&#T!YhU&fRsg!m=NUv7Kzi$)7@&Y<6*_()>pl#w0orP>mrCEBUSM3ihy@`Y!T93LGe5D6EtOykCGZ5I| zzpB`K$<{*K@qj@9Y`{g(gBY}{>`KN`BgM^%bZfh;8zXYSlt8`W5pLlbYe{T6jpI^X zSL-Fww*Lq198U>#&{a0wp*kH^9mflD34sAmdytLZ_g7D~@kIJjlEcTV`yv!&C@1Q3 zY}}R98`C9w#&q&TfJ%pwrcB@C_}#M^N-hDx-@l?c*wDu$;Q^%0x%fv70prHiOe%D@ z(7vO#DMTWYnf$52F{FX9-Y`G284tq+rgIpF#K>Ak^MiLH`&WnUkAr0TzXOvs@)vR% zJUXE*ffvF*!FiGuq&wn!c>;A3=SS?9_P1I{M}~CN(=6q$DGn7cCoEX!mfa_Z8&E^I zdCuH9sDNMvq&C(p_%F~qBryuh(rVB!)B<_Ovxek@{RyQp)8gpxM!f)%;;dH^KFXsg z;N2RqqNO2i9HRTH*g?VHpy}h?g444xG1eA)3I@|!bld+M51krQVq-MHLPMB_)FaC# z_q2Cp(ZzUh@4k7|`Ny8YXKrwp80h@1<<=KwY5A>!qP~ogb`y}cdI#KT>E$5x#=){Z z8OxmpsGfK4QJ!V;mjLfaIil8<-5DpZ+g#euahygA>?vvqdxdVFGTkyq(&OsQR3BYA1#*ry4#B^q>QxLV+nKb zDwlB4%109P&|;zh)Y6W_)VEQ|3SHCTWf0wV4~u&>Qn8j%=9eLDb1`aWH0L>n7bR8J zOgDe0D}moQFpE6VI>mR1ex|j;#mM&9mQ?7wxc-L)gj3B ztx?tptHr6W^D;CP8oVzsMW=OeEB@m_LS$rZTUyoa`Ku87#Jncax85J2;hy_n_CMNF zUvwU){VEHf{i`-E7n^-eHk$VhQ^qkWDc<@~K&W&!sHyKtQrrcY{i{N@A#M9$4O0CP z_QyzsD_i>T=82e9^aS6W%$iHR-rS%gy~G%bGdP7F;C;yZm@*$6$nz6v^A!7zFsF=< zgElLzoQ2t2|G-9+l5=GFdsELRx=A60WR^EMtB@eC_S>aJgit}MJ+lWr(wqQf9P>UP z*_8J()oQBCOp^D-+Gv*}LFmfdN#4Q5ig;MCKg(4864KkJ5j@Xjs1O|Vp zp4e|V-EFV|yChr@bPgA@A{yLA34Wwr*%h$QlBVA18oKmsw6@d8v)ejn5yIDiwIAVc z;g?|Lj`BCi+-=7n%mtg&1(FP^v{3x*HU%QwVUomhx?5z}=f8gb?hc50=2&m$k+LEw z*IK6x6#m%C68+K9j8~Z&U2%*Cca|=eh(MPH7M2*o-%V+hXy--sFEq{tTMYF(U~5WA z!9_DmJymwKA941o{-Q0rmpFDV-RFa9(QkmoIi|_#VPhOD3K$`3tTLG4 zV3!YwP@;DnbNL-bp9M z2BOhkzR4@5;>^f_hGp2s1k+xh-|Z9|hP-5u+Z7eSvyX7#JAq8yWj>Qn)j6Ydva8MJ z`G5ovI7ZVyfN=*5Znm)U?8KjHx_3pxcc32AfPXc0>}V$_z8M_>NRf64o(|wQDBqFA$5888ap;K$iM@5k;n z&q{PWh)KShzL`Cye;I}U_;2dZ7Yhwas(1QOKmb0V)pY!?A5+&kCMc2VoVr2n80{g* z!!2how<1Ni(NwTd#Y;yrWGfO0k{ZB<0J@d=&zO!Oj)e6+C)o(zk-7Gh)HjVMyY8oA z4*mlEer3g>ob8WL#Zs$0uSYhki0xpE(@p+kZJIScv5L{_u!&cd9~)M^RCp_33|p3n zd;7sMGO!NvLy;Xll+;+jn{PzP-f*re2u>^tc`uXRe-F4GyMMEpiL5(Izy9g`e@Q{j zOWCk}aql$i9;DZBs-;RZgcR(V*BI`8N3zehLBfbTMU?lbpgpT(r>1E-(`}dMTG?X< ztAc!3xL-ZBK&vrQRDf=;E{suAtI%(#AQR266G+(dqjD!t9?*pqn%e*(1{sZJ=xbdt zTsz_@GHcCc${McE|CBXUbwzESw>F@|;o2aGXq-rflaa&)Tr7IJB;-}@!~llo3EabZ z0Zd?ieg&lOIsCvl6$#$}Io}tb^mtT7eSyET4mDLT`8RSZ7NIra0XC5CK&ub=XuqC? zdk;7)1_Mf3ejVx>)Tfe=MzN8{RkQ+DeU>Z^%LmcU!WM(44*$9q{=6vB@+U-Nj7vMV zK6PQDMZH;4fk(mHC-BR*_$&6u08c2kZrZ8TQM~_WfGm038%DeDc?4jA#!n!pYga`S zFgfb*UeOX1EaI@-W_y<^pA1|zBtoS#K_Bgt`2b=^`YA>%Yul>26iU)VvRMJ#Pxj!)CW}b2v zRuvbX^#Vp4|AUjX&3hI%lUX=Lf0W^UGg)1o;^Lr8D^K(REgsbAl%J>-Wrg(v23jfb zC7f*)Tt(bAf?nqQ0^E8KT;*I4Z|60WvQKFt6Tmbx()>QUK+Ua&v+9s18)!*YJD55a z4hSxsXB^MfOMeZ-Cxu4-1nzFAT%LVzALz3{3a4pGQ997Wn@?n;fT8D|&%oK`5))S$ zJkSNe(#tZP+f9v$PgXfIEI>-04Z8;XwVAW1LlAIK&{g?YO(7xZmQ07`Shq6rQEW)-zmk(M#?CGbN63ay{ zVi#gxabYUx-F|z%IahBn;GK5+kewh2AYM38lbB4=z&WM4h=#(Owqui? zChyF3;><+r!VA65kE}Afrh4@`?y7E&4e&4F-flP02O#pcP$!TAt)$V-oGbmw1P^z> zcyU9T~9`PPmL1>g5VRF5BA>G`ddCT8=b&$$SaQ>7uO?HK0<+= zuda%^KG>O*axczG49Cr78Pc~q@_Yj(!h>@(17R-pz#b9AaC#Z_fGEw8l?J;WD}6{Z zGXt~NSdkQY1b_nXp>ictTjqb}BG*yrgC9+fCfCSo$VI>CNxn=a1Va&u5YJzRnX(&d z68%LFnxEbPM4hGeFUD*3_x`!}@}YeOE{P*tk;WZiu*E_BrkdV~=)>0A05JDbsH9*! z2KwXhi5#{4&v0f`*!Wm+ENkCg-B@qJd|whYlXCE8@=wK;$g}D`UoXG17RbEQF!^WN z2|eQ-hIQ&CDRw^!3B-!Ff~7Y&)hZ^XrS(5UlJ+zftjQ_UAk^uZu4tcNo-|)8&4Daz zHwS1v90aIXL^P>{sYyL$f6`4UeXy}$)j6)6zz&^!LIo{A9Hje#3Ls;h?{T@5+G$zCX5uv=(Uyh}GoJd`X=b145p3ozI9P&11FrEt@z2|yz zA8rPp!mT}Jol0%)8}5o+hdQkzxB+`PrWhyD#!p?4M1KaW$aL>UsYbWoe(9Ws_5wwS*j%udR>Gu-~oG~B~x zL}2SoRrGq{A{jdW!<6brqn8YVsilgCc5$>5omt^z5f?r*4J)c;g#1K(^{03!cOswn zRcGQ`KMLJX42Wmxl@b|0d>tlOY~5jVHhIy@(Bk;v5?cJdWMZv4!4HP?A_lKFF*4pY z&-H&l*sTgj0F%x$L>g#!ZVr9`iR3f>$+J2Bm11 zxRb!g)NG+29ZCj@j7GYi7P72_Mre$cra-;&{56tCoR7!9uX?r$ThrA*ua9|oCuHDu z9s49hObAhIbpw!(Mb7%VN{}^!TaX(~+zF+^J_Vn5dTZO!VTH?y6+%-`JwD;VcB{Iu zzY~F5d}}CvWz?4sDBhz)q;v8dJuwT-DyC{=1=L zT%@M)Xm9GIf3hQsCk| z|4zs8IfA>{+%!5>mU#e0&GfpDL2D=-90P|3q||ux{v_|g7gY*q| zZIUSh$zSaC=LW{2cIY>)_pm-suYCpz4%0Eph-dsJlFF>fYS}PO@UYr~Arx(Y=UuvC}z6Tnd6;2 zq#7V88YR(}t|UIXolCgs&OkfqGlHC5?H^cP;JJB$FG!k*$OM=oEqdZC#( zbdc*Y(v$TaQeXS~5#3nfGxW_>$Xi?h54lt$xOUT*r2$dH!P;W8bcV)DJ7y)2VelM| zFn;X65eF6!lVPz};Dvdl42gRDWzXezo{c{}Xh!E~^qsy_lGLVer9sLcB;N zOOV;DbP}{Es`Qk((fnPT6^J$hE>+k7%AjgQqs&1i@k~A!5OU{@@6bSOJT8oWc%G@u0s8*2{ROg0h1EyimD<&9SUHJs}@TEY+#}Z{hSzN zTLd|FTKghdIUV%^IQgk;E7MGT`A`gYopDWb3y&3b9}ZlsC2NRjp&Ul{*{7q##n1gcY^BV=VHQnS%Uy!fPL(>b$UjRk~X`JaO1hxG$O_rVek*b1q2%cxF;` z;OablyvGG<$?WgX)P@O&Ze<;GFxk_%+3y#!73a&A`6F`t#Mgy+-!30v3`=0-C42Ae zlZg`AL2b10f~d%dXTzO$hQab-FW4M4$OC>C}xFyVX3rHJ4u!*+Bf2obFI%GV%2 zN389#u6922JRhDtjoLnv<0G&xe#xs#GBXsGFL+UVi`2&XHd=8vms6ThI*~rlo4n?j z!Hb!4qMu2RW}%NJ_+XpVljsIVs*|9R)a8`G5yk>jkvs05;FNDHP3)X4)*_1jo`8FnqY zi(i|ZP1{a-yuk#sI%YNBd)u9GKw5m?==D-em zJ*?A9yeIT|(1PN8a?mec18eWg686IpQEaEnjC~ZsW{1Hbs*-;VE&!*cm9X7b>GiVN z(U7-(1^YSVPyh4_23j-B-(@~upi&p5Ras2?DW|Up_A6C2h!_^2Jf0v0Ryu^pp}Ybi zoY~b#sS?iZ-m47vPG%m9g2NPOULGp1|fJHKF>b{zO z5pv3bN;@qzgUL!Uf(kbpPo2y_r!nhK)V3z-yle6ZJkMd(Zr;3;F zg=;CYq6-hOZsRgZP`Q;|iPm2CwSIK9vwH1dRBHMC)9SIJSfVI9m1y9i z`!puLfV|V2J`Y%ncGZOe4b$V=`9T~!IHb_-DYdoRfr8iPQaW5C0xw|ZMxp;rs?syG z@9Q4sFKv!G9#pI4@(%u^t8RDX?B$n(@K#T!2%P48;x}`I4F~~#;yC+ekUSiQ|8U2R z>0H4as)bgQrq5^mObF33pQYUlH1LK^S}pKBtCMJ6_a8Ia14RSOp_gv@hC|*;yk!D9 zbS>#kU(`2mb|+M^Sa?vi6F1@Y6CS_DnI_L@#!Yuvg}DZ_qBi_8)L=as=aVqe{N${- zogS;_aoIKS;zd6Z`eh-mn z22kJ$M-pD^IbSQvXYY#)>7VPcr;t^3k_QP@$YW1I%oZlx zt^|`lre8je8Cc6|xPm@}$w3ZW6*we+-L;Z5^vkNYq%6ia$>&%ximLl@a7sr|c~iw} zjh1m3J`>S1YlAZ}GI01>7v5Y}TP``mq|I`5okiN=vQS>))I^0YV}66T@zv6l)!MfI zmkW5_u6WP3m-Zw4NCe5I&eHp8Wxc08GEAKcj9h#0CBVkUV4qA5a@X((n8k`M&CRX# z>$T*7pH#iOu-dIqE^~t`-M+0<9=<+mk0#SuxPB!CeS#Wv+2W7Q&dI_ijmor<&}C*A z_Bhm`$LpuFbCH{rxQlWotB)TLi_0_dfFfn>kpP6cWt!Z>>dB)$I_B;0o#8f1jnGSu zD0nHl3$BBX#sCcf5-rhXK8S0D^MrDgm`M!p7zX*Zqo4Ca?PF=xK`oFLnjCD=Rwt@q5|MIT9&|I0hb$BSMlh{f9&$lz_#m? zRqO2C9Vsw|f1@k@9RKprMzqzqOqHyFK1Ht++XgI>T_fuY+s3>voD8G7$>dIxD3GkV zu1mt9zmMEYd=g_QK2>P@z|VC`Z;XbQI(hr`ycDm+UL?3Qr0!9X{Ma&7ZgC)8nhGqx zHN73^DV*-sXS}+>*NG5zOuh+qW^3p{FPgz#sDzBPb~~0!2?H^^o!AR`?FEJ7MrL!N zu~GHDlBRIaSpUf2G+%7lQhcH2jT7{ri5oyd2}mvh1@H zbIA&&lRc-DE{LCz9+4_M(zrz1stQAYvP~mGn^lKCKLQcJNXl zwXjU=iMAlreZDPUBQyYTXtP<_}|-lJ2qRAXM0lP$)m%ni$*w} zgZOzAQJHl*6R+YNJ7@_wy>>=_$31H<6%FgH zQ@i41h8|lE#|v>RLX})nYS4R-#bbl}-UH$j;@}lcgY)1d+bOY7Q1Rl#NyZx%|3?7S zcH`%zsB2ib>#xR(n!FX>L`J5|0j#m~VV@$Lzhn$Zs7rzO;&7;P@TW%R@PY*6ddtkg%WCCXb#LQdcq-_gQx4S*KGmeSRjJQ%;d{CKznkJn_+UZz( zhgrH(u35J-tHc1*ljRBOPa_sA*eIswJJ@7wk5x|&lVrue87^2L3zmP8Y7l|m1d^P8jb-GbMp} zAlcU_p^{~ngG8P}cKGlov4c$ho@od~Iy3RtYO{@2rmYUtBGmoDf7KuH=nqqHlsFNR z&iNb^IRjOq=4fQ0f8Nj~i1_1{W4RADar)A%G}SvYxcGH35@Lmr0Tz&51Nl1*0nu4z zrz83B`NzdW_j#LCbx8q#`VW8B=@p%4cde$%E-Ui-j5U~N&`_se-3RhKa&k&(bg!Gc z0#s_do9tk=1RX=r`xoxfOT)<{Ip0(3I$P?L#l9fqzoNHfSauD!5Q-Rqv4yp~Iesh`Y5-Mm0Nhu=+=AHWD)bL3Audfr%(9=c z_U~<`=ihviQ@62Aywf$5^;mO{i-|fBZ{+%JIc^@hfyv3i*@V~L1tGKOOV+4i&^?6L zUX}Ql7o!ajjLBmzVI#kkO^Loo?kDI#1Jj^Ty9ESkkM0s-4?*#!e|z0My99H*73@_k z^Xl8e$Ke=0=Y5AtC1J^WV0pUbt#Lwt5LC3-d5l}(KR7j)0aE7V@t%#8t!P4Qx_>>!(r%95sU>X56S(&;x4#ZC*UT;+RB9sV;+7sLBeD($g~N5 zr@k4`vaRl*8NsYoK&T7~51pBz&El2PJe-``#~I=fiqTnLyzESY#cbiKxtGolrjkOK zGTGV8fKf*h3Iy(C1{AUu0xUa&EpMYw;s}6K2hLRaHLAQjS%FrSuZl-edrGk(C+j^U+PZ% zM=_J3iB1AyzYn^=k5T_by?v9uY;*HGv{lh4<{Ofpk<3F59=oUY!iL!P!vw=qb+ZZ> zVSxj#Yfnb`y(%p9yNjOaP+oMtB_imv3}oOaTof3}#A1iDKe{LK;sBmCjde1A}O15oCShUlp4;K64q)vK#XHPus3 zG~dTA{OT2|i@-u?<;EDy8@xP1CO%al)aH2$~}%0s<~vm;YD2U-P8suB{jYJqr8E9{9n zq^s$QsHp`PfqhVtjNi|y1~7VXVic{Xfz5$a(j~c=KG4OoCJ{8a)bVfGip|sy-`wtF zXSOho`C4u)M1SBYu@`TtImEQ;0>q`;S}u3ELlLd=_v+9qjO0b+*QHF%AWS75(*9Jl zt{tSSC{W&rARqg%!3(n+?xxaabvsZ)3DfnQzhvZ8?3>SPN5iwS#08nwz-wWZ2c68* z3)}URgEhi+JE7pfU`OKMgYX7Bd`Na?BK-a_D}s(&%(vcVlXP5(iO>1rse3+pwJ0ej(fyiVyg!MwBz#B5F{g6NAsYsD`DC{2DzkObL$r zu$1pc(bh4s7r616V_uS@cW~5t7HZtM`-g%liRK}^!ayY%IB8;yTG2XXnGd1Tsk&rw zvwL~7Cttfhfri^d5T!PxNME@GIQeL-S0{xinoW_>np=*n>|M(Ol55Ad!=A%C3F(g} z#jk?hAhx(E+9z?P4Aze}!x%7pJ#={8V0IZ5`Yk0NQ$OjR&k=|16!2(D!YTC}#dJBz zR5BtT4l$i-ar=CbaV2obTpBQO%3Kj;&N1+Y(z<$Tau=5F|0Duk$y)XHfB>Ep)x~pX zBsWPyz&;OVi!+e9=B6@f!U{dCF?oJ6L0UlzGh#=#IC?9z_NGLc4KrF=JV$mt&sGR& z6@m-r&W|FUwi7MK%h@eCchpvSoMU?|msWZWZVELw15u%?E}(KSEYDB+hww~%7;^bk zD=uHCI#u1ot;)%4t4CF>-s3EF(MJ%9CkW>eHViq>5(w?W}H z`4MR7WM6hvTmq^O4;fMiTx2oebY+0lY)u$Vv6MeG?ucL?01P4~1pRo_{4n1E>2$zm z@U%z<;ime$VYxL-2h25JnekEU(W7ue`O~MsV($DlLQMUTyZXQ8$5^$IdP7CL+5sfl zS!OIUy(vKY5xE#blk;T!Fh#p3bRZWfzJMzXm*}YXvt*a{Dkn?sNtkt3-M3{>| zyE$ssi#x>9urcESoEDF~*I(0<->tHmGq5U-} zwrF|`)C)U;OcSnXOu2@T4|taT3wOL*Dax7tW>(8YPI455 zm~o=Lo`rbmHlAYf*S`KtId%B7kQw5Nt@jpf=4qbPB%p*AjKN^U8criIkf*j6s7O4yd%O}h%w7&BX0$^OU(hEn1PM#=3? zJBy>@?qU+)&j$V2C66UqgujLVBD;#BB!p8{RqDRtC(pJPR z6)>AajRy4zOMNwT!Qyo)kCr(Lx}ST3k$H+oRBQtIOhv+RXC+*^$8rPud|~^euoV8h z6Rsu2pMeHK&6#wsT)ME-@y?6ju!A{ydOtP+HH$yX%nzIee0WiihM=It*LIsJ9w`4_ zXc@o13Oh#;yFq3F;x%ZmmF@2%eUmEN>xFnyVs)4n8mEyI>LGqKi*B-4Pq}&o;Nm*h z5{(j>#3~w+W}8+aC2*~blqs+T{&$fL`>I(t`_Z)c`-PA6RdEcJ(8Up^9J6>M8#FQ` zS+Qc#mcerz9On))gX_{E0`I%Uj_+B6<1rV*c1hMb;f=xGAejbQ3{0W$n}x`1T)@5U?}Yz+2UrD`boB!BZ$1mHK}kW$e{$~ zy#0*WZm~>txCjTI>heb058HHPBif0Y)q~;zC#K_^D8gATAlex60rkp@l!F(qW0&4u zYRn{666I2r=O8pzWior5>UQ5&fs~w|LB}Kd!LWAw+-22B=!k%C=vQC9_Qect)@)h5 z0}$teN5O{M^gf6?3-ZrqL{O+S;v^z!ajAqD&@N0_cO~U}@1vsQwn35Ng6%+n^)IsP zC-zy7D4sJK9F&tFB5z_X;_~Mg-{CptIZ1bnc7X3c8EUNzNzP7$CMGd)gy^6^V{@GU z@e2H={Z)*+G)&7JQ-buTA&*8%a)Fso$h+)JP0a2u%}LU4TgOX5MF<(d1Oailz& z4C>I<3?~+4t&A0vXUpHqui`i<5lAz~K|C5u>aR=KS84?E@q9-d)i}JZ0rk&{EPXW> z38NV7grPA<0C-9AVhI)hljU<=>Lf74B9vn@e?I-=17tX5b}&ig&_!vf5hr`vPbrEh z);2nYD$|6~!5@}GLAINMsBhK{(K?j)N-7k~uaiQQWnL1OkhooN-FuaZD{ za5KJq!W~28SySZ5i>mMGoh!TPV706)Z}mAPo6B7|v2wiTx^Z{I@TrSJ778*4%&E=B z90{7e``#~K<+}UK=qDn>OIYJsHz&+M9|g&8@J&Qfm7V>;US+frp`+gh)?}guYZk$S zl@q`&D~oUVfnadAJ~Oxqle^h7uljJ%lPRxUziM<}Elf1WAd~>nMFY8wK|Z_Ayg1&f zYH0UE&;mz;aiQDj6coyE&747(tnRa`aU7L$!G}@-D}n(#JkM;jcn_UVMfe0!*$N1` zh4x!od3o`_4C84l!;1xgg{`X|lKy?4vP)q@r^gvJe+hEE@%$!enW;{DD|l@QPfq*S zR}FYH`qjZ4jz$oBQi35D9$&!oX~`LQ1Vt6(SeF6betkUY<~~dwZbz^Rz_1)BBf9Nm z(DnT4_0ut#F=!F?$%zf!;d=sv1ctOQ>_e{hkq{xpx}hAlNqRu>53o#cRm5Jw!n!kk z$`2%`>GK^?lkx{*NZx~Pr`WvOPcOB|?&oF(SIQ~Uh5r5RVQz}llX|mUxK?G9qH?AW z1DT^mU%H>>T|s&Gps}~+ih%N=k^!D#7v^;)hvouNhr5a1E)&(5W)>NcijuhylR{pEKL&?8{mLvwx`jHNQ zon8l&+U$m5P7K`*v&75ukuqTjc=l!F$+aS*D*hdk;cZN?UAreIQ(8e3s*sh)a88$$ z@Kt^w#}TQ4fTw4tFrHtSSN zOffL*!!=Ig>tO8@v$Whf!u>OvHw3di(I1FH|P zw}lgR1un9f27fUhYw65Nvt{d8{yC!x%0gps!!q^{W>*&+KxNUhav^Iz<_4brNF~Y! z&bM|2g^fSpSES%3WDL5&D@zQ;Kj=-^l-}obn3WcN*3&70UmyBp3^JuI(+bihO)$JO zWAPeCOe|F%Y3v4sAEH19XJ*x!cm_EcqLV*ZWO{xG?X zn{Fg0M{Zr`DXrv0ZNLasFyD-LqP^iv44s`mLsDg;m7>>!#Y3j?yLmxbc3D~K1`Zt2 zcW0}=oewcO+7Gqf<6Lde3?w%IYEw>gu=;Svr(#{wB<(6rp_dxDUwd^m#VRI#5IzBQ zyl@b?WG^tW(8ei67Pw6MV^0Oo@s6Vh27O@hb7iGpz%pJ< z@ll2jOs~EWDq5BbQ1~kb?oYb^R={ueq}6qd)yJ4`g0BweL-<8@W*ujtIlM}lwECu6 zLmJEM8Val)u9;uf9{$eFu>YARj8^964qB5S6ys$m3EZ&nSg9qqM9n?!a6Xe-V zZ-K}`JvcO$eajW{l!t^+JmM7LeRwjs<9lU})-`Z~M{N&zr;1{7AWZ0 zks{~$r|dlCtM@&Ot|i=*I!M$jQ3`&UB~_Z$x5JLfBe0QIG-@*YNQTN4C$KReYB_@8 zi+scFDN&K8H`X&w6xN2)I~KP7MYzSNQX}NeYjUEdL$jGj*R7;$liD5%w85J7vq9(Q zn+~-~Ctn*X@j9CZRf#7h%vYk;l%+lJF*Kx2C2iOb(z%2U=2ih1(A5KSlqCd9eYKr4 zm#?O@yM0QwKN9{ST?|nZpWYxuzCV-`mqWnl2kS4xQ$b~IUSO8^GQ?B1Lkd2T0bw${ z1_XT`cI=SM*$P8+ffcDKyK-k?_6odW*HAk^7knQd$tM+?2R0(~gZ{ct?Lt5j`=wrB06(69jY$zp_;)X@9YR6tH zchS`JR*7sEA}xkbhwWlM<;7HL&lRms>seLL9%_CDM7?R(rwj;jN5qTTWn$kc)8w8` zm*<(yFB?-*D7dzDzu*92?|+U3hfZj9kId zaTe;do|R*XE7X?!B7M}DLpDj%ecONXCL2^nF1`e)OF6%fsC59rMeOG?HEb|I+`f?u zmaS=dA^MTs@!<<5&vsXf?4i_eh>Xprk9c?Wp7uU;r@c$k-bb3TJ5K%d0F}w%Ds6&( zj8@c1dd#uvH4DkS&j(ZMPiQV_HfUGiz0_@O@6^ z`sqy4v*UHKWzpOi|GCo#-O#Ruz%^h`Gs zkpZVavOLk|W}q6&W%39FfcPHZ_%h>P)2nTmE;T?LPSo|t?{yyUg$RxWcv->mNA96t zSd{Fr5l&W0xUV)#9jhIt&Eh{=)!S@X1Has742Yhb$!0*@=CO=3}@2r(AVNx zuM*4#c8TQyK_Z7j4@Uj~hmweM47pU%7{0* zDI&6$slxyX4_4mmJpowtWdsC}?F?Svf~(eE;^TKX5cpv`{j0Ub=r2|fvVAqYYE5Z) zfIn)U#^@#k*RvuYJ>%mZ?a#aFUJL)Qa37OJ3xsgWVNP-RI5|c#ji+v#DYkPc13>8g zlxeX%6g5>5#7qkSV;`T*^{83clgzDtui93g)fVncYjriHH;@XX>$cGrG76xdxMdz{ zdKx`ynUd#f$L0!gY;U1vuz}oxFNiA@r}9ZqGId@|9VefVi-E_a_5cpvNg-H4CwmWJ zaAB*ld%{}gSE5@5zO)A!6lKs}5ZG{+6C{I|K)2XO5zuXA;IyMkgXVT4GWh|9v$Qle znuaa1ROS*Bqs>4FbZpgwzrRtS7AWFr2*WaB6Idgm{*DVu@siZaMMf>*L#UUQGboBf zWBbCxT>}|zih9fmE_@dv6;~~BF+g6q;mq3>E|Ow8Eq)z9Qn0qGO4d*O6An}z_Laic z6K=HTNHkRC$H3vtE>jFSn_!=h9BA$51Ey~n7o%QWWM7C*gtmu}n;=A03xIb$UAH9W# zwNEGo){6Duwl8H}GlO=mo;k8LV3`Z`Xf{89l6dD;NRPq`pk?jyJK83YVDXrsZD4Be zpp4NHdKeNyo1|;T{KyRMvbT*Ded;tOkhT2rC|i}%9xC+V_qk?*653C^p22Ffh$`Gw86YeS>jaoIq>0G)Ff7GX zUQ)`n2L;yr$|O(I(H+omkA~dK`-ndOf>6kx^AZX#q$x$qJ$R;Dn>4*1)C#w9>p9rF zNkGJg!2y2n=5u#Xe&i3pBZaM;Rh07N=>Wcdn6W=dAB6-ot+Dss0W9mvK*x%5}$Opfl7rg9MfIs%e3vI5^4Y4>SjnnJh z^#yShKf`pJorzW|<4<_?;@9i=d{hGV=c(1VC|oVeEU9Ksfzo#$jdC1eurcr*iF~TT zPT-yIzC92wva-O!hvgp-n;G|b_|j{MZuB#HY^uIaPVw1fb^3RMlEj_JdSN&@=uxLV z!t6rWXd%ZXHSa>cRyFELtDpr5;H~M=_%AWGd}1aW^nijb4#}?|q*`gR$Y0<)LPt+m zYB!<2hRo=$R-!tz&fdN73v)ajaYOkoyE~+0Fum3FronCP@(E(^c-`k?tR}q%s)?o5Y^3e#Hg4!y_mt)gAUUQYt=i}v zQv36@FRW&_ujR1_b1jk{$jf_qYJAC($c!bA6-D9v(hkil%ZDMgVr-R_In-Z>S+q?P7Pz#ii zLpOVV61j1ruEjdoN~UIHbb9G#9oAl@jq~&1u=2xI8LDpf*oL_DE0j5a=UWJboUdPA z_-pu((4)Lu_(W=jxvG0`a3MtVaKrJF8KmdcNd(8hoco4Y*~L~p^N>`{HzMB@I_H60@AQU@Uq(JESh@6nrhI(eJW)--0&04J!oe28CRO!424{{L#?P@;m@8(& zmdXeuNf~DfD1mu%5k}kjAAaE)6^JA_rz398G-ea*&y#(RT@4fvRIRy4d^F!ZEKr1t z!~r+DZ|1nF`hciTfauUCSk$`fkkTV4n)Nc}Qu243wAZ@YFZc^Rh5*ACF(iLl~oKGGMgjK zBC-(cO0!(r;(Mn0j^&^0`%`0ER%?IAG3G{Fi7gGq29zn!8t=|WDQjGVk53x85oMvN zj>FzfV`6&sDFcEjc|!zz6A-~m3w61Oj#qC2{3)Yn_8Lkfisg>yP^fXacuh~`=!l^#W(GW#xn z$ITcN_A|5{_|ZKLB(adVz!)ODL?%Fy;Tj^;Zm-=rSO#Dk|LgQ*Cwt20YLKER3*V!K zC9`8_PL}pMuZ92g3qdu*5dONsAk#?f2g5rT_nM5YwL~&YRD%R5FVF7Bk#x(n zOQ_szCg8Kq7Daix(Z!acCtkwXXXSq;r&Q-G5cVPNsKF4=l$Y|{S)Knd#K!v=o#YpI zb9NQh*)2NV78mimV)`lFO27IaT2iCWO;rip18m%M?Z=%OF-Wj6uAL)j!O6vpXO zr!8qF@P%6GqM4|i+~B)-8JQyP!9j4_iy(E`(gvn1utLL$CJegAKW z+c{QavNDA-`nrwY`Y;uh`kzzds}B&wGnmrVrc(syF6V8oYCqv=)ScnrZM|n4mqv_5h zd*DzoCQCRDbUZx7=tHb;Dqj&QkhG&>frt>5QM>5OHoT16AWAKy=B@t6n)E<^Xo@{2_jokRYP9=#M!gC*wj43HLk-Sol6_>+*?4~uRzV?tM>Vwp zq_M+9=~?If^dG!c{>eX8^xEwXc*3(b3mpI#t-rOZTzpFhRIXeL?ZQLvYlDn$Vs&E5 zfy&ND#VYeXbmp)o>GXBpb)_MQ6q9qzYV=9Mu)25$<`8|~8je$fL1OFrA;f3Wnn`t9 zYFo2ko|5L}Q*Xz1nu|IyoGYsd6dVOXy&P(~!2U~liuaouO29*ZlybH(Cb1TE9eYm(`moco|@ttkxUYX23)9!4U z!Q&5VqBnJmD3@2L@`uT|bjwX8B`7rWb6zoH7}PFO%wf zG114fGstt$F*65|;w1soXKLX|xY9UR7x@le3%uR>v1=3?jvYo$8NNNrK}!8^Cgew$ zc>*X)h!wZ+gZ8P1Sefgv^a|ocx%&|x(`H>T=Tmsn%kKF&bz9JHty%;|*T+R^BI}^A zn7v^^m&C=i`D_|=G~kHFl4}X)SPP9_CeqFqJ_DAl5Yg%SUYZ*hBEtTJ8u*fAS*T&- zUj?M1f%{`7V3kltHSM~3D}fTLNTG3h_rA+NF(^~kiTaTkcLS%3SnT)0@jEQtHb9Gi zDJ}!=cXb1(Auq)hpYng&noaRqwXe*8*MChBT2X4DUck~xAR^=jQ^ZcFRVYt;Edbko zhsw({<3nI6^~+Fyq5xJwvY4GCfpl1ywu=zbGI23>VKq(TkhGB7U<1uN!C> znK@gy3Ch4OBVY*{%3H;&TmE00RoYXh{5)+~DPZAzpK>s+1N9abYSQvf5~B`v-(qOe z!M?j}YqZxQETOnW%It>j^g01!hGh85hZ+>VIR=n4P(m2}$8c-rSqH@0(qXQ8kuf%rF$tMW47ROlf7K7@5BeN5Bnu z)C9pOR=c*6oEG{gqg(?Rf2^6Ywl|A6SM=~j4e69nN%nNaz3!U^=G!y6^4}I=^XQh- zE0VN0$+pSNi@oL!3%{PY${fCb`t1k=&e*#-oD{d4WlM^2#R1_A0IAjQn0PaXT!X9K z+-yD4xr165(W<2d@_(06CgrQS1ffPR9C}^NxsJMW@4a;9ViMxe?0wP6ma8)Ua%z3w zQ}j4(ROOVspr~XLh0uh_Ql1WlYo|Q~>;NhA+9lZZ_)xccE~Z2q;XT1G#acKfx|~;R zQ5ENPoK4o$)&}y^qY&7>#UFT12Vz6YAlt95-iODb(4u%*b5OGq#!aV2}u)=B@5vJa4%RYoguroX>LUzL?zW$^9tuuk~?$p1Kq$S(b0dqyf z1iU_NljzRr)Q|=B%~ULz)F_F7ZHYrYH+^lkB6Sjwix_%w4VqhjK_vCi75swTba1fh zgnt9?&2fNu3mjr1ASON*joPdD5nEe=WQfYGuwV+MqH!PKwBAh5@k;7hB3zjs0I4sx z_gs~|6k)xLZ}jYX$-q57;)Rc_2DC)nizFb(1BkUPJfT%tbY+5k$gkoKcyo>g@=E&}u)3ZbN7n5) zNc7C(qa^bvO@O13k`jc)!C9yp=`sB!55E(*+8?3(7zo-ui2T<1cjPFj1ri>ocUths z85{Q*HQg=?i+s`rwD6GBOO{`?sF@vYU~a=*e+D&7(Q&7xT0A`x6p_*oZX|r9bLNky zNp9Z`_EhA!$VdHABf21}I0BEC?E&fx1!(ZOwMnBU! zK1$mOZb+DEy?}=xi{qwSt;YdP1<;UVf~oAQf*A+$kc{!CLSy;5=$1nQot_U)kXRsm^tTMVnI7sUPjN@lk?9H0HG2p?gm*K9H zCumEY#r}S>EJoqQs|AS&9Wg-eBY>c5edh74QsId4!8weBmzSwS(xt)DGGXte_uX%Rl$tBU3W})CzEch+wIG4r*Zs`UU#8AuJwy(+8C1}XdbM; z%|_MyE(COQRn}9#!*K3)T#phFjOk4i9;!H(y&!gAkCjk66X_lY8dh}%kQa*!TPx!+ z&Y?v<{fE8WG7M$iCE|0N-k2}X-xc>zZ*Kx>E~KZE?bp%Qp25!NL{Z?c;sWpn^|~4< zak)Gw(pet489RhIB?_%`^UJ$NjRu)w#tEisHT%Wqy(!NDVAj^2FY`o2v>SQ|{Qd$0kDq zKpCVf6|G#_JM@B_2mHrE1SUneJfN#Yd4}=n7l@D0{i@1Y2{Wo-@BHmhkJZPY1~`gt zW2$+5xt0Jk(QBza1pk1wry=aQSExZ5*tQ@|b8ejz2hi@9@EDm#bV6xHdc`tfMHgoO z1bOuqmjWUOHamEZ#)45#%IUbTy9Q$8?r?$1m1lPK!!E=vyw8crG1Djd2D5w2Yv{rK z0~7g$?PDGTEut!@K-`M=&LO`$%Umch2dO&$5HtL5IsEa`wXr?}gXI+0`rHlSh}09} zx*=~3TJE=oL;&Qzv`XTjk{Tl}!P2?V{?pNN!@yICE(N*3}H-ng78>Ft8dIuM!lq6h~L%OeY+ zIA{XTO>7OWTvO!R`D32Kt654WW%3jS#o zTT0c@oBROt&jhpN#GgMwz8ro{7njnG#R~n)6_Ia^&YEKPeA&w4{2y!D=3vZ;41sv$ zRSipd17TQ-4ekZ(fr6!l;M`(u%L54qE$`y|aC;xW{4P+|_Th9zgUl)#fk(upC5kfi z5gxcW2$XYpP9Ck9#ZKMk5#^uLx6_~2F;Z5z95c+tddSl@#Hq?asdtCgJmF%A@UbMS&F0QA&Kh&}2cN~;o2u~KO=^)nxVn zVcC;?frJ6I^HZ7uA3`ku+6xd&EJ28G^7zQXd)AIzKi}Ab8{GKlzBXcTZORcZC2MWU^ORkfn0UiT7uq zWZSiacyY5C1Mt{UMHKZ$_HQok;?8NNXEuC8mo{wjo-87j78m@=0oEGDWoObF802vW zG*Fb080mJFN59#4FgolxUzqsl^4la$74GIOmDZOMGf)=OEjHD^=F{QR1n|su&r5M8 z6Xjji-hna*rMNgOiHqyORgB78P64{Pr=#@c{Nia(tg@>|-qF9VW>MDLTXIWn&L!Wn zcx(J)qugwscQVuhwG|k6w^(SqaR1PcuZP{ObP{n6l@4FCZEPk$>P~QF*qQxkX7`2J zDFGOpqboII9n zZNADK%8A#338QZn_ihi@5?WVpEF^}v4ZI($*9G<)JGhkEME-ot50eH)$i7(EeCnv* zEJ_qO>3L=OJ2=42vLzX(WVL3W+}+}hH4q-~4x5Npx?tb(rJlmFfKp~8<#?cqVj@_D zTzJ{|wvO>vY4r(H5~XJ@=O=uV(BtOOBa`w?cC4F8N)E1incm&SbEb(9$NxJiwghzIl{KhApgNs@~qz!6yUohZ+2-j!jyhKc&61OJcG;3 z7aEr5dnU1xVv`Veu6+d9Ilp`4BU|;&q*4Sp`OlZTvi=&Z4jY4>wN&ztes>w2u`k%A zzs89ot{`}=_H(XiXn|GF7q`-=D4q%-uO>sOqxeeJ_BEu=h-u@Jr#!d4HGQ6&b+-I=_*a=Dn9t$ zh`Px_%OFIe8XEM}*B{{pbEFXkf$6?M&gq6A8;%VLzW#6`%Fno5Sd@C5QOpi@Qui}de_6%ScGTK+!5EdfE`H?mb(OqVwb!-Clv84o0?wnNc%>dND zrmUezm71Lhm*e(p|7E$5g@-09(G}ze+O@T6hW}XI0KC!ZL4HHXMADv9-payG|DM+5 z$)-MwQT?n&;&Lmh`Ta1D8*9FHx~2%pq$0*~jdVD6GhFxk1i7;*NwJfF5v_&{Q)1c1 zAhH~VgeFyNnafy*A`~&TK~%yh)4u1SV**S$*0U4U0Ye(_oA% z02XVaw>6@m(P41;jyHPE2DB~5xM%y3<2q-8-%bbNqR@_ZGG>FbeT*$GqC!7eCC-35 zPfcbkWr9q-WH_NDS#;3*WGS0JDAOjMsNh?vto1j~aYig$Y&_;`sqpMoU463OwgGWZ zGNS2L7T>HV8XaDHfMcd|?TT*o#wH^r(uI)kE2QqZ;;>fhq5h?7wK2wZspR;kjzqgz zab_j5oc3;gQCII-IafNB7fdh?&kl*C8nttC6E^%8vl=_yjTdEzuGM9{WOB%Tmg`BG zR}zEpdGzR(fa*KO*rVXB?!P$I8Zc*8Z9e&3h4%?4dnHW2AZ+mkk~;AupxWSM48-sY=)H_qB zVx*H#8%k4-K#4s>eW!KCBIOTd*EG_1B1luVmKV`;dNLFn1Tl6z`a0jZVV~NiN5`oD zIet`*slFd+M9+2J$QXYsuFL|)!5eU#=HpBW3M%wH=5c3+;Ju#bVtoZl1Q&uY4MG3E z)oq$$2z_Y{{v*T&S65Wf1N z9AYR6$n@k6SZD2NC2aHl3oK+*0U(4axTE@>v8m{}S} z!rbUXA_H`RZVY)ubH$$Eqv%HIX0lpq{{~lP{4&)>9dpiV45QDG|0{kp;(nDh5(Tdd z7b{=&C&l5$CN|P?I^$hLXB@7b&W9fEsU#4V^iiwp;?;_3j{mmNG@GQcB6u>qRlBc^ zcj49Qv^i(y5@RIgJyZcE=EU-;x(9&XPlsh!H9zYXvVTRqUGjl)3jD_>)5 zR7J53Q!Q+ZpORO+9~5uzU{D<;wAjL#Tdc5p z2SVC{<}6#yn^c`miDVK8mn+fz$ZN(LstWFCc`KA2JS5m)aJRH;8Jst|4}L<0y1+gq zx&wbV8->0-0a*{>_Ki9fxQ-Y~< z@Typ*IM;=7L2v82((f=)ZIp*mkr$*4j+@L-ED;fl^%5teOhyqeqDKm0a{=$>9*0_Q zqsN7_g*cx`BI|92JB>!~gQ!E1H&pcBGx|M9;0RnUT_EZwQOLwAh%9jqGfc$+1Ju`T z2LM4jVV^JOCk0Id>Y@GM*MWm$A+BE*>01pTz_bIp!@s_q4k9;Acdv%{8y_r2h@@e`$mu7DMair|8M-+?`JLXw)3DMuvp825aHA)%=eb)V;d}}u{Evq@1oEDA|aUHG}muiO8v+I$^+{fQ)g9gV)=$_JMf>WX;gmW89&2$1? zf74%tAs&RzfdxPx3lrDXK`;^O_(axk%r+k%LhJc^En(SnP!&I8$s&@);DP@)(AaGz zj$Q4&DNBP^Yc`s@?EOTi1V*7jy<=JQ5l>24o5uuh%=%!tlee-3_pVa>Z{eNJ)GYKh zK(3w!g|j7&+Ad5rd!P%ZV{vFi@%6*rLZ+i*GhT}Tc*>Uu89M0D;LA^ne5t>>=E zek-Eu5Pzj*Z_+DcW%Om^pJMSvbPO9Mtndvd)EpWK2g-%0T6e&mP$-I7)QZ$pG>+GS zt`3T(U_%o!JrEB4Eoy#jYd27+KhLHUw4=j-;%mAU%tjL_{rll&&A|_NZZf3+29J?K z_p*F==_9LRBTCLHf)V!A_UM=y9zxErh#yM;1BduaCA? zS0zMp5lB9cAV-HSR9Ld8Iqf%E?KEB7IC(QsD&^A3!oFAl1GJw~g;en!zvx|s#!^Ta ztOOtX#TE(d@esI2BXD#XHU-5;Ed4x~n`aAm#R_Ly!*6I1ana6Jl#rbCx6l|4gYcSb zdtXN)^T>K*?%jHLn3PEpkCXvZRjo-1oN2k`qc`ER8^9f2!V_O}G(qCJi2iCwr^NWo z7KQ_oHCY>qI8AsSU+wtx^AI9-^#~^&9^I`-;i~whYWpeizTr4-%Q^s^9oEjH3h=we z)vH6*EK>GgZx&B^YZ@f|1g)=t5yYAz%7AhbZs^88%D>8b&@bebE$q@~{!$~F6BIZ) ztOXZ6yDzYo*hX`PR{1&pMy&0shu$irQ&rq6kI^iD`DfuN(&- zuSYt%xnx@q2Kb}sx0BQOph6XZR*9v2_dINwynOy|qPG2-Vm>OY&~}$F7re1Z>b)`* z+?P5oi|A>U9s}Xgw)CL(DT5>bSv;*AT%4LqiXtx!s? zWK&~SjbwEc&5ubuqLxaCjFz7|qJW7D0y!T=lv61nG2URuN1}lGhs`!mdT-VEMm@8_=iPNW&<1JnZb|=KwzN*D@9Kx!h^SDT`WNNGs?d2E&tijHvuf5$Bmfu4VH$>y0Gm zUrXT-AHj3P*b>!Cx2@Xbl}R^5jG8geG+mNg0$+{ZXYlJ7>~nv%DO^SUhG{&s37?mb zlkHL&hP@(v1D*5OZYoAoOlFN|2#>28TN_f0gci(-pu|iJg?n!GZtWG(hG8#B+jDf- zAjpmokz};9P@$}37A z>k1FpK#QzXQzlD9oq@F+)T`u*D?D2a!;RUc#l`cT{B|fMs*s5tM-50(nO!2Wz3*op zQ;pNh(?j9od?;59?HE(c<1_40vc^B{&Wx>N*zfXRm?VtE5)JEz#^^3yGmoE5NPQ3P z;jz~Yw930tO(elGxLrvivYVz(FGh^fV_+xE)v&i$#k3W}<4xp<3J>}RBJxh{;_eiR zzkr9ftob>bl7?@~-!AJEyaBE>K~bAJ6{f3_$su&Wb2(GGxS;T{6!r%`_!rR+Iq`Iy zwANW3cE^~QgLQ0T#_0agTBI}!K^8-U3mz>ztLosaGeb>HInCsm3GhCgc)R74J zToH9kXVG{QeH)A_7Z5fOx{bmrgxaJfR?rR+{UD=ll>Zux6OzeymyG(B#SIS6qL2V6 zuOyLkrQ0%;hO-Ixl~LCMV8n@G^#T_K!v2Sx|LngKnKA#pe4(FRhQsIS+utn22;0YSx_e%l>gc1Wz#@Ob>n3Weac^OtfX20faFvqh(5_koI&9)o3pSxL7m`ri-?H^gJbcsTF`mD6o9|u+WT=N(!yFX9!&upJ- zWo*oyy@AkEM;}jYlV5LAgYM}}6Y3#Noh|?PN}KAoZwwaSlnl}HCOWa4I4m84b1=e2 znL_FYBUkdt!ZIS`*KG7@5jaw>)8f-tM_ra!qyPP<hRiXc>&;4zPK=T+B;dx4H;cNJ za^{3APi2=j+nMoG9om!GznNiRmZsf+v?{-&hRH+go5k>Py!mD1-y~O`rzkhaUslc~ z<~IU)PV}bWa7K?pMiEtRqu7E;x#N3KURySv#)oZ6Wwn7Txn`nH+1_@Ev@o0sqx!wm zV30xymEzk zGmc!Na;L__BnGTNK(~}?b4V6PbA==yoXRWHonI1Bm@Gvg)cqpW7vxsgk$b?|G`j`{ zD15EJQg>aIbc3a42~nSrI8o1GN^73!WsA@~i1!9=J1bI6dh99E8jC*WuoK=O>dW4% z$ck9K2w_N&j?fD(Xw>JaE`19U^ex?SJI%t%sgM&ULLNJmIy$a|dGmS0xgUbOtUq zkFYX=4b>z?Wo)YBplPz%xipNi6u?yY61zWu&qYfq+R zy|_o93G1*Rg8~o)y-_^qoxESlsmRv{ulWP-%BT4FWHs8^#;6(el7j3eQh%+mNKRj> zED3=JgG8*#c3xzG-f;z2x0xPyqqNQx*_JYUslfQ$HO~_1hZUk1pI3O0;1$5XCp@4E z=RrkYltj&Iy&0euckZx}&Afk@itvC0z6;_c?9M9kcm5e-XglIu|110Z9r+vdz-lam zgz$0=z^@9~(;o6t5fIfJ+%>Q)2+UwP!e>qIUdkboe)p?B|65)}_{l7~BJWS9&1HPM zr-X~isNUEnB}t%v65D!=9reM7@5mv{7AQy7YBIEsn*G5cWgmEhZ#zy6A}%$b-fC+r zNXb6KmS%_J;NJspojIZ0o9>Bt?)z|1R zwT}wmE$Ku--Ljw{1Gk$>NIQFAG+9Z~^5!@{Cz@^pi7t+%OL4j;I8_T||Lr^d31*nyLcV!#RXh-4 z`|dptUU13`ldFIBTuA#yNS$H_Xwa$dY(9h7RP(Hjbb?|1sL*YSHZXRt8N9g|-`Hf8 z%EJZ7;B$O1nTzlM@)34*(~ThWMz83(0^oF~plnhTtpa5dIv{p^#x^S_JuH_DeQXseoAKh%Ne^l$s;-#*$Ik1V zRkmTICtbHGxckDvcS~=uVBgOt17L9G(+`IHaC9F15mB8Iz9&w|!oGKPgH-!?5@Mfk z0QhesFu6h>yqZTAjOv;0@b$(S>75;_fvr*Ld){lQYH_kyX47DBX$p!_NR6_mzh5`i z@^hKHX*11n3Y~pmEv}XMM8GBW_Oar4$&nA_zX)t4@jxaPzR$yjfSe@OU1y)|Y!zT^ zr#om)bSP*oNMQ0*4oteXLRreO_K17SF>eHF)88A{fp9cPblDq;HVawcUw3TLJH1(> zZR)Eppr`||8-nM89C=b>4(BoO1g)Q%T_rKEH}*IGXYXg-DJ9;DbK!S9Iss5L}!g^^4f1vw^3~r znw#4CVLR9ry;AX#3<80uk~B!0AOAcsMx?EC0~P#xoqr3>mvw8>EIjs+9CA<0xWL#yGzJcuhY z|BSmpTgX=Ph>bR+k63F`k+Vp z#JmfUqoZ8vq0tkVRBG{wkyr1GoCm#2t0CDXBWICt<=)07+YJ1a-%Rz2 zGT`u+uB*nXrjbd-b(HbhwOruB36XA2spNn}%Dc>s``;f{zMseA5hfPh^<I{5Qx5E zJG3WKmd0e(scUOmyIv2voE({5A6oH}^GpjuQW-w<;~T%upzHgt7c5zi0KpO@Iq?)Y zuB^SIp@CV?jC_fRblfOWPsqg~MkI>--Y4}Vep9vw;)|x>%CRuOm6kF2-6Pqe!R=J_ zBP^bOwsecKtr|mGY!KhYQ@1Ad&`@EXsHl2u<5K}M-iC4O7PrtwR4^7xb3{mPs>ia# z#PY(y5#K517ym-Y8_<;X6YZ8Xz*{X(`!arV!5mamuB_SmQy&BV$G=)bBm9t}TgfJy zrqR7{w?T(I(zqQw&Rq~jtro5L?ZW5#+m#HJXS?tjTxWX3M$i^4j@QW*@m-jF`t_I>J6q zVFGyl>_At8hOe?hJUV`%mkOR%k$pFekQajvaBltCJC6QYd0pwE@lk%`0HL%PEV+@( z;`B8Wmx9>Jp16wXJ%icN1Xz?EcWMj^(1uzyvlZ69C*e>-kI_HS(}{Mp#E>;10+E@F z=i?gN4`o~4;Gb%ex7Z6@s6>|bZ?#NLb+%U}pXQOARr!pQKl7HDy@ODlX&FK`pS8~@ zZ}eBu%K7#Ld!WBQ*;CCjlod-}qEI-5Gq0LcwG8;e6O7MbpF0A|!aKwiGuKMB9V&YX z^+++O+2O&vQ;=WARyyjgnKLw#XuRaRK?5ATK-`prVpd4H*)%C~TfOIz#N&MNJ}^8h zTYk-7ny?fFqF#w(nRn>)jtCG0F4(Xa?8a^yXn=Z9(;OZwk(fen9$mDf9oraek^**$ zAHR8V)t7+`^`%G^<3r&32M<+!=_X3i za7F%%m8%F)G|J5!H8${ehQkCjljv1j?yM9kJBq`b1>OP~=@F}Ueb-7pw8)x42+)ib zGAtSE9CX{jjR5)uo9|H!x_xgB<0-=_oN4a|)!OaEmeFU);`~kJ_gsdnv-@+v=fYr93LX20LR&$r^*llmNH3@$$d5bW%823THD*kD z5S0|dV)t+X5;Z~q=`q$Qs)}IO7q3b<{7M9m**4_LL3cJ=>J>?qmMxfC-SR^Dy|J3i zJ#Q}s$s@O@Lat+{?r@JbEA7y6!g3egr}tjsZZHzmMDRPD9U^mX1$Lfvt9eo98Rj8) zluKKnw17&9s)D<=Q9$7Pz6xaDJYftmqrdWs6IqXrlPyjyB1j7`{sVRj@88p4VCgur zP3bFFwfWOU5R?VOZ>x?%`u41pdCBexJi7IO6(3Mvl zyAKZ)M7q!D2KmtZf7LSU&U$`YRFHYbk>~Z&nQ~74rfO%=yE=9h_B0hQ z2;BwT&9?Rq$LTvnX>44JK?tCvd0v;y>|i{cE&IzAf}(q{L)Vjl;JY>E8HOg^y>-mG znCtueXtqj5p5IBl=iwAOV_%8Rzmt$Yam=Nl=dcvI8E(u+Zw67coo^osv;hMXl>T@J zx;Ua=7!>?Qr(zqm^y?l5w;b7CCB0swS-9PL=a!^r+;!J}3>6gbCZuDbsrKK0>4irW z7qAd0P0_{g4;!0Q22u2i;bJmo7^}4_zQq|UM6)W~4^Re3PHpzmjAQ|3g+nyh;*qB0 zb~Je2{*A=lPc4yp*T|7U@-EHO4h^b@kp!v@#9S<~)Y^OYO}GGbO>~C)duUWICdo!3 z7Y`lc4+h&qs=#4vk0=k4k8iiudD`v1;YCerVWu1|X}j`huScRDHPQ0ePj8=Yz$Ler z=!J7Q-EG6MNhL)PW*Fsyn5Aq)BSx<)Olu9#$&M&ZH6RfXDQ0H$)$m*x`g{UBI`|e| z%kHS1BZy7#&W->lnBNa5&v>5zO91m8t%^`Fd*@8xn9y7dNjak=U=Gl2AAD=UJ!x3` zRLuEYUPSzFWX{vNlITbS-gTSuG>=-kF0Ox$Gv*tVgVTI+6J91+T0d8}^Db%FBB}*U z*m2fpERZiJ@!!(LQs+H6l=9G!Uk6VJ{-CCc36!qP9e+$N_GE99sdMQjYa5nLZiMGemE3BZNOUV~}iM zc>EYYPCWi-Pnh`C&gnbeBhd>CaEG=x7Hdh_+RaJaTe4;NSG{BSzJJjR%{PlUUQ$0h z3MvvQG5X(snEROAL6ZF~1Jl))o9t_%!FmJ-x_Z=OFVzUm(`z&Pk=V`^$VyjdY~ZVg z^C-P8?gRtcysiS&(8b{1m0hAm0sc>B&GA5r{s$TsG@fLyFd@_PsODMHwEz(d#D1|9#ueKfEw9QI*$6_3-dUl;oTK^1z$Ei1KvQAP=X#_=41;)9 zEslSs9+)B5comlgS6HT(NSWD7ATdwTpifPNFZQ+VV*x*=Y?(F;!U<1TtxsBzIm}PC zOPoL+<1Z_=hO{kv4<6mX|3sc@i=J$$<}yIXh7M!I@GiD|0l=O#X}`!sU_U%?YA@*UK8hnVTC_ zaa5_z7#%Azi&3$i6WSb;t)CKC>6YN*QEB`0)52TT>1HBOvH3wMla46ys6lV+RLJqO z5tD#nhY!Zq{YdIJ)D_xzBX+FhV4Izr9J)-3>Gt=jrn~%Ig*=)h5CNyzFSAs|Z73oA zKWpj5J^DQCVD0eKn?Og5E9eri`v|P^POK?D8w9szUjmcY4hHbI@9|cV$_tHbp zMBf*oQE?qE*ae=(Q2uA*+&JavQfymMEyQA>2_vYOJuorL;}8=!DQQQ#(4 z;m>1d7G$?O@i-(Y&fRc(^7`z1V2DHs>84Lr!Udi_F&c0WylWK&X2PYoy zbJ*@X3U_Eg84}fU$wbzl(sJnZkLOZy{3soThkuzdy4?lc;r>eoNMn;8GPkg-3yk8j z79;va+^66e3ZFc5DM{2C1sNr&=gBb#1Oz}CYJRUrXg1_y&vfK4*u z8P*doW>cgaVAY_WJ+nvx&5V^l!Tyqx{yakQhF1C`cHuypcirt2TDl_|tP|+!7RXgJ zlt!8$pK0gt75xxpCB(0Y;pG-@*0#?G%Ae>>hmlG*G>U;%*kIRLPc0^4Ptjvqg%_77 z9n<*9PfXlSA3Vfp!NHI2plyedzQ(old`N)7-IG#(dDg9sJQGlT?-ieOU?il@bXqDu zl$MBYhJLFPKfM(hO&kyqfSACKg87${nVS4!il#6lhV%JZ2V52u|_K1A7j_G z0;CSXH6cvfNiY8$2tAP2qo@CJI{?E4+jq14;NES=SbwLfcWoSz2u2KQId5m6nC} zdu8Ar%Lc>X@B_g&vpF)bz2}n9SI}{?*7gR@pCIK}-o_!AO*nM&4Z+~7$rfB8f&}Uk zT{V8O@x=|yG$ diff --git a/R/zzz.R b/R/zzz.R index ec593c3f..d1dc62a1 100755 --- a/R/zzz.R +++ b/R/zzz.R @@ -59,16 +59,15 @@ AMR_env$sir_interpretation_history <- data.frame( datetime = Sys.time()[0], index = integer(0), ab_input = character(0), - ab_considered = character(0), + ab_guideline = set_clean_class(character(0), c("ab", "character")), mo_input = character(0), - mo_considered = character(0), + mo_guideline = set_clean_class(character(0), c("mo", "character")), guideline = character(0), ref_table = character(0), method = character(0), - breakpoint_S = double(0), - breakpoint_R = double(0), input = double(0), - interpretation = character(0), + outcome = NA_sir_[0], + breakpoint_S_R = character(0), stringsAsFactors = FALSE ) AMR_env$custom_ab_codes <- character(0) diff --git a/data-raw/_pre_commit_hook.R b/data-raw/_pre_commit_hook.R index 503268ab..c1d6e3d8 100644 --- a/data-raw/_pre_commit_hook.R +++ b/data-raw/_pre_commit_hook.R @@ -31,6 +31,7 @@ # source("data-raw/_pre_commit_hook.R") library(dplyr, warn.conflicts = FALSE) +try(detach("package:data.table", unload = TRUE), silent = TRUE) devtools::load_all(quiet = TRUE) suppressMessages(set_AMR_locale("English")) diff --git a/man/AMR.Rd b/man/AMR.Rd index e380f0ea..5163ffd2 100644 --- a/man/AMR.Rd +++ b/man/AMR.Rd @@ -32,7 +32,7 @@ The \code{AMR} package is a \href{https://msberends.github.io/AMR/#copyright}{fr This work was published in the Journal of Statistical Software (Volume 104(3); \doi{jss.v104.i03}) and formed the basis of two PhD theses (\doi{10.33612/diss.177417131} and \doi{10.33612/diss.192486375}). -After installing this package, R knows \href{https://msberends.github.io/AMR/reference/microorganisms.html}{\strong{~52 000 microorganisms}} (updated december 2022) and all \href{https://msberends.github.io/AMR/reference/antibiotics.html}{\strong{~600 antibiotic, antimycotic and antiviral drugs}} by name and code (including ATC, EARS-Net, ASIARS-Net, PubChem, LOINC and SNOMED CT), and knows all about valid SIR and MIC values. The integral breakpoint guidelines from CLSI and EUCAST are included from the last 10 years. It supports and can read any data format, including WHONET data. This package works on Windows, macOS and Linux with all versions of R since R-3.0 (April 2013). \strong{It was designed to work in any setting, including those with very limited resources}. It was created for both routine data analysis and academic research at the Faculty of Medical Sciences of the \href{https://www.rug.nl}{University of Groningen}, in collaboration with non-profit organisations \href{https://www.certe.nl}{Certe Medical Diagnostics and Advice Foundation} and \href{https://www.umcg.nl}{University Medical Center Groningen}. +After installing this package, R knows \href{https://msberends.github.io/AMR/reference/microorganisms.html}{\strong{~52 000 microorganisms}} (updated December 2022) and all \href{https://msberends.github.io/AMR/reference/antibiotics.html}{\strong{~600 antibiotic, antimycotic and antiviral drugs}} by name and code (including ATC, EARS-Net, ASIARS-Net, PubChem, LOINC and SNOMED CT), and knows all about valid SIR and MIC values. The integral breakpoint guidelines from CLSI and EUCAST are included from the last 10 years. It supports and can read any data format, including WHONET data. This package works on Windows, macOS and Linux with all versions of R since R-3.0 (April 2013). \strong{It was designed to work in any setting, including those with very limited resources}. It was created for both routine data analysis and academic research at the Faculty of Medical Sciences of the \href{https://www.rug.nl}{University of Groningen}, in collaboration with non-profit organisations \href{https://www.certe.nl}{Certe Medical Diagnostics and Advice Foundation} and \href{https://www.umcg.nl}{University Medical Center Groningen}. The \code{AMR} package is available in English, Chinese, Czech, Danish, Dutch, Finnish, French, German, Greek, Italian, Japanese, Norwegian, Polish, Portuguese, Romanian, Russian, Spanish, Swedish, Turkish, and Ukrainian. Antimicrobial drug (group) names and colloquial microorganism names are provided in these languages. } diff --git a/man/eucast_rules.Rd b/man/eucast_rules.Rd index 1fa70208..93f416ee 100644 --- a/man/eucast_rules.Rd +++ b/man/eucast_rules.Rd @@ -105,7 +105,7 @@ To define antibiotics column names, leave as it is to determine it automatically The following antibiotics are eligible for the functions \code{\link[=eucast_rules]{eucast_rules()}} and \code{\link[=mdro]{mdro()}}. These are shown below in the format 'name (\verb{antimicrobial ID}, \href{https://www.whocc.no/atc/structure_and_principles/}{ATC code})', sorted alphabetically: -Amikacin (\code{AMK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB06&showdescription=no}{S01AE08}), amoxicillin (\code{AMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA04&showdescription=no}{J01MA02}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR02&showdescription=no}{J01MA23}), ampicillin (\code{AMP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA01&showdescription=no}{J01MA04}), ampicillin/sulbactam (\code{SAM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR01&showdescription=no}{J01MA08}), arbekacin (\code{ARB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB12&showdescription=no}{J01MA19}), aspoxicillin (\code{APX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA19&showdescription=no}{J01MA16}), azidocillin (\code{AZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE04&showdescription=no}{J01MA15}), azithromycin (\code{AZM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA10&showdescription=no}{J01MA11}), azlocillin (\code{AZL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA09&showdescription=no}{J01MA25}), aztreonam (\code{ATM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DF01&showdescription=no}{J01MA12}), bacampicillin (\code{BAM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA06&showdescription=no}{J01MA24}), bekanamycin (\code{BEK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB13&showdescription=no}{J01MA07}), benzathine benzylpenicillin (\code{BNB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE08&showdescription=no}{J01MA14}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE10&showdescription=no}{D10AF05}), benzylpenicillin (\code{PEN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE01&showdescription=no}{J01MA06}), besifloxacin (\code{BES}, \href{https://www.whocc.no/atc_ddd_index/?code=S01AE08&showdescription=no}{J01MA01}), biapenem (\code{BIA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH05&showdescription=no}{J01MA18}), carbenicillin (\code{CRB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA03&showdescription=no}{J01MA03}), carindacillin (\code{CRN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA05&showdescription=no}{J01MA17}), cefacetrile (\code{CAC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB10&showdescription=no}{J01MA10}), cefaclor (\code{CEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC04&showdescription=no}{J01MA21}), cefadroxil (\code{CFR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB05&showdescription=no}{J01MA09}), cefalexin (\code{LEX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB01&showdescription=no}{J01MA05}), cefaloridine (\code{RID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB02&showdescription=no}{P01AA05}), cefalotin (\code{CEP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB03&showdescription=no}{J01MA22}), cefamandole (\code{MAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC03&showdescription=no}{J01MA13}), cefapirin (\code{HAP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB08&showdescription=no}{J01CA01}), cefatrizine (\code{CTZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB07&showdescription=no}{J01CA04}), cefazedone (\code{CZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB06&showdescription=no}{J01CA12}), cefazolin (\code{CZO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB04&showdescription=no}{J01CR05}), cefcapene (\code{CCP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD17&showdescription=no}{J01CA13}), cefdinir (\code{CDR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD15&showdescription=no}{J01AA02}), cefditoren (\code{DIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD16&showdescription=no}{J01FA10}), cefepime (\code{FEP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE01&showdescription=no}{J01FA09}), cefetamet (\code{CAT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD10&showdescription=no}{J01CR02}), cefixime (\code{CFM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD08&showdescription=no}{J01AA08}), cefmenoxime (\code{CMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD05&showdescription=no}{J01FA06}), cefmetazole (\code{CMZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC09&showdescription=no}{J01CF04}), cefodizime (\code{DIZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD09&showdescription=no}{J01CF05}), cefonicid (\code{CID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC06&showdescription=no}{J01CR01}), cefoperazone (\code{CFP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD12&showdescription=no}{J01CA19}), cefoperazone/sulbactam (\code{CSL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD62&showdescription=no}{J01CE04}), ceforanide (\code{CND}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC11&showdescription=no}{J01CA09}), cefotaxime (\code{CTX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD01&showdescription=no}{J01DF01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD51&showdescription=no}{J01CA06}), cefotetan (\code{CTT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC05&showdescription=no}{J01CE08}), cefotiam (\code{CTF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC07&showdescription=no}{J01CE10}), cefoxitin (\code{FOX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC01&showdescription=no}{J01CE01}), cefozopran (\code{ZOP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE03&showdescription=no}{J01CA03}), cefpiramide (\code{CPM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD11&showdescription=no}{J01CA05}), cefpirome (\code{CPO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE02&showdescription=no}{J01CE07}), cefpodoxime (\code{CPD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD13&showdescription=no}{J01CF02}), cefprozil (\code{CPR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC10&showdescription=no}{J01CF01}), cefroxadine (\code{CRD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB11&showdescription=no}{J01CA07}), cefsulodin (\code{CFS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD03&showdescription=no}{J01CA18}), ceftaroline (\code{CPT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI02&showdescription=no}{J01CA11}), ceftazidime (\code{CAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD02&showdescription=no}{J01CA14}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD52&showdescription=no}{J01CF03}), cefteram (\code{CEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD18&showdescription=no}{J01CA10}), ceftezole (\code{CTL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB12&showdescription=no}{J01CF06}), ceftibuten (\code{CTB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD14&showdescription=no}{J01CE06}), ceftizoxime (\code{CZX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD07&showdescription=no}{J01CE05}), ceftobiprole medocaril (\code{CFM1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI01&showdescription=no}{J01CE02}), ceftolozane/tazobactam (\code{CZT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI54&showdescription=no}{J01CA02}), ceftriaxone (\code{CRO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD04&showdescription=no}{J01CA08}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD63&showdescription=no}{J01CE09}), cefuroxime (\code{CXM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC02&showdescription=no}{J01CE03}), cephradine (\code{CED}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB09&showdescription=no}{J01CG01}), chloramphenicol (\code{CHL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01BA01&showdescription=no}{J01CA16}), ciprofloxacin (\code{CIP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA02&showdescription=no}{J01CR04}), clarithromycin (\code{CLR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA09&showdescription=no}{J01CA15}), clindamycin (\code{CLI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FF01&showdescription=no}{J01CG02}), clometocillin (\code{CLM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE07&showdescription=no}{J01CA17}), cloxacillin (\code{CLO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF02&showdescription=no}{J01CR03}), colistin (\code{COL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XB01&showdescription=no}{J01DB10}), cycloserine (\code{CYC}, \href{https://www.whocc.no/atc_ddd_index/?code=J04AB01&showdescription=no}{J01DC04}), dalbavancin (\code{DAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA04&showdescription=no}{J01DB05}), daptomycin (\code{DAP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX09&showdescription=no}{J01DB01}), delafloxacin (\code{DFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA23&showdescription=no}{J01DB02}), dibekacin (\code{DKB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB09&showdescription=no}{J01DB03}), dicloxacillin (\code{DIC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF01&showdescription=no}{J01DC03}), dirithromycin (\code{DIR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA13&showdescription=no}{J01DB08}), doripenem (\code{DOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH04&showdescription=no}{J01DB07}), doxycycline (\code{DOX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA02&showdescription=no}{J01DB06}), enoxacin (\code{ENX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA04&showdescription=no}{J01DB04}), epicillin (\code{EPC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA07&showdescription=no}{J01DD17}), ertapenem (\code{ETP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH03&showdescription=no}{J01DD15}), erythromycin (\code{ERY}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA01&showdescription=no}{J01DD16}), fleroxacin (\code{FLE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA08&showdescription=no}{J01DE01}), flucloxacillin (\code{FLC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF05&showdescription=no}{J01DD10}), flurithromycin (\code{FLR1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA14&showdescription=no}{J01DD08}), fosfomycin (\code{FOS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX01&showdescription=no}{J01DD05}), framycetin (\code{FRM}, \href{https://www.whocc.no/atc_ddd_index/?code=D09AA01&showdescription=no}{J01DC09}), fusidic acid (\code{FUS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XC01&showdescription=no}{J01DD09}), garenoxacin (\code{GRN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA19&showdescription=no}{J01DC06}), gatifloxacin (\code{GAT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA16&showdescription=no}{J01DD12}), gemifloxacin (\code{GEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA15&showdescription=no}{J01DD62}), gentamicin (\code{GEN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB03&showdescription=no}{J01DC11}), grepafloxacin (\code{GRX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA11&showdescription=no}{J01DD01}), hetacillin (\code{HET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA18&showdescription=no}{J01DD51}), imipenem (\code{IPM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH51&showdescription=no}{J01DC05}), imipenem/relebactam (\code{IMR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH56&showdescription=no}{J01DC07}), isepamicin (\code{ISE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB11&showdescription=no}{J01DC01}), josamycin (\code{JOS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA07&showdescription=no}{J01DE03}), kanamycin (\code{KAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB04&showdescription=no}{J01DD11}), lascufloxacin (\code{LSC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA25&showdescription=no}{J01DE02}), latamoxef (\code{LTM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD06&showdescription=no}{J01DD13}), levofloxacin (\code{LVX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA12&showdescription=no}{J01DC10}), levonadifloxacin (\code{LND}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA24&showdescription=no}{J01DB11}), lincomycin (\code{LIN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FF02&showdescription=no}{J01DD03}), linezolid (\code{LNZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX08&showdescription=no}{J01DI02}), lomefloxacin (\code{LOM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA07&showdescription=no}{J01DD02}), loracarbef (\code{LOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC08&showdescription=no}{J01DD52}), mecillinam (\code{MEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA11&showdescription=no}{J01DD18}), meropenem (\code{MEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH02&showdescription=no}{J01DB12}), meropenem/vaborbactam (\code{MEV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH52&showdescription=no}{J01DD14}), metampicillin (\code{MTM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA14&showdescription=no}{J01DD07}), meticillin (\code{MET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF03&showdescription=no}{J01DI01}), mezlocillin (\code{MEZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA10&showdescription=no}{J01DI54}), micronomicin (\code{MCR}, \href{https://www.whocc.no/atc_ddd_index/?code=S01AA22&showdescription=no}{J01DD04}), midecamycin (\code{MID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA03&showdescription=no}{J01DD63}), minocycline (\code{MNO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA08&showdescription=no}{J01DC02}), miocamycin (\code{MCM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA11&showdescription=no}{J01DB09}), moxifloxacin (\code{MFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA14&showdescription=no}{J01DD06}), nadifloxacin (\code{NAD}, \href{https://www.whocc.no/atc_ddd_index/?code=D10AF05&showdescription=no}{J01DC08}), nafcillin (\code{NAF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF06&showdescription=no}{J01DH05}), nalidixic acid (\code{NAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MB02&showdescription=no}{J01DH04}), neomycin (\code{NEO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB05&showdescription=no}{J01DH03}), netilmicin (\code{NET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB07&showdescription=no}{J01DH51}), nitrofurantoin (\code{NIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XE01&showdescription=no}{J01DH56}), norfloxacin (\code{NOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA06&showdescription=no}{J01DH02}), ofloxacin (\code{OFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA01&showdescription=no}{J01DH52}), oleandomycin (\code{OLE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA05&showdescription=no}{J01DH55}), oritavancin (\code{ORI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA05&showdescription=no}{J01DH06}), oxacillin (\code{OXA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF04&showdescription=no}{J01XA02}), panipenem (\code{PAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH55&showdescription=no}{J01XA01}), pazufloxacin (\code{PAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA18&showdescription=no}{J01XC01}), pefloxacin (\code{PEF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA03&showdescription=no}{J01FA13}), penamecillin (\code{PNM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE06&showdescription=no}{J01FA01}), pheneticillin (\code{PHE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE05&showdescription=no}{J01FA14}), phenoxymethylpenicillin (\code{PHN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE02&showdescription=no}{J01FA07}), piperacillin (\code{PIP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA12&showdescription=no}{J01FA03}), piperacillin/tazobactam (\code{TZP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR05&showdescription=no}{J01FA11}), pivampicillin (\code{PVM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA02&showdescription=no}{J01FA05}), pivmecillinam (\code{PME}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA08&showdescription=no}{J01FA12}), plazomicin (\code{PLZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB14&showdescription=no}{J01FA16}), polymyxin B (\code{PLB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XB02&showdescription=no}{J01FA02}), pristinamycin (\code{PRI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FG01&showdescription=no}{J01FA15}), procaine benzylpenicillin (\code{PRB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE09&showdescription=no}{J01FA08}), propicillin (\code{PRP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE03&showdescription=no}{J01FF02}), prulifloxacin (\code{PRU}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA17&showdescription=no}{J01FG01}), quinupristin/dalfopristin (\code{QDA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FG02&showdescription=no}{J01FG02}), ribostamycin (\code{RST}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB10&showdescription=no}{J04AB02}), rifampicin (\code{RIF}, \href{https://www.whocc.no/atc_ddd_index/?code=J04AB02&showdescription=no}{J01XX09}), rokitamycin (\code{ROK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA12&showdescription=no}{J01XX08}), roxithromycin (\code{RXT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA06&showdescription=no}{J01AA07}), rufloxacin (\code{RFL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA10&showdescription=no}{J01XB01}), sisomicin (\code{SIS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB08&showdescription=no}{J01XB02}), sitafloxacin (\code{SIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA21&showdescription=no}{J01XE01}), solithromycin (\code{SOL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA16&showdescription=no}{J01AA12}), sparfloxacin (\code{SPX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA09&showdescription=no}{J01EA01}), spiramycin (\code{SPI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA02&showdescription=no}{J01XX01}), streptoduocin (\code{STR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GA02&showdescription=no}{J01BA01}), streptomycin (\code{STR1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GA01&showdescription=no}{J01GB06}), sulbactam (\code{SUL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CG01&showdescription=no}{J01GB12}), sulbenicillin (\code{SBC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA16&showdescription=no}{J01GB13}), sulfadiazine (\code{SDI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC02&showdescription=no}{J01GB09}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE02&showdescription=no}{D09AA01}), sulfadimethoxine (\code{SUD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED01&showdescription=no}{J01GB03}), sulfadimidine (\code{SDM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB03&showdescription=no}{J01GB11}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE05&showdescription=no}{J01GB04}), sulfafurazole (\code{SLF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB05&showdescription=no}{S01AA22}), sulfaisodimidine (\code{SLF1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB01&showdescription=no}{J01GB05}), sulfalene (\code{SLF2}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED02&showdescription=no}{J01GB07}), sulfamazone (\code{SZO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED09&showdescription=no}{J01GB14}), sulfamerazine (\code{SLF3}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED07&showdescription=no}{J01GB10}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE07&showdescription=no}{J01GB08}), sulfamethizole (\code{SLF4}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB02&showdescription=no}{J01GA02}), sulfamethoxazole (\code{SMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC01&showdescription=no}{J01GA01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED05&showdescription=no}{J01GB01}), sulfametomidine (\code{SLF6}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED03&showdescription=no}{J01EE01}), sulfametoxydiazine (\code{SLF7}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED04&showdescription=no}{J01MB02}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE03&showdescription=no}{J01FF01}), sulfamoxole (\code{SLF8}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC03&showdescription=no}{J01XA04}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE04&showdescription=no}{J01XA05}), sulfanilamide (\code{SLF9}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB06&showdescription=no}{J01XA03}), sulfaperin (\code{SLF10}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED06&showdescription=no}{J04AB01}), sulfaphenazole (\code{SLF11}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED08&showdescription=no}{J01XX11}), sulfapyridine (\code{SLF12}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB04&showdescription=no}{J01EC02}), sulfathiazole (\code{SUT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB07&showdescription=no}{J01ED01}), sulfathiourea (\code{SLF13}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB08&showdescription=no}{J01EB03}), sultamicillin (\code{SLT6}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR04&showdescription=no}{J01EB05}), talampicillin (\code{TAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA15&showdescription=no}{J01EB01}), tazobactam (\code{TAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CG02&showdescription=no}{J01ED02}), tebipenem (\code{TBP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH06&showdescription=no}{J01ED09}), tedizolid (\code{TZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX11&showdescription=no}{J01ED07}), teicoplanin (\code{TEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA02&showdescription=no}{J01EB02}), telavancin (\code{TLV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA03&showdescription=no}{J01EC01}), telithromycin (\code{TLT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA15&showdescription=no}{J01ED05}), temafloxacin (\code{TMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA05&showdescription=no}{J01ED03}), temocillin (\code{TEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA17&showdescription=no}{J01ED04}), tetracycline (\code{TCY}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA07&showdescription=no}{J01EC03}), ticarcillin (\code{TIC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA13&showdescription=no}{J01EB06}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR03&showdescription=no}{J01ED06}), tigecycline (\code{TGC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA12&showdescription=no}{J01ED08}), tilbroquinol (\code{TBQ}, \href{https://www.whocc.no/atc_ddd_index/?code=P01AA05&showdescription=no}{J01EB04}), tobramycin (\code{TOB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB01&showdescription=no}{J01EB07}), tosufloxacin (\code{TFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA22&showdescription=no}{J01EB08}), trimethoprim (\code{TMP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EA01&showdescription=no}{J01EE02}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE01&showdescription=no}{J01EE05}), troleandomycin (\code{TRL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA08&showdescription=no}{J01EE07}), trovafloxacin (\code{TVA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA13&showdescription=no}{J01EE03}), vancomycin (\code{VAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA01&showdescription=no}{J01EE04}) +Amikacin (\code{AMK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR01&showdescription=no}{J01CR01}), arbekacin (\code{ARB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://www.whocc.no/atc_ddd_index/?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH05&showdescription=no}{J01DH05}), carbenicillin (\code{CRB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA05&showdescription=no}{J01CA05}), cefacetrile (\code{CAC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE01&showdescription=no}{J01DE01}), cefetamet (\code{CAT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD10&showdescription=no}{J01DD10}), cefixime (\code{CFM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC07&showdescription=no}{J01DC07}), cefoxitin (\code{FOX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC10&showdescription=no}{J01DC10}), cefroxadine (\code{CRD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD14&showdescription=no}{J01DD14}), ceftizoxime (\code{CZX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01BA01&showdescription=no}{J01BA01}), ciprofloxacin (\code{CIP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA02&showdescription=no}{J01MA02}), clarithromycin (\code{CLR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE07&showdescription=no}{J01CE07}), cloxacillin (\code{CLO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://www.whocc.no/atc_ddd_index/?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA04&showdescription=no}{J01XA04}), daptomycin (\code{DAP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA23&showdescription=no}{J01MA23}), dibekacin (\code{DKB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF01&showdescription=no}{J01CF01}), dirithromycin (\code{DIR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA04&showdescription=no}{J01MA04}), epicillin (\code{EPC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA07&showdescription=no}{J01CA07}), ertapenem (\code{ETP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://www.whocc.no/atc_ddd_index/?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XC01&showdescription=no}{J01XC01}), garenoxacin (\code{GRN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB04&showdescription=no}{J01GB04}), lascufloxacin (\code{LSC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA12&showdescription=no}{J01MA12}), levonadifloxacin (\code{LND}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC08&showdescription=no}{J01DC08}), mecillinam (\code{MEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH52&showdescription=no}{J01DH52}), metampicillin (\code{MTM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://www.whocc.no/atc_ddd_index/?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://www.whocc.no/atc_ddd_index/?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MB02&showdescription=no}{J01MB02}), neomycin (\code{NEO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XE01&showdescription=no}{J01XE01}), norfloxacin (\code{NOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA06&showdescription=no}{J01MA06}), ofloxacin (\code{OFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA01&showdescription=no}{J01MA01}), oleandomycin (\code{OLE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA05&showdescription=no}{J01FA05}), oritavancin (\code{ORI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF04&showdescription=no}{J01CF04}), panipenem (\code{PAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE06&showdescription=no}{J01CE06}), pheneticillin (\code{PHE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR05&showdescription=no}{J01CR05}), pivampicillin (\code{PVM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XB02&showdescription=no}{J01XB02}), pristinamycin (\code{PRI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FG02&showdescription=no}{J01FG02}), ribostamycin (\code{RST}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://www.whocc.no/atc_ddd_index/?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA12&showdescription=no}{J01FA12}), roxithromycin (\code{RXT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA10&showdescription=no}{J01MA10}), sisomicin (\code{SIS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GA01&showdescription=no}{J01GA01}), sulbactam (\code{SUL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CG01&showdescription=no}{J01CG01}), sulbenicillin (\code{SBC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA15&showdescription=no}{J01CA15}), tazobactam (\code{TAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CG02&showdescription=no}{J01CG02}), tebipenem (\code{TBP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://www.whocc.no/atc_ddd_index/?code=P01AA05&showdescription=no}{P01AA05}), tobramycin (\code{TOB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA13&showdescription=no}{J01MA13}), vancomycin (\code{VAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA01&showdescription=no}{J01XA01}) } \section{Reference Data Publicly Available}{ diff --git a/man/like.Rd b/man/like.Rd index ebcd5093..76ba8a99 100644 --- a/man/like.Rd +++ b/man/like.Rd @@ -46,8 +46,8 @@ These \code{\link[=like]{like()}} and \verb{\%like\%}/\verb{\%unlike\%} function Using RStudio? The \verb{\%like\%}/\verb{\%unlike\%} functions can also be directly inserted in your code from the Addins menu and can have its own keyboard shortcut like \code{Shift+Ctrl+L} or \code{Shift+Cmd+L} (see menu \code{Tools} > \verb{Modify Keyboard Shortcuts...}). If you keep pressing your shortcut, the inserted text will be iterated over \verb{\%like\%} -> \verb{\%unlike\%} -> \verb{\%like_case\%} -> \verb{\%unlike_case\%}. } \examples{ -# data.table has a more limited version of \%like\%, so: -detach("package:data.table", unload = TRUE) +# data.table has a more limited version of \%like\%, so unload it: +try(detach("package:data.table", unload = TRUE), silent = TRUE) a <- "This is a test" b <- "TEST" diff --git a/man/mdro.Rd b/man/mdro.Rd index 60aebfab..cb957cdd 100644 --- a/man/mdro.Rd +++ b/man/mdro.Rd @@ -169,7 +169,7 @@ To define antibiotics column names, leave as it is to determine it automatically The following antibiotics are eligible for the functions \code{\link[=eucast_rules]{eucast_rules()}} and \code{\link[=mdro]{mdro()}}. These are shown below in the format 'name (\verb{antimicrobial ID}, \href{https://www.whocc.no/atc/structure_and_principles/}{ATC code})', sorted alphabetically: -Amikacin (\code{AMK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB06&showdescription=no}{S01AE08}), amoxicillin (\code{AMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA04&showdescription=no}{J01MA02}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR02&showdescription=no}{J01MA23}), ampicillin (\code{AMP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA01&showdescription=no}{J01MA04}), ampicillin/sulbactam (\code{SAM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR01&showdescription=no}{J01MA08}), arbekacin (\code{ARB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB12&showdescription=no}{J01MA19}), aspoxicillin (\code{APX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA19&showdescription=no}{J01MA16}), azidocillin (\code{AZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE04&showdescription=no}{J01MA15}), azithromycin (\code{AZM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA10&showdescription=no}{J01MA11}), azlocillin (\code{AZL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA09&showdescription=no}{J01MA25}), aztreonam (\code{ATM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DF01&showdescription=no}{J01MA12}), bacampicillin (\code{BAM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA06&showdescription=no}{J01MA24}), bekanamycin (\code{BEK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB13&showdescription=no}{J01MA07}), benzathine benzylpenicillin (\code{BNB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE08&showdescription=no}{J01MA14}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE10&showdescription=no}{D10AF05}), benzylpenicillin (\code{PEN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE01&showdescription=no}{J01MA06}), besifloxacin (\code{BES}, \href{https://www.whocc.no/atc_ddd_index/?code=S01AE08&showdescription=no}{J01MA01}), biapenem (\code{BIA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH05&showdescription=no}{J01MA18}), carbenicillin (\code{CRB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA03&showdescription=no}{J01MA03}), carindacillin (\code{CRN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA05&showdescription=no}{J01MA17}), cefacetrile (\code{CAC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB10&showdescription=no}{J01MA10}), cefaclor (\code{CEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC04&showdescription=no}{J01MA21}), cefadroxil (\code{CFR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB05&showdescription=no}{J01MA09}), cefalexin (\code{LEX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB01&showdescription=no}{J01MA05}), cefaloridine (\code{RID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB02&showdescription=no}{P01AA05}), cefalotin (\code{CEP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB03&showdescription=no}{J01MA22}), cefamandole (\code{MAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC03&showdescription=no}{J01MA13}), cefapirin (\code{HAP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB08&showdescription=no}{J01CA01}), cefatrizine (\code{CTZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB07&showdescription=no}{J01CA04}), cefazedone (\code{CZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB06&showdescription=no}{J01CA12}), cefazolin (\code{CZO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB04&showdescription=no}{J01CR05}), cefcapene (\code{CCP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD17&showdescription=no}{J01CA13}), cefdinir (\code{CDR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD15&showdescription=no}{J01AA02}), cefditoren (\code{DIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD16&showdescription=no}{J01FA10}), cefepime (\code{FEP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE01&showdescription=no}{J01FA09}), cefetamet (\code{CAT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD10&showdescription=no}{J01CR02}), cefixime (\code{CFM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD08&showdescription=no}{J01AA08}), cefmenoxime (\code{CMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD05&showdescription=no}{J01FA06}), cefmetazole (\code{CMZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC09&showdescription=no}{J01CF04}), cefodizime (\code{DIZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD09&showdescription=no}{J01CF05}), cefonicid (\code{CID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC06&showdescription=no}{J01CR01}), cefoperazone (\code{CFP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD12&showdescription=no}{J01CA19}), cefoperazone/sulbactam (\code{CSL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD62&showdescription=no}{J01CE04}), ceforanide (\code{CND}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC11&showdescription=no}{J01CA09}), cefotaxime (\code{CTX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD01&showdescription=no}{J01DF01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD51&showdescription=no}{J01CA06}), cefotetan (\code{CTT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC05&showdescription=no}{J01CE08}), cefotiam (\code{CTF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC07&showdescription=no}{J01CE10}), cefoxitin (\code{FOX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC01&showdescription=no}{J01CE01}), cefozopran (\code{ZOP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE03&showdescription=no}{J01CA03}), cefpiramide (\code{CPM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD11&showdescription=no}{J01CA05}), cefpirome (\code{CPO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE02&showdescription=no}{J01CE07}), cefpodoxime (\code{CPD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD13&showdescription=no}{J01CF02}), cefprozil (\code{CPR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC10&showdescription=no}{J01CF01}), cefroxadine (\code{CRD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB11&showdescription=no}{J01CA07}), cefsulodin (\code{CFS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD03&showdescription=no}{J01CA18}), ceftaroline (\code{CPT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI02&showdescription=no}{J01CA11}), ceftazidime (\code{CAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD02&showdescription=no}{J01CA14}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD52&showdescription=no}{J01CF03}), cefteram (\code{CEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD18&showdescription=no}{J01CA10}), ceftezole (\code{CTL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB12&showdescription=no}{J01CF06}), ceftibuten (\code{CTB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD14&showdescription=no}{J01CE06}), ceftizoxime (\code{CZX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD07&showdescription=no}{J01CE05}), ceftobiprole medocaril (\code{CFM1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI01&showdescription=no}{J01CE02}), ceftolozane/tazobactam (\code{CZT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI54&showdescription=no}{J01CA02}), ceftriaxone (\code{CRO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD04&showdescription=no}{J01CA08}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD63&showdescription=no}{J01CE09}), cefuroxime (\code{CXM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC02&showdescription=no}{J01CE03}), cephradine (\code{CED}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB09&showdescription=no}{J01CG01}), chloramphenicol (\code{CHL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01BA01&showdescription=no}{J01CA16}), ciprofloxacin (\code{CIP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA02&showdescription=no}{J01CR04}), clarithromycin (\code{CLR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA09&showdescription=no}{J01CA15}), clindamycin (\code{CLI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FF01&showdescription=no}{J01CG02}), clometocillin (\code{CLM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE07&showdescription=no}{J01CA17}), cloxacillin (\code{CLO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF02&showdescription=no}{J01CR03}), colistin (\code{COL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XB01&showdescription=no}{J01DB10}), cycloserine (\code{CYC}, \href{https://www.whocc.no/atc_ddd_index/?code=J04AB01&showdescription=no}{J01DC04}), dalbavancin (\code{DAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA04&showdescription=no}{J01DB05}), daptomycin (\code{DAP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX09&showdescription=no}{J01DB01}), delafloxacin (\code{DFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA23&showdescription=no}{J01DB02}), dibekacin (\code{DKB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB09&showdescription=no}{J01DB03}), dicloxacillin (\code{DIC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF01&showdescription=no}{J01DC03}), dirithromycin (\code{DIR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA13&showdescription=no}{J01DB08}), doripenem (\code{DOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH04&showdescription=no}{J01DB07}), doxycycline (\code{DOX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA02&showdescription=no}{J01DB06}), enoxacin (\code{ENX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA04&showdescription=no}{J01DB04}), epicillin (\code{EPC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA07&showdescription=no}{J01DD17}), ertapenem (\code{ETP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH03&showdescription=no}{J01DD15}), erythromycin (\code{ERY}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA01&showdescription=no}{J01DD16}), fleroxacin (\code{FLE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA08&showdescription=no}{J01DE01}), flucloxacillin (\code{FLC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF05&showdescription=no}{J01DD10}), flurithromycin (\code{FLR1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA14&showdescription=no}{J01DD08}), fosfomycin (\code{FOS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX01&showdescription=no}{J01DD05}), framycetin (\code{FRM}, \href{https://www.whocc.no/atc_ddd_index/?code=D09AA01&showdescription=no}{J01DC09}), fusidic acid (\code{FUS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XC01&showdescription=no}{J01DD09}), garenoxacin (\code{GRN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA19&showdescription=no}{J01DC06}), gatifloxacin (\code{GAT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA16&showdescription=no}{J01DD12}), gemifloxacin (\code{GEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA15&showdescription=no}{J01DD62}), gentamicin (\code{GEN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB03&showdescription=no}{J01DC11}), grepafloxacin (\code{GRX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA11&showdescription=no}{J01DD01}), hetacillin (\code{HET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA18&showdescription=no}{J01DD51}), imipenem (\code{IPM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH51&showdescription=no}{J01DC05}), imipenem/relebactam (\code{IMR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH56&showdescription=no}{J01DC07}), isepamicin (\code{ISE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB11&showdescription=no}{J01DC01}), josamycin (\code{JOS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA07&showdescription=no}{J01DE03}), kanamycin (\code{KAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB04&showdescription=no}{J01DD11}), lascufloxacin (\code{LSC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA25&showdescription=no}{J01DE02}), latamoxef (\code{LTM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD06&showdescription=no}{J01DD13}), levofloxacin (\code{LVX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA12&showdescription=no}{J01DC10}), levonadifloxacin (\code{LND}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA24&showdescription=no}{J01DB11}), lincomycin (\code{LIN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FF02&showdescription=no}{J01DD03}), linezolid (\code{LNZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX08&showdescription=no}{J01DI02}), lomefloxacin (\code{LOM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA07&showdescription=no}{J01DD02}), loracarbef (\code{LOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC08&showdescription=no}{J01DD52}), mecillinam (\code{MEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA11&showdescription=no}{J01DD18}), meropenem (\code{MEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH02&showdescription=no}{J01DB12}), meropenem/vaborbactam (\code{MEV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH52&showdescription=no}{J01DD14}), metampicillin (\code{MTM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA14&showdescription=no}{J01DD07}), meticillin (\code{MET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF03&showdescription=no}{J01DI01}), mezlocillin (\code{MEZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA10&showdescription=no}{J01DI54}), micronomicin (\code{MCR}, \href{https://www.whocc.no/atc_ddd_index/?code=S01AA22&showdescription=no}{J01DD04}), midecamycin (\code{MID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA03&showdescription=no}{J01DD63}), minocycline (\code{MNO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA08&showdescription=no}{J01DC02}), miocamycin (\code{MCM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA11&showdescription=no}{J01DB09}), moxifloxacin (\code{MFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA14&showdescription=no}{J01DD06}), nadifloxacin (\code{NAD}, \href{https://www.whocc.no/atc_ddd_index/?code=D10AF05&showdescription=no}{J01DC08}), nafcillin (\code{NAF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF06&showdescription=no}{J01DH05}), nalidixic acid (\code{NAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MB02&showdescription=no}{J01DH04}), neomycin (\code{NEO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB05&showdescription=no}{J01DH03}), netilmicin (\code{NET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB07&showdescription=no}{J01DH51}), nitrofurantoin (\code{NIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XE01&showdescription=no}{J01DH56}), norfloxacin (\code{NOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA06&showdescription=no}{J01DH02}), ofloxacin (\code{OFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA01&showdescription=no}{J01DH52}), oleandomycin (\code{OLE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA05&showdescription=no}{J01DH55}), oritavancin (\code{ORI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA05&showdescription=no}{J01DH06}), oxacillin (\code{OXA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF04&showdescription=no}{J01XA02}), panipenem (\code{PAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH55&showdescription=no}{J01XA01}), pazufloxacin (\code{PAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA18&showdescription=no}{J01XC01}), pefloxacin (\code{PEF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA03&showdescription=no}{J01FA13}), penamecillin (\code{PNM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE06&showdescription=no}{J01FA01}), pheneticillin (\code{PHE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE05&showdescription=no}{J01FA14}), phenoxymethylpenicillin (\code{PHN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE02&showdescription=no}{J01FA07}), piperacillin (\code{PIP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA12&showdescription=no}{J01FA03}), piperacillin/tazobactam (\code{TZP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR05&showdescription=no}{J01FA11}), pivampicillin (\code{PVM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA02&showdescription=no}{J01FA05}), pivmecillinam (\code{PME}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA08&showdescription=no}{J01FA12}), plazomicin (\code{PLZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB14&showdescription=no}{J01FA16}), polymyxin B (\code{PLB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XB02&showdescription=no}{J01FA02}), pristinamycin (\code{PRI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FG01&showdescription=no}{J01FA15}), procaine benzylpenicillin (\code{PRB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE09&showdescription=no}{J01FA08}), propicillin (\code{PRP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE03&showdescription=no}{J01FF02}), prulifloxacin (\code{PRU}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA17&showdescription=no}{J01FG01}), quinupristin/dalfopristin (\code{QDA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FG02&showdescription=no}{J01FG02}), ribostamycin (\code{RST}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB10&showdescription=no}{J04AB02}), rifampicin (\code{RIF}, \href{https://www.whocc.no/atc_ddd_index/?code=J04AB02&showdescription=no}{J01XX09}), rokitamycin (\code{ROK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA12&showdescription=no}{J01XX08}), roxithromycin (\code{RXT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA06&showdescription=no}{J01AA07}), rufloxacin (\code{RFL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA10&showdescription=no}{J01XB01}), sisomicin (\code{SIS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB08&showdescription=no}{J01XB02}), sitafloxacin (\code{SIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA21&showdescription=no}{J01XE01}), solithromycin (\code{SOL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA16&showdescription=no}{J01AA12}), sparfloxacin (\code{SPX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA09&showdescription=no}{J01EA01}), spiramycin (\code{SPI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA02&showdescription=no}{J01XX01}), streptoduocin (\code{STR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GA02&showdescription=no}{J01BA01}), streptomycin (\code{STR1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GA01&showdescription=no}{J01GB06}), sulbactam (\code{SUL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CG01&showdescription=no}{J01GB12}), sulbenicillin (\code{SBC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA16&showdescription=no}{J01GB13}), sulfadiazine (\code{SDI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC02&showdescription=no}{J01GB09}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE02&showdescription=no}{D09AA01}), sulfadimethoxine (\code{SUD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED01&showdescription=no}{J01GB03}), sulfadimidine (\code{SDM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB03&showdescription=no}{J01GB11}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE05&showdescription=no}{J01GB04}), sulfafurazole (\code{SLF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB05&showdescription=no}{S01AA22}), sulfaisodimidine (\code{SLF1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB01&showdescription=no}{J01GB05}), sulfalene (\code{SLF2}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED02&showdescription=no}{J01GB07}), sulfamazone (\code{SZO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED09&showdescription=no}{J01GB14}), sulfamerazine (\code{SLF3}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED07&showdescription=no}{J01GB10}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE07&showdescription=no}{J01GB08}), sulfamethizole (\code{SLF4}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB02&showdescription=no}{J01GA02}), sulfamethoxazole (\code{SMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC01&showdescription=no}{J01GA01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED05&showdescription=no}{J01GB01}), sulfametomidine (\code{SLF6}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED03&showdescription=no}{J01EE01}), sulfametoxydiazine (\code{SLF7}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED04&showdescription=no}{J01MB02}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE03&showdescription=no}{J01FF01}), sulfamoxole (\code{SLF8}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC03&showdescription=no}{J01XA04}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE04&showdescription=no}{J01XA05}), sulfanilamide (\code{SLF9}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB06&showdescription=no}{J01XA03}), sulfaperin (\code{SLF10}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED06&showdescription=no}{J04AB01}), sulfaphenazole (\code{SLF11}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED08&showdescription=no}{J01XX11}), sulfapyridine (\code{SLF12}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB04&showdescription=no}{J01EC02}), sulfathiazole (\code{SUT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB07&showdescription=no}{J01ED01}), sulfathiourea (\code{SLF13}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB08&showdescription=no}{J01EB03}), sultamicillin (\code{SLT6}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR04&showdescription=no}{J01EB05}), talampicillin (\code{TAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA15&showdescription=no}{J01EB01}), tazobactam (\code{TAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CG02&showdescription=no}{J01ED02}), tebipenem (\code{TBP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH06&showdescription=no}{J01ED09}), tedizolid (\code{TZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX11&showdescription=no}{J01ED07}), teicoplanin (\code{TEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA02&showdescription=no}{J01EB02}), telavancin (\code{TLV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA03&showdescription=no}{J01EC01}), telithromycin (\code{TLT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA15&showdescription=no}{J01ED05}), temafloxacin (\code{TMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA05&showdescription=no}{J01ED03}), temocillin (\code{TEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA17&showdescription=no}{J01ED04}), tetracycline (\code{TCY}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA07&showdescription=no}{J01EC03}), ticarcillin (\code{TIC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA13&showdescription=no}{J01EB06}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR03&showdescription=no}{J01ED06}), tigecycline (\code{TGC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA12&showdescription=no}{J01ED08}), tilbroquinol (\code{TBQ}, \href{https://www.whocc.no/atc_ddd_index/?code=P01AA05&showdescription=no}{J01EB04}), tobramycin (\code{TOB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB01&showdescription=no}{J01EB07}), tosufloxacin (\code{TFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA22&showdescription=no}{J01EB08}), trimethoprim (\code{TMP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EA01&showdescription=no}{J01EE02}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE01&showdescription=no}{J01EE05}), troleandomycin (\code{TRL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA08&showdescription=no}{J01EE07}), trovafloxacin (\code{TVA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA13&showdescription=no}{J01EE03}), vancomycin (\code{VAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA01&showdescription=no}{J01EE04}) +Amikacin (\code{AMK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR01&showdescription=no}{J01CR01}), arbekacin (\code{ARB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://www.whocc.no/atc_ddd_index/?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH05&showdescription=no}{J01DH05}), carbenicillin (\code{CRB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA05&showdescription=no}{J01CA05}), cefacetrile (\code{CAC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE01&showdescription=no}{J01DE01}), cefetamet (\code{CAT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD10&showdescription=no}{J01DD10}), cefixime (\code{CFM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC07&showdescription=no}{J01DC07}), cefoxitin (\code{FOX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC10&showdescription=no}{J01DC10}), cefroxadine (\code{CRD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD14&showdescription=no}{J01DD14}), ceftizoxime (\code{CZX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01BA01&showdescription=no}{J01BA01}), ciprofloxacin (\code{CIP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA02&showdescription=no}{J01MA02}), clarithromycin (\code{CLR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE07&showdescription=no}{J01CE07}), cloxacillin (\code{CLO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://www.whocc.no/atc_ddd_index/?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA04&showdescription=no}{J01XA04}), daptomycin (\code{DAP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA23&showdescription=no}{J01MA23}), dibekacin (\code{DKB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF01&showdescription=no}{J01CF01}), dirithromycin (\code{DIR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA04&showdescription=no}{J01MA04}), epicillin (\code{EPC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA07&showdescription=no}{J01CA07}), ertapenem (\code{ETP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://www.whocc.no/atc_ddd_index/?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XC01&showdescription=no}{J01XC01}), garenoxacin (\code{GRN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB04&showdescription=no}{J01GB04}), lascufloxacin (\code{LSC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA12&showdescription=no}{J01MA12}), levonadifloxacin (\code{LND}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DC08&showdescription=no}{J01DC08}), mecillinam (\code{MEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH52&showdescription=no}{J01DH52}), metampicillin (\code{MTM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://www.whocc.no/atc_ddd_index/?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://www.whocc.no/atc_ddd_index/?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MB02&showdescription=no}{J01MB02}), neomycin (\code{NEO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XE01&showdescription=no}{J01XE01}), norfloxacin (\code{NOR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA06&showdescription=no}{J01MA06}), ofloxacin (\code{OFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA01&showdescription=no}{J01MA01}), oleandomycin (\code{OLE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA05&showdescription=no}{J01FA05}), oritavancin (\code{ORI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CF04&showdescription=no}{J01CF04}), panipenem (\code{PAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE06&showdescription=no}{J01CE06}), pheneticillin (\code{PHE}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR05&showdescription=no}{J01CR05}), pivampicillin (\code{PVM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XB02&showdescription=no}{J01XB02}), pristinamycin (\code{PRI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FG02&showdescription=no}{J01FG02}), ribostamycin (\code{RST}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://www.whocc.no/atc_ddd_index/?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA12&showdescription=no}{J01FA12}), roxithromycin (\code{RXT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA10&showdescription=no}{J01MA10}), sisomicin (\code{SIS}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GA01&showdescription=no}{J01GA01}), sulbactam (\code{SUL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CG01&showdescription=no}{J01CG01}), sulbenicillin (\code{SBC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://www.whocc.no/atc_ddd_index/?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA15&showdescription=no}{J01CA15}), tazobactam (\code{TAZ}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CG02&showdescription=no}{J01CG02}), tebipenem (\code{TBP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://www.whocc.no/atc_ddd_index/?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://www.whocc.no/atc_ddd_index/?code=P01AA05&showdescription=no}{P01AA05}), tobramycin (\code{TOB}, \href{https://www.whocc.no/atc_ddd_index/?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://www.whocc.no/atc_ddd_index/?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://www.whocc.no/atc_ddd_index/?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://www.whocc.no/atc_ddd_index/?code=J01MA13&showdescription=no}{J01MA13}), vancomycin (\code{VAN}, \href{https://www.whocc.no/atc_ddd_index/?code=J01XA01&showdescription=no}{J01XA01}) } \section{Interpretation of SIR}{